Hearings

Assembly Standing Committee on Health

June 30, 2026
  • Mia Bonta

    Legislator

    Good afternoon, and welcome to the Assembly Health Committee's hearing on Tuesday, June 30. Before we begin, I wanna make sure everyone understands our committee procedures to to ensure we maintain order and run a fair and efficient hearing with the goal of hearing as much from the public within the limits of our time. We seek to protect the rights of all who participate in the legislative process so that we can have effective deliberation on the critical issues facing California.

  • Mia Bonta

    Legislator

    The rules of conduct by members of the public include no engaging in conduct that disrupts, disturbs, or otherwise impedes the orderly conduct of this hearing, engaging in personal attacks of members of this committee, authors, staff, or other witnesses, talking or loud noises from the audience, please be aware that violations of these rules may subject you to removal or other enforcement processes. If you're providing witness testimony at this hearing, all witnesses will be testifying in person.

  • Mia Bonta

    Legislator

    Main support and opposition will be allowed two main witnesses for a maximum of two minutes each. As a reminder, primary witnesses in support must be those accompanying the author or who otherwise have registered a support position within with the committee. And the primary witnesses in opposition must have their opposition registered with the committee per the instructions on our website. All other supports and opposition can be stated at the standing mic when called upon to simply state your name, affiliation, and position.

  • Mia Bonta

    Legislator

    All testimony comments are limited to the bills at hand. I would like to note, we have a few interpreters by providing, who are providing American sign language interpretation for those attending today's hearing in support of SB 331 by Menjivar, the let California kids hear act. And I would just pause for a second and ask if the interpreter is in a location where those who need that interpretation are able to see unobstructed.

  • Mia Bonta

    Legislator

    Assuming that they are and do not need to be relocated, as I'm looking out in the public hearing right now, I will continue on. I also ask that everyone in the audience help ensure the interpretation remains visible and accessible by avoiding disruptions, such as blocking the interpreter or obstructing the view of participants who are relying on the interpretation. For consent, the following bills have been proposed for consent today's at today's hearing.

  • Mia Bonta

    Legislator

    Any member of the committee may remove the bill from consent calendar. Item number 14, SB 1447. Author is the Senate Health Committee with a motion of do pass to appropriations. With that, we do have our first, member or Senator who is able to present. We will begin with as a subcommittee with file item one, SB 331 by Menjivar. Whenever you are ready, Senator. Thank you.

  • Caroline Menjivar

    Legislator

    Madam Chair, you know this bill very well. I-- this is my third time trying this bill, and last year, you and I tried together to increase the essential health benefits and we were able to pass those bills but we were roadblocked by the federal government who put a pause on approving them. This is the fourth time the legislature has attempted this coverage, and I think we're almost there.

  • Caroline Menjivar

    Legislator

    Just couple-- just yesterday, the legislature passed and the governor signed the budget that assumes savings--should this bill pass--that assumes saving on shifting the coverage of individuals who need hearing aids away from the department's program--also known as the Hearing Aid Coverage for Children Program--and have the large plans cover this. With the budget assuming those savings, we just need this bill to get passed. We all have been hearing this conversation for the past four years.

  • Caroline Menjivar

    Legislator

    In the state of California, a physician provider will tell you by law that your child was born hard of hearing or deaf, but that's as far as their responsibility goes. It is then on the parent to somehow figure out how to pay every couple years 3 to $6,000 as their baby's ears continue to grow if they want to provide hearing aids for their kids.

  • Caroline Menjivar

    Legislator

    In 2021, the governor vetoed a bill saying that they would implement a program in the department to cover this. However, year after year, we're seeing that we're spending more money on the administration of the program instead of actually providing hearing aids for our kids, which is why for the past three years, we've been trying to rectify that situation and ensure that it's flipped, that we provide the services more than we pay for the administration.

  • Caroline Menjivar

    Legislator

    The Let California Kids Hear campaign has been relentless, has persevered, has traveled here, has been wearing those shirts here in the Capitol year after year, and I wanna commend them for never giving up, for Michelle for never giving up on this, which is why I'm here once again to ensure that we allow--and then some more narrow version of the bill that we've introduced--to have mandated coverage for all health insurance plans, including those in the exchange, which was before and which was in limbo, to now just include the large plans. I will stop there and turn it over to my witnesses who I think does a more beautiful way of explaining why this is so important for our children.

  • Marie Marciniak

    Person

    Hi. My name is Marie, and I've been coming to Sacramento since 1st grade. Some of my fellow advocates here today have been coming here since they were babies and toddlers. Year after year, we've come back asking for the same exact thing, equal access to sound. Although I was born with hearing, I lost some of it after an illness.

  • Marie Marciniak

    Person

    Before my fourth birthday, my preschool teacher told my mom, Marie isn't the same confident little girl who walked into this classroom in September. She's removing herself from circle time and crying. She's losing language skills she once had. Something isn't right. The day I got hearing aids changed my life.

  • Marie Marciniak

    Person

    I danced around the house because I could hear my feet tapping on the floor. I was happy again. My parents carried guilt because, for months, I hadn't fully heard them say, I love you, or the bedtime stories they read to my brother and me. One night, they found themselves at a support group in LA. They were quickly humbled as mom after mom shared devastating financial decisions their families had to make.

  • Marie Marciniak

    Person

    The first three moms quit their jobs so their kids could qualify for Medi-Cal. The fourth said, I've got five kids. Our family isn't going down. He'll go without. Then my mom learned that kids were showing up at centers at age five unable to say their own names because they had never heard them.

  • Marie Marciniak

    Person

    That was the moment our advocacy journey began. I know what access to hearing aids has made possible in my life. Without them, I would not have had the same opportunities as my peers to learn to speak, attend mainstream school, and hear and connect with my peers and families. This bill will help 8,000 children. It'll provide access for 8,000 children's hearing aids.

  • Marie Marciniak

    Person

    While some families choose different ways to communicate, a family's-- a child's access to sound should never be dictated by their family's health plan. One of the first pictures of me in Sacramento was in front of the California For All sign outside of the Governor's Office wearing an oversized turquoise backpack. Vote to let California kids hear and include deaf and hard-of-hearing in California for all. Thank you.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Dylan Chan

    Person

    Thank you so much, Marie. It's such an inspiration to see you here. Thank you so much, Senator. Assembly Member Bonta and Health Committee, thank you so much for this opportunity. My name is Dylan Chan. I'm a Professor of Pediatric Otolaryngology at UC San Francisco. Our team at the children's hospitals in San Francisco and Oakland take care of about 2,000 children who are deaf and hard of hearing every year, and we've published nearly 100 articles on pediatric hearing health access outcomes and disparities.

  • Dylan Chan

    Person

    One thousand children are born in California deaf and hard of hearing every single year. For these children, hearing aids are an absolute medical necessity. There's overwhelming evidence that failure to provide appropriate intervention for deaf and hard-of-hearing children causes permanent speech, language, cognitive, educational, and social-emotional deficits.

  • Dylan Chan

    Person

    Because of this, pediatric hearing loss is considered a developmental emergency where every month without sound confers increased risk for permanent developmental delays. Despite this, only 14% of California children in large group plans have coverage for hearing aids. A pair of hearing aids costs $6,000 every few years. In our clinics, we see hardworking families who delay necessary treatment because they can't afford it or simply go without.

  • Dylan Chan

    Person

    We also see the permanent speech and language delays that happen when these children don't get the hearing aids that they need. These preventable and permanent consequences are not only devastating for the child and the family; they cost society. It's estimated that a child who is deaf or hard of hearing without intervention costs about $1.9 million in special education and lost productivity.

  • Dylan Chan

    Person

    We need to act now. A developmental emergency is unfolding for years and has been unfolding in California for every child who has gone without hearing aids because of inadequate coverage. Thirty-five states already have mandated coverage in large market or exchanges or both. Support of this bill is essential to provide California children equal access to hearing healthcare and enable them to thrive. Thank you so much.

  • Mia Bonta

    Legislator

    Thank you so much. Are there-- press on the mic.

  • Michelle Marciniak

    Person

    Thank you, Marie. I just want to thank you guys. Senator Menjivar, you have stood with us for so long, and we're really grateful and we're really grateful for both of you carrying the application--

  • Mia Bonta

    Legislator

    Thank you.

  • Michelle Marciniak

    Person

    --and for you guys standing with us every year and the legislature being with us every year. And Marie speaks better, so I thought I'd let her do the talking today, but thank you. We're so grateful to be here today.

  • Mia Bonta

    Legislator

    Thank you. Are there others in the hearing room who would like to offer support for this measure?

  • Bryant Miramontes

    Person

    Good afternoon. Bryant Miramontes with the California Teachers Association in support.

  • Olivia Herrera

    Person

    Good afternoon. Olivia Herrera, intern at Stone Advocacy, on behalf of the California Children's Hospital Association, in support. Thank you.

  • Christine Smith

    Person

    Christine Smith, Health Access California, in support.

  • Kasha B Hunt

    Person

    Kasha Hunt with Political Solutions, here on behalf of the American Academy of Pediatrics and the California Children's Specialty Care Coalition, in support.

  • Angela Hill

    Person

    Angela Hill with the California Medical Association, in support.

  • Shamir Washington

    Person

    Shamir Washington with California Care Kids, here in support. Thank you.

  • Alex Levy

    Person

    Alex Levy, parent, here in support and representing my four-year-old who has hearing loss and who benefits from hearing aids, and I can tell you that in addition to all the wonderful--

  • Mia Bonta

    Legislator

    Thank you so much. Just a yes or aye support. Thank you so much.

  • Unidentified Speaker

    Hi. Hi.

  • Mia Bonta

    Legislator

    Hi.

  • Todd Jolly

    Person

    Hi. Todd Jolly representing Sonoma County, my two boys who both benefited greatly from hearing aids, and I support.

  • Samuel Jain

    Person

    Samuel Jain with Disability Rights California. Really appreciate the author's shift on this bill number. Proud support.

  • Nora Angeles

    Person

    Nora Angeles with Children Now, in support, along with the 30 organizations in the analysis.

  • Unidentified Speaker 002

    Hi. My name is Kimmy. I'm a deaf single mother with two deaf and hard-of-hearing children. I've been here since 2019, and I've testified in front of the Senate seven or eight years ago, and it's very important-- it's very important because of language deprivation and the school equal access--

  • Mia Bonta

    Legislator

    Thank you. Just an aye support is sufficient.

  • Mia Bonta

    Legislator

    Thank you.

  • Unidentified Speaker 002

    I support--

  • Unidentified Speaker 002

    --SB 331.

  • Mia Bonta

    Legislator

    Thank you.

  • Unidentified Speaker 003

    Hi. My name is Chloe, and I support Let California Kids Hear.

  • Mia Bonta

    Legislator

    Thank you.

  • Unidentified Speaker 004

    Hi. My name is Sophie. I'm 14 and I'm deaf. I support SB 331. Thank you.

  • Unidentified Speaker 005

    Hi. My name's Avery. I'm hard of hearing, and I think it's time to let California kids hear.

  • Unidentified Speaker 006

    I'm here for my sister, and let California kids hear.

  • Unidentified Speaker 007

    Hi. My name is Caprice. I'm here for my daughter, Avery, and I'm in support of SB 331.

  • Unidentified Speaker 008

    Hi. My name is Vicky, and I'm here as a grandparent, and I support the Let California Kids Hear. Thank you.

  • Robert Schuller

    Person

    Hello. My name is Robert Schuler, grandfather of Avery. Please help. Thank you very much.

  • Unidentified Speaker 009

    Hi. My name is Shelley, and I am Avery's grandma, and I think it's time to let California kids hear.

  • Mia Bonta

    Legislator

    Thank you.

  • Sofia Goldsby

    Person

    Hi. My name is Sofia Goldsby. This is my son, Sebastian Goldsby, who's eight years old, and we support. He's the example of what happens when you don't get access early.

  • Mia Bonta

    Legislator

    Thank you. I think there's a request from the public to continue to sign while--are you--while people are up there. Okay, thank you.

  • Lauren Jolly

    Person

    My name is Lauren Jolly and this is my son, Owen Jolly. Please let California kids hear.

  • Unidentified Speaker 010

    My name is Mateo, and it's time to let California kids hear.

  • Mia Bonta

    Legislator

    Thank you, Mateo.

  • Daniel Cabrera

    Person

    Hello. My name is Daniel Cabrera. I am a teacher, and I support the bill.

  • Unidentified Speaker 011

    Hi. My name is Robin. I'm a hard-of-hearing medical student at Harvard Medical School, and I'm I'm in support of all medical students, and I support this bill.

  • Johanna Wonderly

    Person

    My name is Johanna Wonderly. I'm parent to four hard-of-hearing children, and it's time to let California kids hear.

  • Unidentified Speaker 012

    Hi. My name Carter. I'm hard of hearing. Let California kids hear.

  • Caitlyn Wonderly

    Person

    Hello. My name is Caitlyn. I've been coming here for my ear a lot, and I think that it's now time to let California kids hear.

  • Cassie Wonderly

    Person

    My name is Cassie Wonderly, and let California kids hear.

  • Cara Wonderly

    Person

    My name is Cara Wonderly, and let California kids hear.

  • Tony Anderson

    Person

    Tony Anderson, Association of Regional Center Agencies, in support.

  • Mary Tollner

    Person

    I am Mary Tollner. I'm here for all the kids who have waited way too long for this. I'm supporting SB 331.

  • Grace Tollner

    Person

    Hi. My name is Grace Tollner. I support Let California Kids Hear.

  • Joy Kearns

    Person

    Hi. My name is Joy Kearns. I'm the Clinical Liaison for the Audiology Department at UCSF Benioff Children's Hospital Oakland. Please let California kids hear.

  • Florentina Gennaro

    Person

    Hi. Florentina Di Gennaro in full support of this bill.

  • David Bolog

    Person

    Hi. David Bolog of the SFV Alliance. It's not too often that we get to support one of Caroline's--excuse me--Senator Menjivar-- honorable Senator Menjivar's bill. We are in full support. Thank you.

  • Mia Bonta

    Legislator

    Thank you. We will now move to any primary witnesses in opposition who are here. Seeing none, we will move to anyone in the hearing room who would just like to register their opposition. Seeing none, we can bring it back to the committee for any comments or questions. Assembly Member. Go ahead.

  • Jeff Gonzalez

    Legislator

    Thank you, Madam Chair. I just wanna thank the author for this, for her leadership-- her continued leadership from the yellow footsteps to the Capitol. I know what you're made of, and that's pure grit and a dragon slayer, and this is just another example of your great leadership. I'm proud to be a co-author along with you. One of the things that I will say about this is, we just have to make sure that not only this happens but we continue to advocate for our superheroes who are out there, so you can count me as part of your team.

  • Mia Bonta

    Legislator

    Assembly Member Caloza.

  • Jessica Caloza

    Legislator

    Thank you so much, Chair, and thank you to the senator. Thank you to the witnesses and all the families, kiddos, and advocates who are in the audience voicing their support. I think this is a great bill and I think you've, you know, continued to elevate an issue that even though it's not made its way successfully through the process in past years, you didn't give up. You continued to fight for all of our children in California who who want to hear.

  • Jessica Caloza

    Legislator

    We hear you now, and I'm super proud to support this bill. I also represent the Children's Hospital of Los Angeles and know that, you know, this is much needed to continue to make California accessible to everyone, and would love to be added as a co-author, Senator. And somehow you just pick the bills with the cutest public comment, whether it was this one or your allergen bill, so kudos to you. Thank you, Senator.

  • Caroline Menjivar

    Legislator

    I learned the trick, Assembly Member.

  • Jessica Caloza

    Legislator

    I see you. Yeah. Thank you.

  • Mia Bonta

    Legislator

    Assembly Member Patel.

  • Darshana Patel

    Legislator

    Thank you for bringing this very important bill forward. As a former trustee in a school district and as a PTA mom, bills such as these have been coming to us for support for many years and it's great to see it moving so far through the process this time around. I have written letters of support myself for similar bills in the past, and hopefully the governor will sign this one. Happy to give you an aye vote and would love to be a co-author as well.

  • Caroline Menjivar

    Legislator

    Appreciate it.

  • Mia Bonta

    Legislator

    Well, thank you, Senator, for bringing this forward. You and I had an opportunity to work on trying to make sure that this would be an essential health benefit along with many other benefits that we knew were absolutely critical. I think what stands apart between this and the other essential health benefits that we sought to introduce is that we have an advocacy group that has been at this for nearly a decade, sadly, and also astoundingly and inspiringly.

  • Mia Bonta

    Legislator

    I wanna thank you all for making sure that California is able to put at the forefront our ability to ensure that our kids have the ability to hear, and that in so doing, parents and families aren't faced with crushing medical debt to be able to allow that to be a part of their developmental process. To be able to have hearing aids that actually grow with the child over time is something that is very different and distinct from other kind of equipment that we need and it does allow us to just be able to ensure our children have the ability to be able to connect with their families, with their communities, with their educational opportunities, and with life.

  • Mia Bonta

    Legislator

    And so with that, I would love to be able to be a co-author on this bill as well. I just wanna say for the record for those in the back up in-- on the--I don't know where they are, 9th or 10th floor, wherever they are--this has been a very, very long journey for many advocates who want to do right by their children, and where California has the opportunity to push and to ensure that we are doing right by their folks is in this moment in time right now.

  • Mia Bonta

    Legislator

    So I am very much hoping that the senator will be able to be a part of a signing ceremony where this one crosses the finish line after nearly a decade from way before many of us were actually in this legislature, have this happen for our children. And with that, Senator, please close.

  • Caroline Menjivar

    Legislator

    I think that was a beautiful close, Madam Chair. Michelle has been the 121st legislator for the past 10 years. She has gone to D.C., she has met with the Governor's Office, she's met with probably every single legislator you can think of even before my time.

  • Caroline Menjivar

    Legislator

    Her daughter has grown up in the legislature here from having to testify as a 1st grader to now a young lady. We have done our part, the legislators have done their part year after year, and I'm very hopeful that I think this year will be the year that we'll get it to the finish line. The program we've installed a couple years ago just isn't working how it's intended to be, so their money is there to shift around and I think it just now takes political will. I'm-- call me naive, but I think this might be the year that we'll get it to the finish line, and I welcome anybody for a co-author. I appreciate my brother for your wonderful words. Respectfully ask to let California kids hear.

  • Mia Bonta

    Legislator

    And when we have a quorum, we will be able to consider this bill. Thank you, Marie. Thanks for speaking today. Thank you, Michelle. All right. Just so that we can have a motion and a second on the record, we have Ahrens first and Caloza second for consideration when the time comes. We are going to move on now to Item Number Four: SB 608 by Menjivar.

  • Caroline Menjivar

    Legislator

    I'll get started as my witness come here. This bill you've also seen before.

  • Mia Bonta

    Legislator

    Go ahead.

  • Caroline Menjivar

    Legislator

    SB608 is the third year in attempt. I do not give up as you can see. On ensuring that individuals, young people have access to, be protected should they make that personal decision to be intimate at a at a younger age. While the bill was vetoed last year, we were able to get funding in the bill in the budget for this bill. So now we just need to pass the bill to use the money we've already allocated for or we've have set aside from last year's budget.

  • Caroline Menjivar

    Legislator

    And in this year's budget, we were also able to get even more funding to help fulfill the requirements of SB 608 that is asking to that wants to bar school based health centers from making condoms available. We wanna make sure that they they have them available for grades seven to 12. We wanna make sure that when there is an educational or health program happening at the school that they make they are not prevented from providing, contraceptions, during those, educational, hearings or webinars.

  • Caroline Menjivar

    Legislator

    And we wanna make sure that pharmacies and retailers are not asking for an ID because there is no state law requiring for ID to purchase contraceptive contraception at these locations. And we wanna make sure, while not in this health committee purview, we wanna make sure that the California Department of Education has the authority to monitor the already established California Healthy Youth Act.

  • Caroline Menjivar

    Legislator

    With that, madam Chair, I'll turn over to my first witness in support.

  • Mia Bonta

    Legislator

    Thanks. You'll have two minutes.

  • Joaquin Avalos

    Person

    Good afternoon, Chair Bonta and Assembly members. My name is Joaquin Avalos, and I just completed my junior year at Da Vinci High School located in Hawthorne, California. I am here on behalf of hundreds of students who are in strong, strong support of Senate bill 608. I work hard to be healthy, and a part of that is to understand how SDIs work and how comprehensive sex education can help me and my friends become healthier.

  • Joaquin Avalos

    Person

    Expanding access to condoms in schools and communities and actually implementing comprehensive sex education would support us to lead healthy lives.

  • Joaquin Avalos

    Person

    California youth, and in particular, youth of color like myself and many of my high school peers, are disproportionately affected by the STI crisis. I know for a fact that students in my high school have experienced difficulties in the process of purchasing condoms. For example, some have been judged, some have been asked for ID, some have been shamed, and some even being harassed in the process.

  • Joaquin Avalos

    Person

    Youth with low incomes are often left without the option to regularly use condoms to help protect their health and prevent unintended pregnancy from occurring just because of the cost. My peers and I need comprehensive sex education to make informed choices about our health and our lives.

  • Joaquin Avalos

    Person

    You all are the leaders that can change this. California needs you to take more action. Senate bill 608 is a solution to this problem. California's youth deserves access. On behalf of students in California, I respectfully urge your aye vote.

  • Joaquin Avalos

    Person

    Thank you very much for your time.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Nicole Wertleman

    Person

    Good afternoon, Assemblymember Bonta and committee members. My name is Jubilee Adams. I'm a UCSC student, and I've spent the past two years serving as a youth board member with the California School Based Health Alliance or CSHA, a cosponsor of SB 608. In high school, I accessed reproductive health services through my school based health center. The care and education I received there helped me make informed decisions that kept me healthy and focused on my future.

  • Nicole Wertleman

    Person

    That access made a real difference, and not every student has it. The California Healthy Youth Act guarantees students the right to medically accurate sexual health education, but SB 608 is the necessary next step. CSHA supports 450 school based health centers and wellness centers in k through 12 schools in California. These centers provide comprehensive, confidential care to students facing barriers outside of school, such as cost, transportation, stigma, and lack of privacy.

  • Nicole Wertleman

    Person

    For students in low income, immigrant, and LGBTQ plus communities, these barriers are even higher.

  • Nicole Wertleman

    Person

    According to the CDC, twenty one percent of California high school students were sexually active in 2023, and fifty two percent of them did not use a condom during their last sexual encounter. Teens are often shamed or denied service when trying to purchase condoms or even asked for ID despite no age requirement existing. SB 608 addresses this directly and ensures that school based health centers can distribute free condoms as a proven harm reduction strategy.

  • Nicole Wertleman

    Person

    Increasing access to condoms does not mean an increase in sexual activity. It increases safety.

  • Nicole Wertleman

    Person

    Some high schools already provide free condoms. SB 608 ensures a fair uniform approach so that all students have the same opportunity to protect their health. Thank you all for your time, and I respectfully urge your aye vote.

  • Mia Bonta

    Legislator

    Thank you so much. We are gonna move now to any of those in the hearing room who aren't in support of this measure with your name, affiliation, and position. We need the mic on.

  • Kathleen Mossburg

    Person

    Chair. Chair and members, Kathy Mossberg on behalf of Essential Access Health and Black Women for Wellness Action Fund, both cosponsors, as well as APLA Health and SFAF, San Francisco AIDS Foundation. Thank you. Thank you.

  • Nicole Wertleman

    Person

    Thank you, Chair and members. Angela Pontes on behalf of Planned Parenthood Affiliates of California in support.

  • Ryan Spencer

    Person

    Ryan Spencer on behalf of the American College of OBGYN's District 9 in support.

  • Nicole Wertleman

    Person

    Nicole Wertleman on behalf of the Children's Partnership in support.

  • Rand Martin

    Person

    Madam Chair and members, Rand Martin on behalf of the AIDS Healthcare Foundation in very strong support of this bill. Thank you.

  • Martin Rodasovich

    Person

    Martin Rodasovich on behalf of Reproductive Freedom for All California in support.

  • Kasia Hunt

    Person

    Kasia Hunt with Political Solutions here on behalf of American Academy of Pediatrics in support.

  • Angela Hill

    Person

    Angela Hill with the California Medical Association in support.

  • Unidentified Speaker 014

    Kelly Brooks on behalf of the board of supervisors, Santa Clara County in support.

  • Dennis Romero

    Person

    Madam Chair and members, Dennis Cuevas Romero with the California Primary Care Association advocates in support.

  • Karen Stout

    Person

    Good afternoon. Karen Stout here on behalf of the California Nurse Midwives Association in support. Thank you.

  • Nora Angeles

    Person

    Nora Angeles with Children Now in support.

  • Mia Bonta

    Legislator

    Thank you. We are now going to move to any primary witnesses in opposition.

  • Mia Bonta

    Legislator

    Thank you. We are now going to move to any primary witnesses in opposition.

  • Mia Bonta

    Legislator

    Thanks. You'll have two minutes. You'll need to press the button so we can hear you.

  • Greg Burt

    Person

    Thanks. Chair members, my name is Greg Burt, and I'm with the California Family Council, and we're in opposition to this bill. First, parental authority. California law already gives parents a limited opt out from sex education. SB 608 builds a separate channel for handing out contraception entirely outside of that framework.

  • Greg Burt

    Person

    Under this bill, a seventh grader could obtain condoms at school with no parental notification at all. Parents are the constitutionally recognized primary decision makers for their children's health and moral formation, and courts have affirmed this for decades. This bill also strips the decision from local school districts. A community that believes handing condoms to 12 year olds is a bad idea can say so through its elected school board.

  • Greg Burt

    Person

    SB 608 takes that choice away and impose it imposes one answer on every district no matter what the local parents want.

  • Greg Burt

    Person

    The public record cuts public health record cuts against this bill too. The CDC's own youth youth risk behavior survey shows that early sexual initiation correlates with more partners in higher risk behavior. Teens who delay do better. SB 608 pushes the opposite direction by normalizing early sexual activity. And it treats condom access as if it were disease prevention when it's not.

  • Greg Burt

    Person

    The CDC is clear that condoms reduce, but do not eliminate the risk. And they are less effective against skin to skin infections like HPV, herpes, and Syphilis. California is in a congenital Syphilis epidemic right now. Handing condoms to minors without honestly communicating these limits creates a false sense of security. Abstinence remains the only method that is a 100% effective.

  • Greg Burt

    Person

    Honest policy should say so, and we urge you to invest instead in strengthening the parent child communication. We encourage you to oppose this bill. Thank you.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Brandon Campbell

    Person

    My name is pastor Brandon Campbell, and I have served in Pastoral Ministry for twenty five years, fourteen of those as a youth pastor. Seven of them teaching in a private school. I am currently the senior pastor of the Faith Baptist Church and the Northern California director for the California Baptist for Biblical Values. I am in opposition to SB 608, this bill expanding condom access in schools and removing age barriers for non prescription contraceptives. But while intentioned, I believe it rests on a flawed premise that the solution to rising STD rates among youth is to make condoms more available and encourage them.

  • Unidentified Speaker 035

    those as a youth pastor. Seven of them teaching in a private school. I am currently the senior pastor of the Faith Baptist Church and the Northern California director for the California Baptist for Biblical Values. I am in opposition to SB 608, this bill expanding condom access in schools and removing age barriers for non prescription contraceptives. But while intentioned, I believe it rests on a flawed premise that the solution to rising STD rates among youth is to make condoms more available and encourage them.

  • Brandon Campbell

    Person

    According to the CDC, condoms do not prevent the spread of all sexually transmitted diseases. For example, they offer limited or no protection against diseases like syphilis that are transmitted through skin to skin contact. Constant incorrect condom use does reduce the risk of some fluid transmitted infections, but it cannot provide absolute protection against any STD. Encouraging young people to participate in sexual activity with the promise of protection is not the answer. Instead, we should courageously promote the healthiest choice, abstinence from sexual activity until marriage.

  • Brandon Campbell

    Person

    This approach lines with both CDC statements, public health reality, and biblical values. As the Bible states in Hebrews thirteen four, marriage is honor bono in the bed undefiled. Our young people deserve better than risk reduction strategies that accept premature sexual activity as inevitable. They deserve a message of hope, self control, and the profound benefits of waiting. I urge you to reject SB 608 and prioritize policies that truly protect California's youth.

  • Brandon Campbell

    Person

    Thank you very much.

  • Mia Bonta

    Legislator

    Thank you. Are there others in the hearing room who would like to register opposition? Please come forward.

  • David Bullock

    Person

    Hi. David Bullock, SFI Alliance representing parents and families in Senator Menjivar own 20th 10th Senate District in opposition. Thank you.

  • Christine Campbell

    Person

    Christine Campbell, concerned parent in opposition.

  • Florentina Degenera

    Person

    Florentina Degenera representing Mom's Army, thousands of moms in California, also representing Church of God Tidings and Freedom Coalition opposition.

  • Mia Bonta

    Legislator

    Thank you. I see no other opposition. I will bring it back to the committee for any comments or questions. Moved by Arons, seconded by Colosa. Senator, I wanna thank you for bringing forward this measure.

  • Mia Bonta

    Legislator

    I know that this is also one that you've had to review and kind of reconsider over time. I think that you've sufficiently addressed the concerns that have been addressed in in the prior legislation. And with that, I will certainly be supporting this bill. I wanna thank everybody for offering their testimony, particularly the students who are coming from their schools to be able to share what they want to have happen in their schools. With that, would you like to close?

  • Caroline Menjivar

    Legislator

    Y'all keep it short and simple. So just respectfully asking for an aye vote.

  • Mia Bonta

    Legislator

    Thank you. And when we have quorum, we will be able to consider that. Okay. We are gonna move on now to item number seven, SB 971 by Senator Choi. Senator, we, at the Assembly, we just sit at the sit at the desk right there.

  • Mia Bonta

    Legislator

    It's a different setup over here, I know. I think you might have to press the button so we can hear you.

  • Steven Choi

    Legislator

    Okay. Good afternoon, chairperson and all committee members. I would like to begin by accepting the committee's amendments, and I'm thankful for the collaboration on this measure. I'm proud to present Senate bill 971 of which would connect the California's growing older adult population with the community based interventions to achieve healthy aging outcomes.

  • Steven Choi

    Legislator

    SB 971 is geared toward individuals ages 60 and over for opportunities that allow them to remain connected, informed, independent, and engaged in their communities with respect to already existing local resources, including community colleges and the area agents agencies on aging.

  • Steven Choi

    Legislator

    While there are many programs for older adult education that are already going great great doing great work through classes and the curriculum. SB 971 incorporates engagement and implements localized support for seniors and the caregivers to achieve specific healthy aging outcomes. SB 971 encourages collaborative partnerships, opportunities between local government entities and the existing systems that are working toward the same goal of serving seniors. This bill has received bipartisan support without a single no vote.

  • Steven Choi

    Legislator

    With me today, I have, Mister Steve Lipson, with the California senior legislature who is sponsoring this bill.

  • Steven Choi

    Legislator

    Thank you.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Steve Lipson

    Person

    Good afternoon, Chair Bonta and committee members. My name is Steve Lipson. I serve as a senior Senator in the California senior legislature, a sponsor of SB 971. While the bill includes educational and enrichment activities, it is not primarily an education bill. It is a healthy aging bill designed to help older Californians remain connected, informed, engaged, and independent in their communities.

  • Steve Lipson

    Person

    For example, a local partnership might offer technology assistance, social engagement activities, caregiver support, caregiver support resources, or other opportunities that promote healthy aging and community connection. These activities are not simply educational. They are preventive. Healthy, helping older adults avoid isolation, remain engaged, access technology, and recognize scams or practical strategies that help people remain independent and age in place longer. Equally important, SB 971 gives communities a recognized framework for bringing local partners together around shared healthy aging goals.

  • Steve Lipson

    Person

    It resources in our communities is older adults themselves. These partnerships don't simply provide services to older adults. They create opportunities for older adults to continue contributing through volunteering, mentoring, and helping one another. That sense of purpose and connection is itself an important part of healthy aging. Participation is entirely voluntary and subject to available local resources and partnerships.

  • Steve Lipson

    Person

    It is not a mandate. SB 971 gives communities another flexible way to bring local partners together so older Californians can remain healthy, connected, independent, and able to age in space in in place. That said, I respectfully ask for your iFO. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Are there others in support in the hearing room who'd like to register their support?

  • Andrew Mendez

    Person

    Andrew Mendez on behalf of the Alzheimer's Association in support.

  • Darby Kernan

    Person

    Darby Kernan on behalf of LeadingAge California in support. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Seeing no others in support, we'll move on to any primary witnesses in opposition. Seeing none, any in the hearing room who would like to register opposition? Seeing none, I will bring it back to the committee for any comments or questions. Senator, I wanna thank you for bringing forward this measure.

  • Mia Bonta

    Legislator

    I think it's very much in keeping with what I know to be very important for the elders in my family and in our community, and I'm very grateful for this bill. Would you like to close?

  • Steven Choi

    Legislator

    Thank you, madam. I would like to thank my bipartisan group of colleagues who have coauthored the SB 971 showing our commitment to California. So although adults such as me, myself is included here, I respectfully ask for your aye vote for SB 971.

  • Mia Bonta

    Legislator

    Thank you so much, Senator. Can we have a motion and a second? Moved by Colosa, seconded by Patel, and we will be able to vote on the bill when we have quorum. Thank you so much, Senator.

  • Steven Choi

    Legislator

    Thank you.

  • Mia Bonta

    Legislator

    I appreciate your testimony. For those senators who might be monitoring or their staff, we have next up on the file item order, Umberg, Perez, Weber Pearson, Blake Spear, Allen, or Reyes. Alright. We are going to move forward with Senator Weber Pearson's slate of bills. So for those other senators, you can have a little bit of a moment because she'll be here for a while.

  • Mia Bonta

    Legislator

    We will start with whichever you prefer. Item number five, SB 869 is the first in the order, which is regarding restaurant menus added sugar warnings. Whenever you're ready.

  • Akilah Weber Pierson

    Legislator

    Good afternoon, Chair, madam Chair, and members. I'm here to present SB 869, a measure focused on transparency, consumer awareness, and public health, and we'll be accepting the committee amendments today. Excessive added sugar consumption is linked to obesity, which twenty nine percent of Californians have with three point five million Californians diagnosed with type two diabetes and nine million Californians prediabetic. In addition to these, excess sugar consumption can lead to heart disease and other chronic illnesses that continue to impact millions of Californians.

  • Akilah Weber Pierson

    Legislator

    Sugary beverages remain one of the largest sources of added sugar in the American diet.

  • Akilah Weber Pierson

    Legislator

    Yet many consumers do not realize how much sugar these drinks contain when ordering them at restaurants or drive thrus. AB 869 would require chain restaurants with 20 or more locations to place a clear added sugar warning icon next to beverages that contain extremely high levels of sugar. Specifically, beverages containing a 100% or more of the recommended daily value of added sugar in a single serving.

  • Akilah Weber Pierson

    Legislator

    This bill would also require a brief factual statement explaining what the symbol means so consumers can make informed decisions at the point of purchase. Because the reality is that these decisions are often made quickly, on a menu board, out of counter, or on a phone app.

  • Akilah Weber Pierson

    Legislator

    And consumers deserve information that is clear, visible, and easy to understand in those moments. SB 869 does not ban any product. It does not restrict consumer choice. It simply is a transparent information method so that Californians can make decisions that are best for them and their families. My staff and sponsors work with committee and opposition and attempt to come to a resolution around disclosure of added sugars on the menu.

  • Akilah Weber Pierson

    Legislator

    Opposition wanted flexibility in providing this language similar to the allergens bill from last year. However, all language stating that the QR code or other digital disclosures would not refer that information to basically state that it was related to added sugars. It was just a nutritional thing. So this would effectively turn the bill into requiring just QR code on the menus. The goal of this bill is not to disclose nutritional information.

  • Akilah Weber Pierson

    Legislator

    This bill is to inform consumers about added sugars. We decided to take some of the opposition amendments and increase the beverage sugar content requiring the icon from 25 grams to 50 grams of added sugar. This captures a lot less products. And while some restaurants had over 50% of the menu containing 25 grams or more of sugar, increasing 50 grams of sugar dropped it to about 25% of beverages. Other restaurants have even less.

  • Akilah Weber Pierson

    Legislator

    This icon is meant to be simple and not overly burdensome. In conversations, it was brought up that a QR code could be done with a sticker on the menu that was a part of what was being done for allergens, but a sticker would suffice for the icon and statement, but it would still be very challenging for individuals to actually be able to easily get that information at the point of purchase.

  • Akilah Weber Pierson

    Legislator

    When you go to a restaurant and you see the menu, you order from the menu, you rarely say, oh, let me take up my phone and look at this QR code and scroll through other information. This bill takes a practical and balanced approach by applying only to large chain restaurants that already standardized menu offerings across locations. This was specifically done to not burden our small mom and pop or community restaurants in our neighborhoods.

  • Akilah Weber Pierson

    Legislator

    This is a very simple bill with a very simple goal, giving consumers better information about the beverages that they purchase every day. And although this is a very simple bill with a very simple goal, it can have significant impacts on someone's health. To me, this is one of my most important bills. And I'm so proud that I have today with me, Sarah Bachtor, a student advocate with the American Heart Association, and Christine Falabel representing the American Diabetes Association.

  • Akilah Weber Pierson

    Legislator

    Additionally, we have Sarah Sosher with the Center for Science in the Public Interest for any technical questions.

  • Akilah Weber Pierson

    Legislator

    And I respectfully ask for your aye vote at the appropriate time.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Sarah Bauchter

    Person

    Good afternoon, Chair and members of the committee. My name is Sarah Bauchter, and I was a student at Galileo High School, now incoming freshman at Cal Poly SLO, and a volunteer with the American Heart Association. I'd like to start off by saying thank you for the opportunity to speak today in support of Senate bill 869 and the importance of providing clear icons on menus to identify standard beverage menu items with high levels of added sugar.

  • Sarah Bauchter

    Person

    As a high school student and like many of us, I'm busy, burnt out, and I like to alleviate some of that stress by hanging out with my friends and ordering smoothies or coffee after school or over the weekend, sometimes both. When I order, I'm not sitting there googling nutrition facts, scanning QR codes, or giving staff an extra task of giving me calorie information.

  • Sarah Bauchter

    Person

    I look at the menu, pick whatever sounds the most appetizing, and keep it moving. And to be honest, I'm ordering enough to satisfy my craving, which is about a medium. And if I'm really feeling it, I'll get the harge. It wasn't until learning about this bill in school and seeing examples of nutrition information and drinks that I realized just how much added sugar was in my usual drink.

  • Sarah Bauchter

    Person

    I was shocked and I had no idea that I was starting my day with almost all the sugar I should be having for an entire day.

  • Sarah Bauchter

    Person

    If that information had been right there on the menu when I had ordered, I would have made a different choice or at the very least, I would be more mindful about the rest of the sugar I eat that day. I also know that my peers want this information and want to be more cautious of their sugar consumption as well. I learned through further research that too much added sugar is linked to serious health issues like heart disease, type two diabetes, and obesity.

  • Sarah Bauchter

    Person

    As a first generation person going to school in my family, I have high expectations of myself. I hope to become a cardiologist in the future for a multitude of reasons.

  • Sarah Bauchter

    Person

    My biggest reasons, however, is to help the future. As a cardiologist, I'd rather have fewer patients coming in or at the very least, older patients for natural reasons than have multiple patients coming in as young children and young adults for diseases that shouldn't be their burden to carry so early on in life. I like to think that you all want that for our children as well.

  • Mia Bonta

    Legislator

    Thank you.

  • Sarah Bauchter

    Person

    Icons are easy to see and understand. My own mother who has had to learn English on her own oh, didn't have the easiest time asking for sugar and content and drinks, and it's not realistic. We respectfully ask for your aye vote on SB869 so that not only young people like me, but all Californians can start our days informed and end our days as healthy as possible. Thank you.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Christine Harabedian

    Person

    Good afternoon, madam Chair and members of the committee. Thank you for taking the time to hear about such an important issue today. My name is Christine Harabedian I lead state government affairs for the American Diabetes Association. I'm here today to speak in support of Senate bill 869. For too long, we've asked people to make better choices without giving them the tools or the truth that they need to actually do that.

  • Christine Harabedian

    Person

    Sugary beverages are one of the clearest examples of this gap. They're marketed as refreshing, energizing, and even healthy. But what's often missing is simple, honest transparency about how these drinks impact our bodies, especially for communities already facing higher rates of chronic conditions like type two diabetes and obesity. That's where Senate Bill 869 comes in. This bill is not about taking choices away.

  • Christine Harabedian

    Person

    It's about making those choices real and transparent. Currently, there are no mandates for restaurants to label added sugar, the most detrimental sugar to our health and well-being, even though the dietary guidelines for Americans recommend a limiting added sugar to less than fifty grams per day for most adults. Transparency levels the playing field. It replaces confusion with clarity and empowers people to make decisions that align with their health goals. We know that small daily choices add up.

  • Christine Harabedian

    Person

    A single beverage may not seem like much, but over time, it can significantly impact someone's health trajectory. Studies show that adding just one twelve ounce sugary drink daily increases for developing type two diabetes by twenty six percent. Liquid sugar without any fiber is especially dangerous for health insulin resistance, weight gain, and health complications. Senate bill 869 is a step toward respect for consumers, for families, and for communities. It acknowledges that people can make good decisions when they're given honest information.

  • Christine Harabedian

    Person

    We support Senate bill 869 and ask for your aye vote. Thank you very much.

  • Mia Bonta

    Legislator

    Thank you. Any in the hearing room who would also like to register support for this measure, please come forward. Name, affiliation, position on the bill.

  • Ryan Spencer

    Person

    Thank you, madam Chair. Thank you, madam Chair. Ryan Spencer on behalf of the American College of OBGYN's District 9 in support.

  • Angela Hill

    Person

    Angela Hill with the California Medical Association in support.

  • Alex Khan

    Person

    Good afternoon. Alex Khan with the California Chronic Care Coalition in support.

  • Sarah Sorscher

    Person

    Sarah Sorscher, Center for Science in the Public Interest in support.

  • Unidentified Speaker 018

    Kathy Mossberg, Public Health Institute in support.

  • Kasia Hunt

    Person

    Kasia Hunt with Political Solutions here on behalf of the California Dental Association and the American Academy of Pediatrics in support.

  • Jonathan Clay

    Person

    Jonathan Clay on behalf of Scripps Health in support.

  • Andrea Gill

    Person

    Britney Lemon, epidemiologist at UC Davis in support.

  • Tim Madden

    Person

    Tim Madden, representing the California chapter of the American College of Cardiology in strong support.

  • Kennel Gray

    Person

    Kennel Jack Gray with the Weidman Group on behalf of the California Chiropractic Association in support. Thank you.

  • Andrea Gill

    Person

    Hello. Andrea Gill, PhD candidate in the department of nutrition at UC Davis in support.

  • Ali Raimold

    Person

    Ali Raimold, behavioral scientist at UC Davis in support.

  • Mia Bonta

    Legislator

    Thank you. Are there any in the hearing room who would like to offer primary opposition to this measure? Please come forward. Thank you. You'll have two minutes.

  • Mia Bonta

    Legislator

    You need to press the button.

  • Patrick Joyce

    Person

    Thank you. Good afternoon, madam Chair and members. I am Pat Joyce with KP Public Affairs here on behalf of the California Restaurant Association who's opposed unless amended to SBA 69, which mandates on many warning symbols and labeling for certain sugar sweetened beverages. The CRA greatly appreciates the author's dedication and strong interest in these issues. And while a deal seemed very close to the end of last week, we still believe we're very close to achieving a mean a meaningful compromise on the issue.

  • Patrick Joyce

    Person

    CRA has been an industry leader on menu disclosure issues in the state capital for a long time. And here again, we're not objecting to the disclosure itself. Restaurants in the scope of SB 869 are already required to have a series of on menu nutritional labels. The CRA then Senator Alex Padilla achieved the first in the nation on menu labeling law for calories and nutritional information for both food and drink including sugar.

  • Patrick Joyce

    Person

    The groundbreaking policy was later adopted at the national level is now across all 50 states.

  • Patrick Joyce

    Person

    In 2018, CRA again stepped up working on legislation that removed sugar sweetened beverages as the default beverage for kids meals. As this committee deliberated and the governor Newsom signed additional new menu labeling disclosures for allergens just last year. Now, we find ourselves with that new menu labeling law barely having the ink dry on it and taking effect tomorrow, July 1, and we already are facing another menu labeling mandate here today.

  • Patrick Joyce

    Person

    It proposes a very rigid and prescriptive set of on menu labeling mandates for certain drinks that exceed sugar thresholds. Menu labeling laws are expensive as menus, menu boards, and other menu resources are forced to be changed out, and actual menu items get crowded out given the limited real estate of menus and menu boards.

  • Patrick Joyce

    Person

    These force increasingly frequent changes to menus and menu boards drive up cost significantly. And unfortunately, those costs fall on the guests. Eight six nine imposes rigid and costly disclosure requirements for eating establishments as those mandate mandated disclosures would be required on physical menus as opposed to a more flexible and less expensive disclosure approach that would better address guest needs in the different formats and concepts captured by the bill. In fact, last year's restaurant allergen disclosure law established a set of my time is up.

  • Patrick Joyce

    Person

    I can hear.

  • Patrick Joyce

    Person

    Let me just close with this. The disclosure sorry. So obviously, the concern from the author is, how will the guest draw their attention to these additional resources off menu?

  • Patrick Joyce

    Person

    And to address that, we've expressed to the author's office, the Chair, and the committee staff that we are willing to consider ways that a restaurant could flag those off menus in some way, possibly with clear and conspicuous notices in the restaurant or the concise on menu statement or symbols alerting guests to additional resources, including for added sugar. So hoping to get a compromise and I'll I'll close and that's why we're gonna oppose a non submitted position. Thank you.

  • Christine Campbell

    Person

    Thank you.

  • Mia Bonta

    Legislator

    Forward.

  • Jack Yanos

    Person

    Thank you, Madam Chair. Jack Yanos on behalf of California Fuels Convenience Alliance, we'll align our comments with the restaurants. Thank you.

  • Shari McHugh

    Person

    Good afternoon. Shari McHugh representing the American Beverage Association. We have concerns with the bill, and we look forward to continue continuing to work with the author to see if those concerns can be addressed. Thank you.

  • Mia Bonta

    Legislator

    Thank you. I will bring it back to the committee now. Seeing no other opposition, Assembly member Aguiar Curry.

  • Cecilia Aguiar-Curry

    Legislator

    I wanna thank the Senator for bringing this bill forward, and I'll be supporting it today. But I did have a question about QR codes. Can you just clarify for me, please?

  • Akilah Weber Pierson

    Legislator

    And I will

  • Unidentified Speaker

    Yep.

  • Akilah Weber Pierson

    Legislator

    Turn it over to one of my witnesses. Oh, I'm sorry? Oh, is the technical witness here?

  • Mia Bonta

    Legislator

    You're bringing up a technical witness?

  • Akilah Weber Pierson

    Legislator

    Yes.

  • Sarah Sorscher

    Person

    Yes. Sarah Sorscher, Center for Science in the Public Interest. I'd be happy to answer any questions you have about QR codes. Is there anything specific you want me to talk about?

  • Cecilia Aguiar-Curry

    Legislator

    I was just wondering why they wouldn't be used in trying to find out a solution for this or to make sure the public's aware. Thank you.

  • Sarah Sorscher

    Person

    Yeah. I think the issue is that consumers are already really struggling with a food environment that is stacked against them when it comes to health. So we did a study in 2021 showing that, for example, most small sized beverages exceed the daily value for added sugars, so it's a very distorted environment.

  • Sarah Sorscher

    Person

    And the problem with the QR codes is that they sort of hide the information about what you're getting behind this technological this technical device, that a number of consumers don't have access to.

  • Sarah Sorscher

    Person

    We know the elderly. We know children. We know people in rural areas may not have be able to use a smartphone to inform purchasing decisions. And so it just puts in additional barriers to accessing the information, and that's the concern.

  • Sarah Sorscher

    Person

    What we've seen from the studies also is that, really to be effective, the warning labels need to be conspicuous, they need to be clear, they need to be accessible, and QR codes just don't provide that.

  • Cecilia Aguiar-Curry

    Legislator

    Thank you. Because when I go and try to do the menu thing, I never know what I'm ordering. So, anyway, thank you for clarifying.

  • Akilah Weber Pierson

    Legislator

    Yes. Yeah. And I know that's a thank you, Assemblymember Aguiar Curry for answer for asking that question. I know that that is one of the things that we continue to work out with opposition. As I stated at the beginning, the information should be very clear at the point of cert, at point of purchase.

  • Akilah Weber Pierson

    Legislator

    I can only speak for myself. I'm not whipping out my phone. I'm not looking, trying to look through a bunch of different things. Many of these QR codes will take you to the nutritional information, which I agree, that CRA has worked and you can find, that if you dig deep enough. But the information that oftentimes they will reveal is the total amount of sugar, not the added amount of sugar.

  • Akilah Weber Pierson

    Legislator

    There is a difference, and there is a difference in terms of the impacts to your health. And so you can go and you can look and you can see if you are savvy enough to have a phone or go on their website. Many of them will have the total amount of sugar, but this is really focused on added sugars because that is what has been linked to diabetes, heart disease, Alzheimer's, obesity.

  • Akilah Weber Pierson

    Legislator

    And, you know, it's this is a very a very simple bill, but like I said, it can have significant impacts, not on one's health but also on our health care system in general. Think about the amount of money that we are spending to treat these preventable conditions that end up being very chronic long term conditions that we can treat by allowing people to have better choices when they're purchasing drinks, which we all do every single day.

  • Mia Bonta

    Legislator

    Any other questions? Assemblymember Ahrens and then Patel.

  • Patrick Ahrens

    Legislator

    Thank you, Senator, for your leadership on this issue. I know that I agree with you on the need to address the high sugar content in our beverages. And you know, there's not any one bill that's going to solve the epidemic and the crisis facing our country, certainly. I know that I also know that, you know, the opposition comments are really resonating with me, and I know that you've, you know through discussions have been trying to get there. I think you were almost there at one point.

  • Patrick Ahrens

    Legislator

    I know you're gonna continue to try. I will be extending a courtesy aye vote today and like to move the bill at the appropriate time. But would just like to see if we can continue to have you all talking so that we, you know, strike that right balance to try and do that. Because I do, I do understand the, you know, the concerns of trying to make this right, and we ultimately want people to make those right decisions. I think transparency is always important.

  • Patrick Ahrens

    Legislator

    How we are going about it and how we are striking the balance with with industry and and proper transparency, I think, is very important. But I also trust your leadership on this issue, Doctor Weber Pierson.

  • Patrick Ahrens

    Legislator

    So we'll move at the appropriate time, but would love to see the continued conversations as it moves closer to the floor so that we can perhaps come to a resolution soon.

  • Akilah Weber Pierson

    Legislator

    Thank you.

  • Akilah Weber Pierson

    Legislator

    Thank you.

  • Patrick Ahrens

    Legislator

    Thank you.

  • Mia Bonta

    Legislator

    Thank you. Assemblymember Patel.

  • Darshana Patel

    Legislator

    Thank you, Doctor Senator Akilah Weber Pierson for bringing this bill forward. Clearly, you have been very passionate about this. I have come to learn that you have been, very active in this area even on social media. I tend not to follow a lot of social media, but, it's come to my attention that this is such a passionate issue for you, I think, as a physician, as a parent, as someone who cares about their community.

  • Darshana Patel

    Legislator

    As a scientist and a mom, I have also noticed how much added sugar there is in the beverages that our young people consume to the point where I don't think they even realize how much sugar is in their drinks.

  • Darshana Patel

    Legislator

    And one thing we do know is that we get increasingly desensitized to sugar consumption as we consume more sugar. So we may not even realize how much sugar we're slowly creeping up on consuming added sugar. And with that in mind, I also want to give a nod to those who are running businesses and trying to keep costs low and keep costs low to consumers.

  • Darshana Patel

    Legislator

    And we'll be supporting this bill today, but wanna make sure that you're able to keep working with those in this, the chain restaurant community to make sure that it's implementable, that it's operational on the ground. I know that we keep bringing these bills forward with nutritional guidelines and warnings on our menu items that are very important to protect consumers.

  • Darshana Patel

    Legislator

    But at the same time, yeah, sure, it may be crowding out the actual menu description and the font gets smaller and smaller and it becomes harder to read as we try to figure all of it out. And with the QR code specifically, I also tend to not bring out my phone at a restaurant. And in fact, my children, we have a rule that we don't have phones at the table, and that's even phones at the table at a restaurant.

  • Darshana Patel

    Legislator

    And so when we see restaurants that have their menu option as a QR code, sometimes it's like, oh, man, we gotta get out our phones. So I want to acknowledge that, yes, there are barriers and some of them are by choice and some of them are by a lack of ability of being able to access that QR code.

  • Darshana Patel

    Legislator

    But with that in mind, I'm definitely interested in making sure that there's appropriate runways and ramps for businesses to implement that we don't annually come to them with these massive menu changes. And that it doesn't become problematic for them to to communicate that to consumers. So thank you for bringing this bill forward and trying to care take care of the health and well-being of all of Californians.

  • Mia Bonta

    Legislator

    Thank you, Senator, for bringing this forward. I will say, that I've had an opportunity to speak with opposition and hear, as well some of the concerns and to certainly, receive the testimony offered today. I also know that we are in a sugar crisis that you started talking, and I started to push all these little snackies that I have up here, the candies, knowing that I had already consumed my sugar for the day, allowable sugar for the day.

  • Mia Bonta

    Legislator

    I think a couple things to just really note in terms of the way in which you've amended this bill. The first is, having the icon only apply for a threshold not from 50% to a 100% of the daily value of sugar, which we heard from your testimony can be received from one sugary drink consumed in a day.

  • Mia Bonta

    Legislator

    And we know that we are struggling with issues related to tooth decay, type two diabetes, heart disease, and I'm sure many others that are serious concerns for us. We also know that this type of legislation was moved forward in places like New York City, and we know that this does have an impact. I wanna acknowledge that on our chain restaurants and eateries.

  • Mia Bonta

    Legislator

    I would hope one thing that we might consider to address the concern of having to comply year over year, is that we perhaps move into a preventative posture in all aspects of our business, enterprises. And so I think last year, we were focused on allergens, which was critically important.

  • Mia Bonta

    Legislator

    This year, the Senator has brought before us a bill related to added sugars. In those conversations that I had with opposition, we talked about the likelihood that perhaps trans fats might be something that people focus on, and we know that we have moved many legislation piece of legislation around ultra processed food.

  • Mia Bonta

    Legislator

    So I think for me, that means that we are now in the legislature focused on, what we have consumers put in their bodies and that we need to be able to create a regulatory framework that allows us to do that.

  • Mia Bonta

    Legislator

    So I would encourage, those who are wanting to make sure that they have their business concerns, have some pattern of certainty to recognize the label on the wall that is coming your way and perhaps move more into a space of helping to make sure that we are providing the necessary messaging to keep our consumers healthier in the State of California.

  • Mia Bonta

    Legislator

    And perhaps it might just be one overhaul that might be voluntarily taken on as opposed to being compliance oriented around this on the timetable that we're focused on.

  • Mia Bonta

    Legislator

    With that, Senator, would you like to close?

  • Akilah Weber Pierson

    Legislator

    Well, I wanna thank you, Committee Chair and your committee again for working with us with this bill. I wanna thank you all for the conversations today. I love your suggestion. I would love to not have to do legislation, and to have, you know, the people in our restaurants to really work as partners with their consumers to ensure that what they are taking in is as healthy or at least allow them to have the information.

  • Akilah Weber Pierson

    Legislator

    As you stated this, you know, I wanted California to be the first in the nation to do this, but, unfortunately, we're not because New York has already done this and without a QR code.

  • Akilah Weber Pierson

    Legislator

    And they have been able to adjust so that their residents can have that transparency and make those decisions for themselves. We passed an allergen bill last year, which was extremely important. Over twice as many people in California have diabetes or are prediabetic as those who have actual food allergens.

  • Akilah Weber Pierson

    Legislator

    And so, yes, it was important, but this is also extremely important because of not only who it impacts, but as was stated, our kids are just drinking up these sugary drinks, and so it's also about who will be impacted in the future. And with that, I respectfully ask for an aye vote at the appropriate time on SB 869. Thank you.

  • Mia Bonta

    Legislator

    Thank you. We actually can establish quorum if you give us a minute to call roll.

  • Committee Secretary

    [quorum]

  • Mia Bonta

    Legislator

    We have a quorum. And on this measure, we have a motion. Can I get a second by Aguiar Curry. Please call the roll.

  • Committee Secretary

    The motion is do pass as amended to the Appropriations Committee.

  • Committee Secretary

    [roll call]

  • Mia Bonta

    Legislator

    That measure's on call. Thank you, Senator. We're gonna move now. I'll excuse these witnesses for this measure. We're gonna move on to another of Senator Weber Pierson's bills.

  • Mia Bonta

    Legislator

    Item number 6, SB 950. Regarding health coverage and dementia.

  • Mia Bonta

    Legislator

    Whenever you're ready, Senator.

  • Akilah Weber Pierson

    Legislator

    Thank you. Good afternoon again. I am presenting SB 950, which will ensure timely access to FDA approved medically necessary treatments for Californians with early onset Alzheimer's disease.

  • Akilah Weber Pierson

    Legislator

    I wanna thank the committee staff for working with our office, and I accept the committee amendments which remove the explicit parameters around the coverage. Alzheimer's disease is a chronic and irreversible neurological condition that affects over seven million people nationally with 12% residing here in California.

  • Akilah Weber Pierson

    Legislator

    Alzheimer's disease, while often thought of as a condition of aging, reflects broader disparities in our public health care system. Women, those with lower income, communities of color face disproportionate elevated risk, higher diagnostic race, and poor outcomes once living with the disease.

  • Akilah Weber Pierson

    Legislator

    For many years, little could be done to slow or stop the disease once it was diagnosed, but that reality began to change with the development of an FDA approval of medications that meaningfully slow the clinical decline of early Alzheimer's disease.

  • Akilah Weber Pierson

    Legislator

    These innovative medical breakthroughs that remove the plaques responsible for the disease progression finally provide families precious time, hope, and memories they deserve. These treatments are generally covered by MediCare, MediCal, and CalPERS, which together covers a significant share of Californians living with Alzheimer's.

  • Akilah Weber Pierson

    Legislator

    However, coverage is less consistent in the commercial market where enrollees can be subject to plan by plan determinations and utilization management. As identified in the JURB analysis, coverage of both disease modifying and symptomatic treatments is not universal across commercial plans.

  • Akilah Weber Pierson

    Legislator

    SB 950 reaffirms our goal to have universal and equitable access to these treatments when medically necessary. Timely and easy access is an important, especially because there are no FDA approved disease modifying therapies for later stage Alzheimer's.

  • Akilah Weber Pierson

    Legislator

    One extra denial, one more phone call, one failed medication, one extra month of waiting for a decision can be a huge barrier and the difference between receiving life changing treatment and losing that opportunity altogether.

  • Akilah Weber Pierson

    Legislator

    SB 950 specifically ensures that all enrollees on commercial plans regulated by the state can access medically necessary, FDA approved treatments for Alzheimer's disease. It prohibits inappropriate rerouting of medically necessary treatment, preserves utilization management and prior authorization process, and establishes Alzheimer's as an exigent circumstance to ensure expeditious coverage determination process.

  • Akilah Weber Pierson

    Legislator

    SB 950 help alleviates pressure from our families, caregivers, and health care system while navigating a very complex and time sensitive disease.

  • Akilah Weber Pierson

    Legislator

    Alzheimer is a fourth leading cause of death in California, and families deserve clarity, consistency, and timely care. Today, I'm joined by Andrew Mendoza with the Alzheimer's Association and Andrew Cope, an advocate who will share his personal experience with Alzheimer's disease.

  • Akilah Weber Pierson

    Legislator

    Thank you.

  • Andrew Mendoza

    Person

    Andrew Mendoza, on behalf of the Alzheimer's Association, proud sponsor of SB 950. Thank you, Madam Chair, members of the committee, and staff for your work to advance this important measure. We appreciate what Senator Weber Pierson prioritizing early intervention strategies to improve brain health.

  • Andrew Mendoza

    Person

    SB 950 clarifies existing law to ensure that people living with Alzheimer's disease have coverage for the treatment plan that their doctor deems medically necessary, and it streamlines access by removing unnecessary barriers to care.

  • Andrew Mendoza

    Person

    The disease modifying treatments approved by the FDA present a paradigm shift for those contending with an Alzheimer's diagnosis.

  • Andrew Mendoza

    Person

    These therapies and lifestyle interventions provide proactive measures to delay cognitive and functional decline. California recognized the importance of providing coverage for biomarker testing, which helps many assess the risk for Alzheimer's disease. These developments encourage early detection and diagnosis.

  • Andrew Mendoza

    Person

    Treatment is the natural next step for an early intervention strategy. Unfortunately, issues in our health care delivery system often delay someone for receiving a diagnosis from primary care and the lack of specialist delay confirmation.

  • Andrew Mendoza

    Person

    They very well could exit their eligibility window for treatment during that time. Moreover, co occurring conditions, the lack of infusion sites and qualified providers, or the cost incurred from the necessary tests in addition to lacking insurance coverage can all be prohibited for someone seeking access to care.

  • Andrew Mendoza

    Person

    Most of, most of the most people with Alzheimer's disease are 65 and on MediCare, which minimizes the affected population to those with early onset or diagnosed prior to 65, which represents less than one percent of those with Alzheimer's disease in California.

  • Andrew Mendoza

    Person

    However, the access that SB 950 would provide can make a meaningful difference in the lives of individuals continuing with the diagnosis at a young age as it affords time to create plans and cherish family.

  • Andrew Mendoza

    Person

    This bill is an important measure here for assuring in a new era for the treatment of Alzheimer's disease, and we appreciate Senator Weber Pierson for meeting the moment and closing the gap in coverage that would otherwise be a significant and consequence if left unaddressed.

  • Andrew Mendoza

    Person

    Thank you for your consideration. I'm respectfully asking for your aye vote at the appropriate time, and I will now turn it over to our advocate, Andrew Cope, to share his experience receiving in the diagnosis of early onset Alzheimer's disease.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Andrew Cope

    Person

    Hi. My name is Andrew Cope. I'm 56 years old, and I'm from Menlo Park, California. As Andrew mentioned, I'm here today because I'm also living with Alzheimer's disease. My journey began when a genetic test revealed I had the double APOE four genotype, which if you're unfamiliar, has the highest incidence of Alzheimer's and the highest incidence of early onset.

  • Andrew Cope

    Person

    That test sent me on a year long journey that started with my primary care physician, and then I waited six months to get an appointment with a neurologist. And then I waited an additional three months to get the PET scan, which revealed my diagnosis. It was a year of anxiety, worry, uncertainty. I had no idea how much quality time I have left with my wife and two children. However, as has been mentioned here, I'm an incredibly lucky person to be born when I was.

  • Andrew Cope

    Person

    Medical research right now is making life changing progress for people like me. There's now a very simple blood test that reveals the pathology for Alzheimer's and as is mentioned, there are two therapies, two infusion therapies that are approved that are proven to slow the progression of the disease. And there are clinical trials, one of which I'm going to be joining, that are pushing the progress even further. So it's giving people like me true optimism and hope.

  • Andrew Cope

    Person

    These treatments that we referenced, they've been shown to reduce the plaque progression growth in the brain by as much as 30%.

  • Andrew Cope

    Person

    So I ask each one of you to sort of take a moment and imagine somebody important to you, whether it's a family member or a very close friend, and maybe they have a diagnosis like mine, and now you tell them that you're gonna be able to give them months, years, or maybe a decade of life to live and plan. That's absolutely priceless.

  • Andrew Cope

    Person

    I'm here as a volunteer because, this disease face is changing in real time, and more and more people are going to look like me that are living with this disease. And I feel it's my responsibility to do something positive for anybody else who is facing this disease and to the millions of people who never had the chance. Everybody in this room right now has a chance to make a difference in this pivotal moment.

  • Andrew Cope

    Person

    You can do it for me. You can do it for people that are important to you. You can do it for all of California. So I really urge you to pass SB 950 and be on the right side of history on this one. Thank you for your time and thank you for your consideration.

  • Andrew Cope

    Person

    Very much appreciated.

  • Mia Bonta

    Legislator

    Thank you. Others in the hearing room who would like to register support? please come forward.

  • Howard Posner

    Person

    I'm Howard Posner, volunteer advocate with the Alzheimer's Association. I support the bill.

  • Lisa Bishop

    Person

    Good afternoon. My name is Lisa Bishop. I'm a volunteer advocate with the Alzheimer's Association, and I support SB 950.

  • Kylie Oshioka

    Person

    Hello. Kylie Oshioka, also volunteer advocate with the Alzheimer's Association, in support.

  • Veronica Mead

    Person

    Hi. Veronica Mead with the Alzheimer's Association in support of SB 950.

  • Lynette Blumhardt

    Person

    Lynette Blumhardt, volunteer advocate with the Alzheimer's Association. I'm here in support of SB 950.

  • Cloyce Dickerson

    Person

    Cloyce Dickerson, Board member, Northern California Alzheimer's Association in support.

  • Darby Kernan

    Person

    Good afternoon. Darby Kernan on behalf of LeadingAge California in support.

  • Sandra Poole

    Person

    Good afternoon. Sandra Poole on behalf of Western Center on Law and Poverty in support.

  • Jennifer Snyder

    Person

    Jennifer Snyder on behalf of the California Life Sciences in support.

  • Alex Kahn

    Person

    Alex Kahn with the California Chronic Care Coalition in support.

  • Jessica Hayes

    Person

    Jessica Hayes with AFSCME California in support.

  • Mia Bonta

    Legislator

    Thank you. Are there any primary witnesses in opposition? Please come forward.

  • Mia Bonta

    Legislator

    You'll have two minutes each.

  • Kassidy M. Heckmann

    Person

    Thank you. Kassidy Heckmann on behalf of the California Association of Health Plans. Wanna start by thanking the author, her staff, and the sponsor for continued conversations on this bill. Regrettably, we are still opposed to it today. As outlined in our letter, one of our primary concerns is the ban on step therapy.

  • Akilah Weber Pierson

    Legislator

    Thank you.

  • Kassidy M. Heckmann

    Person

    While the bill states that if FDA, if the FDA has approved one or more types of treatment for Alzheimer's disease, that health plan does not have to cover all types of treatment without step therapy. It specifies this as conditional on a plan covering at least one anti amyloid without step therapy. We appreciate the intent behind this language.

  • Kassidy M. Heckmann

    Person

    However, there are currently only two anti amyloids that are FDA approved, both brand name, and they cost between $26,000 and $32,000. We believe this language will limit plans from offering enrollees a therapeutically equivalent and more affordable alternative when they eventually come to market.

  • Kassidy M. Heckmann

    Person

    Additionally, we are concerned about the requirement that health plans cover all FDA approved drugs for the treatment of Alzheimer's disease and dementia. As the analysis notes, health plans already cover all medically necessary drugs, including anti amyloids. However, we have concerns the language can unintentionally prevent plans from updating their formularies as new data emerges and from designing products that are both affordable and appropriate.

  • Kassidy M. Heckmann

    Person

    Finally, we are concerned with the recent amendment that requires anti amyloids and other Alzheimer's drugs to be treated as exigent circumstances.

  • Kassidy M. Heckmann

    Person

    A 24 hour review is an incredibly short timeline for an entire class of drugs, specifically ones like anti amyloids that are new to market and are required to be used under strict guidelines and supervision.

  • Kassidy M. Heckmann

    Person

    For these reasons, we remain respectfully opposed. Thank you.

  • Matt Akin

    Person

    Good afternoon, Chair members. Matt Akin with the Association of California Life and Health Insurance Companies, also in respectful opposition to SB 950. I just wanna first say we sincerely appreciate the author's intent and goal of improving care for individuals living with Alzheimer's and dementia. I'd like to align my comments with my colleague and briefly highlight one additional concern we do have with the bill.

  • Matt Akin

    Person

    As my colleague noted, the bill would significantly limit plan's ability to use step therapy for FDA approved Alzheimer's treatments, requiring that at least one anti amyloid therapy be available without it.

  • Matt Akin

    Person

    We are concerned that the efficacy of these drugs has not been strongly proven. As CHBRP noted, there is some evidence that disease modifying medications are effective at slowing cognitive decline, but the effects generally fell below minimum clinically important difference thresholds. CHBRP also noted that there is not enough research to determine whether amyloid plaque reduction improves health outcomes.

  • Matt Akin

    Person

    Given the evolving clinical evidence and the potential for side effects with some of these medications, we believe plan should maintain the ability to apply evidence based utilization management tools, such as step therapy.

  • Matt Akin

    Person

    For these reasons, we respectfully oppose the bill, but we'd like to sincerely thank the author and sponsors for their engagement so far, and we do look forward to future conversations if it moves forward today. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Any others in the hearing room who would like to offer opposition?

  • Mia Bonta

    Legislator

    Seeing none, I will bring it back to committee for any comments or questions. Assembly member Stefani and then Patel.

  • Catherine Stefani

    Legislator

    Thank you. I just wanna thank the Senator for bringing this forward. I had a dad pass away. My dad just passed away April 29 this year after suffering from Lewy body dementia for eight and a half years. And I was just saying to my daughter the other day that I wish I had been able to do more at the early stages in 2016 and 2017.

  • Catherine Stefani

    Legislator

    And the suffering that my family went through, that he went through, the health care, the hurdles, it's traumatic. And with all due respect to the opposition, I think these are just the same tired arguments we hear about what we need to be doing for Alzheimer's and dementia. And I wanna thank the Alzheimer's Association and the witness for bravely sharing your story.

  • Catherine Stefani

    Legislator

    When I told my daughter I wish there was more I can do, I'm glad I get to be here today and vote aye on your bill. So thank you.

  • Mia Bonta

    Legislator

    Assembly member Patel.

  • Darshana Patel

    Legislator

    Thank you, Senator for bringing this bill forward. It's very important we have our patients have access to life saving therapeutics. And anything that can improve quality of life is is certainly worth looking into. I do have one question, specifically from what the oppo brought up about the designation as an exigent condition. Can you address concerns around that?

  • Andrew Mendoza

    Person

    Yes. We're making it exigent circumstance because these medications have a limited eligibility window. They're only available for people that are in the early stage of Alzheimer's. Something that was mentioned in the, in the presentation is that they this is specifically also targeting the insurance insured population that is living with early onset.

  • Andrew Mendoza

    Person

    So that's diagnosed younger than 65, but the treatments are available for people that are in the early stage before they move into the mild to moderate, aspects of Alzheimer's disease when they're going to need either more assistance with their activities of daily living or they will need higher levels of care at a long term care facility.

  • Andrew Mendoza

    Person

    So, essentially, that is why we're making that circumstance exigent instead of the normal.

  • Darshana Patel

    Legislator

    Thank you for explaining that. That's something I didn't have a quite a good grasp on understanding. So these therapeutics a follow-up question, maybe even two. So these therapeutics are such that they have to be used at the very early stages. Are they then able to continue to be used for the duration of the condition?

  • Andrew Mendoza

    Person

    That is something that we are still finding out. Essentially, there is a subcutaneous maintenance dose for Lekembe, which is one of the anti amyloid therapies, so that would continue on. There is a notion that you'll be able to stop Consumla at a certain point, but I don't think that we're there yet to say that for sure. But they are not essentially to carry over to those other stages. Those other stages are where the symptomatic medications are generally used.

  • Darshana Patel

    Legislator

    Okay. Thank you for that explanation.

  • Akilah Weber Pierson

    Legislator

    Yeah. So I think I'm sorry. The think of these medications on the very, very front end to try to prevent the progression. Once you get to a certain point, the medications are used to treat the symptoms. And so that's also one of the reasons why we're not going with the step therapy because the step therapy will make you do the symptom treatment first, fail before you can do this.

  • Akilah Weber Pierson

    Legislator

    But you really need this first if you're able to be diagnosed at a, at the early stage.

  • Darshana Patel

    Legislator

    So it's almost like treating two different kinds of diseases or disease profiles?

  • Akilah Weber Pierson

    Legislator

    Yeah. It's targeting different things.

  • Akilah Weber Pierson

    Legislator

    This is targeting the formation of the amyloid plaques versus the other medications that target the symptoms of Alzheimer's.

  • Darshana Patel

    Legislator

    Thank you for that. I'd like to move the bill.

  • Mia Bonta

    Legislator

    Thank you. Assemblymember Patel, a second by Stefani.

  • Mia Bonta

    Legislator

    Senator, I wanna thank you for bringing forward this measure. And again, I wanna thank, as well, thank the testimony provided. It's, this is certainly something that I feel very personally having two members of my family who suffered from Alzheimer's and dementia and were taken from us too long.

  • Mia Bonta

    Legislator

    I think to Assembly member Stefani's point and very loving commentary, when people have dementia and Alzheimer's, they are with us for a very, very long time often, but physically so. And we have to recognize that we are dealing with people who are not able to be their full selves. And that creates other kind of quite frankly health concerns and puts people into acute health care needs and creates much more cost to the consumer, the family, and to our overall health care system.

  • Mia Bonta

    Legislator

    I think you've put forward a very strong argument for why we need to make sure that we are treating this particular opportunity for effective delivery of care sooner and to classify it with exigent circumstances. Very helpful explanation with that.

  • Mia Bonta

    Legislator

    Senator, would you like to close?

  • Akilah Weber Pierson

    Legislator

    Yes. Once again, wanna thank you, Chair and the committee. Really wanna thank my the sponsors, the Alzheimer's Association, but my witness in particular, for coming and being so vulnerable and sharing your story. Wanna acknowledge, Assembly member Stefani. Thank you so much, and I'm sorry for your loss.

  • Akilah Weber Pierson

    Legislator

    I didn't know, but thank you for, for sharing that because, it highlights how widespread these conditions are and how they impact families and communities. And, you know, the treatments that we're talking about today. Unfortunately, were not there with a cure.

  • Akilah Weber Pierson

    Legislator

    So this is not going to cure, but it can provide something incredibly meaningful that may have otherwise not felt possible. More time, a better quality of life, new found memories with loved ones that can be passed down for generations. Those things are invaluable.

  • Akilah Weber Pierson

    Legislator

    And as we look ahead, these medical discoveries are just the beginning. We know that we have ongoing research and innovation to move us closer to expanding access, improving lives, and one day, achieving a future that is free from Alzheimer's disease. And with that, I respectfully ask for an aye vote on SB 950. Thank you.

  • Mia Bonta

    Legislator

    Thank you, we have a motion and a second. Please call the roll.

  • Committee Secretary

    The motion is do pass as amended to the Appropriations Committee.

  • Committee Secretary

    [roll call]

  • Mia Bonta

    Legislator

    That measure's on call, Senator. We are going to pause from the rest of your, slate of bills to move to item number two, SB490 by Umberg regarding alcohol and drug programs. Thank you, Senator. Whenever you're ready.

  • Thomas Umberg

    Legislator

    Thank you, madam Chair. And a special thank you to Senator Weber Pearson for your accommodation. Very much appreciate that. Madam Chair and members, I'm here to present SB490. Thank you to you personally, madam Chair, and also to Logan Hess for your continuing help with Umburg bills.

  • Thomas Umberg

    Legislator

    We'll be accepting committee's amendments. I'm happy to present SB490, which was established timelines for the Department of Health Care Services, DHCS, to investigate allegations of licensed treatment at unlicensed sober living homes if DHCS cannot meet the timelines. SB490 would authorize counties to request approval to conduct site visits and enforce compliance with existing state licensing requirements. The challenge of unlicensed sober living homes is particularly acute in Orange County, but it is a statewide phenomenon and is a statewide concern.

  • Thomas Umberg

    Legislator

    And it's a concern because DHCS doesn't frankly have the resources to be able to do the kinds of site inspections that we would hope or audits.

  • Thomas Umberg

    Legislator

    A recent state audit revealed significant shortcomings in DHCS' oversight of unlicensed treatment facilities. The audit found that DHCS has not consistently investigated allegations of unlicensed facilities providing or advertising treatment services. So there are many examples. There are many examples where there's been a complaint, an initial take take a look see and and no follow-up.

  • Thomas Umberg

    Legislator

    For the recommendation of the state auditors report, SB490 institutes a timeline to assign a complaint to an analyst within ten days, complete investigations within a hundred and twenty days, issue violation notices within ten days of completing the investigation, and conduct mandatory follow-up site visits to ensure unlawful services have been stopped.

  • Thomas Umberg

    Legislator

    If this is the gravamen of the bill. If DHCS fails to meet these timelines, then counties can work with DHCS to enforce licensure laws and protect public health and safety. With me testifying in support of the bill are Anaheim City Council member, Kristin Moss, and found who is also founder and director of the National Patient Brokering and Prevention Initiative. I'm sorry. I've got that confused.

  • Thomas Umberg

    Legislator

    Founder and director of the National Patient Brokering Prevention Initiative, Sequoia Thiesen. So thank you very much. Back to you, madam Chair.

  • Mia Bonta

    Legislator

    Thank you, Senator. You each have two minutes.

  • Unidentified Speaker 025
    ID Pending

    Thank you. Good afternoon, Chair Bonta and committee members. I'm Kristen Maas, City Council member for the city of Anaheim. On behalf of Anaheim, thank you for this important opportunity to offer input on the topic for our city in all of California. Like other cities, Anaheim provides a frontline perspective on this issue.

  • Unidentified Speaker 025
    ID Pending

    Recovery treatment in many forms plays a vital role in our city as it does across our state. The challenge of substance abuse disorder brings real impacts on people, families, and neighborhoods. Anaheim is supportive of community care facilities. We estimate our city is home to more than a 150 facilities of many varieties. We share a belief that recovery is most effective in the right setting and with the best help possible, but we also know that there are challenges.

  • Unidentified Speaker 025
    ID Pending

    As a city, we are limited in our ability to regulate treatment or as a city, we're limited in our ability to, regulate treatment facilities or group homes. That makes California's rule and your consideration of this proposed legislation so important. Recovery is only as strong as the support someone receives. There are many great operators whose work changes lives, but we also know of horror stories. Stories of billing exploitation, client cycling, disruptive operations, unlicensed treatment, and ultimately failed recovery.

  • Unidentified Speaker 025
    ID Pending

    Undermining recovery in one case undermines treatment and supportive recovery as a whole. What is being proposed is enhanced oversight in a reasonable incremental way. SB 490 embraces the state auditors' recommendations for investigating unlicensed treatment. It would bring partnership with counties to do site visits and ensure licensing. This would allow the state to leverage local support and to better respond to violations, ensure compliance, and to protect the health and safety of those in treatment.

  • Unidentified Speaker 025
    ID Pending

    The proposal would strengthen state oversight backed by local governments. It is critical for all of us to ensure that recovery meets the highest standards, brings better outcomes, and supports healthier communities. Thank you for your consideration on this proposal. On behalf of the city of Anaheim, I extend our city's appreciation for your support of enhanced recovery outcomes and a stronger treatment system. Thank you.

  • Mia Bonta

    Legislator

    Thank you so much. You'll have two minutes as well.

  • Darshana Patel

    Legislator

    Thank you.

  • Unidentified Speaker 046
    ID Pending

    My name is Sequoia Thiessen. I'm the founder and director of the National Patient Brokering and National Patient Brokering Prevention Initiative and a UC Berkeley student. I support SB490 because from my perspective as both a survivor and someone who works on this issue every day, California's oversight of fraudulent and unlicensed treatment centers has not kept pace with the reality on the ground. I founded this organization because after surviving this industry and then researching it, I realized that exploitation is not the exception.

  • Unidentified Speaker 046
    ID Pending

    It has unfortunately become the norm.

  • Unidentified Speaker 046
    ID Pending

    When people are entering treatment, they are in their most vulnerable. These become more than licensing violations because they create environments where serious harm can go unchecked. When oversight fails, there are serious consequences. I have witnessed patients, including myself, be subjected to conditions akin to human trafficking. Because of the lack of oversight, there is immeasurable exploitation going on here in California, including kidnapping, rape, coercion, and both labor and sex exploitation.

  • Unidentified Speaker 046
    ID Pending

    The people exploiting this system count on enforcement gaps and delays. They want to delay these consequences so that they can continue commodifying people's health and sobriety. SB 490 also acknowledges that many fraudulent rehab act or actors own more than one facility, and they often move patients between facilities to avoid oversight and accountability.

  • Unidentified Speaker 046
    ID Pending

    In practice, this mirrors human trafficking because patients are brought from all over The United States and being coerced with housing, food, and medical income or medical care to generate income for these unlicensed facilities. It is not uncommon for patients to be brokered across 50 plus facility over a number of years.

  • Unidentified Speaker 046
    ID Pending

    This bill will help close an important gap within collaboration and trust building as well. One of the main reasons victims struggle to come forward in this industry is because they are typically come coming from backgrounds that have fractured trust with the state. This bill tells patients that you care about the conditions they are subjected to while in treatment and that their reports will not go uninvestigated. Thank you.

  • Mia Bonta

    Legislator

    Thank you for that testimony. We will hear from anybody else in the hearing room who would like to offer support for the measure.

  • Unidentified Speaker 006
    ID Pending

    Good afternoon. Sylvia Solis Shaw here on behalf of the City of Beverly Hills in support. Thank you.

  • Brittany Barsati

    Person

    Cassidy Heckman on behalf of the California Association of Health Plans in support.

  • Unidentified Speaker 009
    ID Pending

    Good afternoon. Olivia Herrera, intern at Stone Advocacy on behalf of the California District Attorneys Association in support. Thank you.

  • Unidentified Speaker 038
    ID Pending

    Good afternoon. Kendra Begley on behalf of the city of Carlsbad and the city of Thousand Oaks in support.

  • Unidentified Speaker 010
    ID Pending

    Stephanie Watkins on behalf of the Association of California Life and Health Insurance Companies also in support.

  • Mia Bonta

    Legislator

    Thank you. Are there any primary witnesses in opposition? Thanks. You all have two minutes.

  • Unidentified Speaker 047
    ID Pending

    Thank you, Chair and members, for the opportunity to speak to you today. My name is Amara Sheehy, the director of legislative affairs for for the County Behavioral Health Directors Association of California, representing the leaders of the public behavior health agencies that serve the mental health and substance use disorder needs of California's Medi Cal uninsured and underinsured populations. CBHDA respectfully stands in opposition to SB 490.

  • Unidentified Speaker 047
    ID Pending

    SB 490, as is in print, instructs the Department of Health Care Services and potentially county behavioral health agencies to investigate sober living homes providing unlicensed substance use disorder treatment, an activity those centers should not be engaged in and one that the department already has jurisdiction to investigate. The issue that the author discusses are rooted in private sober living facilities, which advertise detoxification services or other unlicensed residential SUD treatment and are not contracted or under the jurisdiction of county behavior health in any way.

  • Unidentified Speaker 047
    ID Pending

    SB 490's proposed timeline for DHCS to complete investigations for facilities engaged in unlicensed residential SUD treatment in conjunction with the proposed option for county behavioral health department to instead perform the function of investigating those private entities in which they have no jurisdiction over, represents a significant liability risk and a potential unfunded workload increase for county behavioral health agencies.

  • Unidentified Speaker 047
    ID Pending

    It's for that reason that we thank the committee for the proposed amendments in the analysis, which take the bill to a more appropriate step in assisting in the aims to ensuring that the investigations of these entities engaged in inappropriate unlicensed SUD treatment are happening in a thorough and timely manner through DHCS, the appropriate jurisdiction and oversight authority of these facilities.

  • Unidentified Speaker 047
    ID Pending

    However, with these proposed amendments, there still seem to be a number of technical concerns, which will result in unnecessary burdens to some of the counties that we hope to continue to engage in discussion with the author's office on in order to mitigate for. And it is for those reasons that CBHD at this time respectfully opposes SB 490 and thank the Chair and members for the time today.

  • Mia Bonta

    Legislator

    Thank you. Any others in the hearing room with position of opposition to the bill? Seeing none, I will bring it back to the committee for any comments or questions. Assembly member Patel.

  • Darshana Patel

    Legislator

    Thank you for bringing this bill forward. Certainly, it's an important thing to take on these, unlicensed behavioral health mental health clinics, especially for behavioral subs or substance abuse disorders. Want to ask if you could address some of the concerns raised by the opposition here from our county behavioral health folks.

  • Thomas Umberg

    Legislator

    Sure. I I think that's correct. In an ideal world, there would be adequate resources, adequate capacity at DHCS to be able to timely investigate abuses. But that's not the world in which we live. And so as a consequence, cities and counties, some counties, but particular cities and neighborhoods have said, we need to do something about this.

  • Thomas Umberg

    Legislator

    And if DHCS doesn't have the capacity, where do we turn? I understand that the counties don't want additional workload, and, indeed, they don't have to do anything. We're simply telling them, hey. Here's what's going on. Please investigate.

  • Thomas Umberg

    Legislator

    Please take action. So, if if they don't want to, they don't have to. There's no mandate in this bill. There's no consequence. There's no penalty.

  • Thomas Umberg

    Legislator

    But, in order to address the the violations and the challenges that exist, we need to do something. And it's a good matter of public policy that we basically, we empower localities to actually do site visits and investigate. But as a practical reality, if DHCS stops it, they can stop it. In other words, they can stop any investigation. They can stop any further process with respect to the sober living homes.

  • Darshana Patel

    Legislator

    K. Thank you for that.

  • Unidentified Speaker 037
    ID Pending

    Seeing

  • Mia Bonta

    Legislator

    Assembly member.

  • Pilar Schiavo

    Legislator

    I wanna thank you for this bill too. I mean, I think at the end of the day, if we don't if there's no one with eyes on situations and if there's no one checking, then there are literally no checks on what people are doing. And especially, you know, when you're talking about people who are in a vulnerable state and in a really difficult time in their life where they could be taken advantage of, it's it's really unconscionable.

  • Pilar Schiavo

    Legislator

    And there's been some terrible horror stories about what is happening in some of these centers. And and so, you know, unfortunately, until we get to the point where we as a state can fund the kind of oversight and investigation that needs to be done, I think that we should certainly not stand in the way of localities being able to being able to, you know, look into the sober living facilities themselves.

  • Pilar Schiavo

    Legislator

    So I'm happy to support it today, happy to move the bill, and would love to be added as a coauthor if you'll have me.

  • Thomas Umberg

    Legislator

    Alright. Thank you very much.

  • Mia Bonta

    Legislator

    Thank you.

  • Thomas Umberg

    Legislator

    She said. So right. Thank you.

  • Mia Bonta

    Legislator

    What she

  • Akilah Weber Pierson

    Legislator

    said as you're close, sir?

  • Thomas Umberg

    Legislator

    Closed. Yeah. That's my

  • Mia Bonta

    Legislator

    Appreciate it.

  • Unidentified Speaker 004
    ID Pending

    Thank you, madam Chair.

  • Mia Bonta

    Legislator

    With that, I think we have a a motion. Oh, Assembly member?

  • Darshana Patel

    Legislator

    Yeah. One follow-up. I do after processing this a little more, seeing that this is not a mandate and it's an option for localities to pursue investigation, I do feel like it's okay and I would like to add on as a co author as well.

  • Unidentified Speaker 005
    ID Pending

    Thank you.

  • Thomas Umberg

    Legislator

    Thank you very much. Thank you.

  • Mia Bonta

    Legislator

    Can you also second that one?

  • Darshana Patel

    Legislator

    And I will second it.

  • Mia Bonta

    Legislator

    Thank you. Senator has already closed. Please call the roll.

  • Unidentified Speaker 023
    ID Pending

    The motion is do pass as amended to the Appropriations Committee. Bonta.

  • Mia Bonta

    Legislator

    Aye.

  • Unidentified Speaker 023
    ID Pending

    Bonta, Aye. Sanchez, Addis, Agaracuri, Arons, Colosa, Carrillo Carrillo, Aye. Jeff Gonzalez. Jeff Gonzalez, Aye. Mark Gonzalez, Johnson.

  • Unidentified Speaker 023
    ID Pending

    Johnson, Aye. Patel. Patel, Aye. Patterson. Rodriguez.

  • Unidentified Speaker 023
    ID Pending

    Schiavo. Schiavo, Aye. Sharp Collins. Stephanie.

  • Mia Bonta

    Legislator

    That measure's on call. Thank you so much, Senator.

  • Thomas Umberg

    Legislator

    Thank you, madam Chair. Thank you, Assemblymember Schiavo. Thank you, Assemblymember Patel, and all the other members. Thank you.

  • Mia Bonta

    Legislator

    Thank you. We're gonna move back to our file item number nine, s B1037 by Weber Pearson for one of three bills that she still has to be heard. Go go ahead. Item number nine, s B1037.

  • Akilah Weber Pierson

    Legislator

    Thank you. Thank you, madam Chair. I wanna thank you and your staff for the work on this bill. I accept the amendments described in the analysis and that are reflected in the mock up. The focus of this bill, SB 1037, is affordability of state regulated commercial health insurance.

  • Akilah Weber Pierson

    Legislator

    This bill with the amendments requires health plans and insurers to demonstrate where the premium rate growth meets the cost growth target established by OCA. If the rate growth will exceed the cost target, the plan must indicate why and what steps it will take to address it and reconcile this with any relevant analysis published by OCA.

  • Akilah Weber Pierson

    Legislator

    SB 1037 codifies the federal definition from the Affordable Care Act of, quote, unreasonable rate increase, end quote, which is a determination state regulators are currently authorized to declare when reviewing health insurance rate. This bill also requires regulators to consider specific revenue indicators when determining if a rate increase is unreasonable, but not in a way that conflicts with the financial solvency of the plan.

  • Akilah Weber Pierson

    Legislator

    With the amendments, this bill will require regulations in consultation with OCA to be reevaluated as a part of the rate review process if the insurer's rate meets the ACA affordability standard benchmark for an individual and for a family of four with household income at 200, 400, and 600% of the federal poverty level.

  • Akilah Weber Pierson

    Legislator

    The findings of the evaluation will be will be reported as required under existing law at a public meeting on health insurance rates. With the loss of federal enhanced premium tax credits, many covered California enrollees have experienced an average of a 97% increase in monthly health care insurance premiums. As predicted, almost 400,000 Californians canceled or terminated their coverage California coverage covered California coverage. Cancellations were highest among middle income Californians and people of color.

  • Akilah Weber Pierson

    Legislator

    Those who are still covered have moved to higher deductible plans with lower premiums, but a higher cost sharing when services are needed.

  • Akilah Weber Pierson

    Legislator

    This will aims to add health insurance rate reviews and affordability focus. With me today to testify are Caitlin Van Steyn from Health Access California and Benjamin Eckert Eckert from NUHW. Thank you.

  • Mia Bonta

    Legislator

    Thank you. You'll each have two minutes.

  • Katelin Van Deynze

    Person

    Good afternoon, madam Chair and members. Katie Van Dines for Health Access California. We're strongly in support of SB 1037 as amended that will evaluate the impact of proposed rate increases on affordability. And detail how health plans will show the benefits of the office of health care affordability, cost growth targets, and their rates. The most common question we get about the office of health care affordability is when will my health care cost be less because of OCA?

  • Katelin Van Deynze

    Person

    Then in fact, the UC Labor Center says that if we have these targets three years ago, premiums of family coverage would have been $5,800 less over those three years. The bill requires that the health plan and insurers explain in the rate review process how the OCA targets will be affecting health care costs they are asking consumers and employers to pay.

  • Katelin Van Deynze

    Person

    And as the Senator noted, we'll see if they're going to meet those targets, and if not, what proactive steps are being taken and what are those cost drivers leading to those increases. Health SB 1037 will help us ensure the savings and the cost of targets are realized in consumer premiums.

  • Katelin Van Deynze

    Person

    And to affordable to evaluate how affordable rates are, the under this bill, the departments will consult with OCA and look at that through an affordability standard and look at that based on different Californians' incomes.

  • Katelin Van Deynze

    Person

    We think this is a really important measure and really appreciate this in this bill. And with that, I respectfully ask for your aye vote on SB 1037. Thank you. Thanks.

  • Benjamin Eichert

    Person

    Good afternoon, Chair and members. My name is Benjamin Eichert, and I'm the public policy director for the National Union of Healthcare Workers here in strong support of SB 1037. NUHW represents frontline caregivers across California, including, 4,500 mental health clinicians at Kaiser Permanente, and we often hear how unaffordable care has become for the patients our members serve. SB 1037 sharpens what plans must show in rate review, including how OCA's cost growth targets reach the premiums people pay and add something new.

  • Benjamin Eichert

    Person

    If a plan will miss the target, it has to tell regulators, explain what's driving the higher costs and what it's doing to fix it.

  • Benjamin Eichert

    Person

    We strongly support OCA's all in approach. We also support measuring whether rates are truly affordable year over year as a share of people's income. The piece we most, wanna speak to is letting regulators weigh excessive financial capacity. The analysis before you shows excess reserves at full service plans topped $94,000,000,000 in 2024. These reserves are largely funded by California consumers who have paid the increasing rates whether individually or as businesses burdened with higher premiums.

  • Benjamin Eichert

    Person

    They've also been paid by workers who did not get a wage increase because instead, that money was diverted to maintain increasingly costly health care benefits. When a tax exempt plan sits on such large reserves and still wants a rate increase, regulators should be able to ask, are the rates too high or should that money be going into care? Often the answer is both. We're grateful to the author for advancing this important issue. For the patients our members serve, I respectfully ask for your aye vote.

  • Mia Bonta

    Legislator

    Thank you. Any others in the hearing room who would like to offer support for the measure?

  • Megan Loper

    Person

    Megan Loper on behalf of the California Hospital Association in support.

  • Mia Bonta

    Legislator

    Thank you. Are there any primary witnesses in opposition?

  • Mia Bonta

    Legislator

    Thank you. Are there any primary witnesses in opposition?

  • Mia Bonta

    Legislator

    Thank you. You'll each have two minutes.

  • Olga Shilo

    Person

    Thank you. Chair members, Olga Shiloh with the California Association of Health Plans. Regrettably, we remain opposed to, SB 1037. We all agree that affordability is one of the biggest challenges facing Californians today. It's why health plans support policies that address the underlining underlying drivers of health care costs and oppose proposals to make coverage more expensive.

  • Olga Shilo

    Person

    The reality is that premiums are not set arbitrarily. They are certified by actuaries, reviewed by state regulators, subject to public scrutiny, and can be deemed unreasonable. Health plans are already required to spend the vast majority of premium dollars on medical care with access funds returned to consumers through rebates. California has some of the strongest consumer protections and transparent transparency requirements in the country. The issue we're we're facing is not a lack of oversight.

  • Olga Shilo

    Person

    The issue is that the underlying cost of care continue to rise. Hospital costs have increased by more than 265% over the last five years, and pharmaceutical costs have risen by more than 70%. In addition to these pressures, the legislature had just approved and the governor signed a new MCO tax that places a $1,500,000,000 tax on commercial coverage. Given that action, it's difficult to reconcile the affordability goals of SB 1037 with the reality that health insurance will now bear additional costs.

  • Olga Shilo

    Person

    S B 1037 adds new regulatory requirements without addressing the factors that are actually driving premiums higher.

  • Olga Shilo

    Person

    Help hints want to be part of the solution, but meaningful affordability gains will come from addressing the cost of care itself. For these reason reasons, we respectfully oppose ten thirty seven. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Madam Chair

  • Steffanie Watkins

    Person

    and members, Stephanie Watkins on behalf of the Association of California Life and Health Insurance Companies, regrettably here in opposition to the bill today. We do appreciate the early conversations that we had with the author, the sponsor, and staff. Unfortunately, as my colleague mentioned, we share the legislature's goal of ensuring all Californians have access to comprehensive affordable health care. Unfortunately, as drafted, SB 1037 introduces a new and subjective rate review process.

  • Steffanie Watkins

    Person

    More specifically, while we understand the desire to delink existing definition of unreasonable rate increases from the Federal Affordability Care Act in order to reflect California specific market, the framework proposed in this bill creates significant implementation challenges.

  • Steffanie Watkins

    Person

    As it's currently drafted, ten thirty seven introduces numerous new terms that have a potential to make the process not only confusing, but potentially inconsistent across regulatory bodies. We're concerned that the lack of certainty regarding compliance will lead to significant regulatory confusion as well as increased cost to the system. The bill also appears to combine the function of the office of health care affordability, application health care cost targets with DMHC and CDI's rate review process, which are fundamentally distinct.

  • Steffanie Watkins

    Person

    Additionally, while we appreciate the interest of considering affordability and the analysis that references the actual premium impact, we are confused about whether or not there are true deficiencies within the current process. If the argument is that there are there is additional information necessary to determine something to be unreasonable or reasonable, we certainly wanna have those conversations going forward.

  • Steffanie Watkins

    Person

    But if this is an an exercise in looking at affordability disconnected from the actual functional rate inputs that create a reasonable or unreasonable rate, we're not sure that this actually benefits the consumer rather than just add its additional cost to the system. So for those reasons, we remain opposed to the bill, but certainly do look forward to continuing conversations if it moves forward today. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Are there others in the hearing room who would like to offer opposition to this measure? Seeing none, I will bring it back to committee for any comments or questions. Assembly Murshiavo.

  • Pilar Schiavo

    Legislator

    I wanna thank the author for this bill. I think, you know, as was stated, and this is something that I saw for workers for many, many years that they will go to the bargaining table. And after COVID, I mean, there are some unions, hotel workers, for example, who got zero wage increases because everything went to health care. And so it's something that we don't think about all the time about the downward pressure on wages that health care actually has.

  • Pilar Schiavo

    Legislator

    But because health benefits are taking up so much of the money that is on the table, it's a huge, huge detriment and is one of the, you the biggest cost that is really keeping workers behind in the state and in the nation.

  • Pilar Schiavo

    Legislator

    And, you know, as the impacts of HR 1 are felt and the cuts to our health care and subsidies have disappeared, we know that people are really struggling. You know, some people in my district have talked about paying more for their health insurance than they do for their mortgage.

  • Pilar Schiavo

    Legislator

    And so, you know, I think having daylight on this and having more transparency for us to inform us as policymakers to be able to make decisions that make sense and how we best can support folks and and policies that need to be changed, I think, is really, you know, critical for the work that we do. And, really grateful for your leadership on this and happy to move the bill.

  • Mia Bonta

    Legislator

    Thank you. We have a motion Seconded by Patel. Senator, I wanna thank you also for bringing for this bill. I did, just want to, have you address the opposition's concerns around the kind of conflation, if you will, between the rate review process and the impact of cost targets, which are outlined as something that is pretty, seminal to this to this measure.

  • Unidentified Speaker 014

    Thank you, madam Chair. I think the having the rate review process and the office of health care affordability, cost growth targets work together is essential to the rates being, those benefits being realized for consumers. And because, I think, to what, like, what the opposition said, like, the office of health care affordability has the all in approach around, there's cost growth targets for health plans, large physician organizations, and hospitals.

  • Unidentified Speaker 014

    To see the benefits of all that, the slowing of the of the increases in costs, we wanna make sure that all of those benefits are are realized on the rate side so that if we're seeing that the health plan isn't gonna meet the the cost growth target or there's gonna be big increases in rates.

  • Unidentified Speaker 014

    We now have this data on cost drivers at OCA to be able to reconcile and check against and see what are the actual drivers of what is being proposed in the rate on the rate side.

  • Unidentified Speaker 014

    I know I've heard on from the opposition arguments around, while the the rate regulation is looking forward, it's looking at proposed rates, whereas the office of health care affordability is looking backwards. We're looking at spending from the previous years and then doing enforcement over the next couple years after the actual, enforceable year.

  • Unidentified Speaker 014

    I think we can do both, and it's important that we can do both so that we can see moving forward what are the cost drivers, but also are looking backward with the data we have from the previous years to inform all of those decisions and what we can do to try to actually see those benefits and bring down the rising cost of care for Californians.

  • Mia Bonta

    Legislator

    Thank you. Senator, would you like to close?

  • Akilah Weber Pierson

    Legislator

    I wanna thank you and your committee staff once again. You know, eight out of 10 Californians say that health care affordability is a top priority. This bill and my next two bills will be specifically addressing that. You know, we can all agree that health insurance is extremely expensive, and health insurance premium growth is surpassing medium household income and cost of living.

  • Akilah Weber Pierson

    Legislator

    SB 1037 connects the work of OCA with regulated reviews of health insurance premium rates and respectfully ask for an aye vote on this bill.

  • Mia Bonta

    Legislator

    Thank you. We have a motion and a second. Please call the roll.

  • Committee Secretary

    The motion is do passes amended to the Appropriations Committee. Vonta.

  • Mia Bonta

    Legislator

    Aye.

  • Committee Secretary

    Vonta, aye. Sanchez, Addis, Agarakuri, Aarons, Koloza, Carrillo? Aye. Carrillo, aye. Jeff Gonzales?

  • Committee Secretary

    Jeff Gonzales, no. Mark Gonzales? Johnson? Johnson, no. Patel?

  • Committee Secretary

    Aye. Patel, aye, Patterson? Patterson, no. Rodriguez? Shievo?

  • Committee Secretary

    Shievo, Aye. Sharp Collins? Stephanie?

  • Mia Bonta

    Legislator

    That measure's on call, Senator. Thank you. We're gonna move on now to item number 10, SB 1094 by Weber Pierson.

  • Akilah Weber Pierson

    Legislator

    Okay. Thank you. Thank you, Chair, committee members, committee staff for all of your work on this bill. I will be accepting amendments to require plans and insurers to notify providers about this bill and that beginning 01/01/2027, their patients who are on a reference biologic will be eligible for pharmacy substitution of biosimilars on the formularies listing the patients and the possible substitutions.

  • Akilah Weber Pierson

    Legislator

    It also lengthens the period of another required notice to patients and providers about formulary change to sixty days in advance from thirty days and adding more details to the notice including which of the provider's patients will be affected and the expected cost sharing as well as provider options to keep their patient on the reference product if necessary.

  • Akilah Weber Pierson

    Legislator

    We'll also prohibit a PBM health plan or insurer or affiliated entity from requiring utilization of only a biosimilar product in which the entity has direct or indirect financial interest when other biosimilars may be available. So as I stated in the last bill, health care affordability is one of the top concerns of Californians. Over half Californians report health care costs rising faster than their incomes, and 60% rep report that they or a family member has skipped medical care due to cost.

  • Akilah Weber Pierson

    Legislator

    One of the underlying factors in this rising cost of health care is the cost of prescription drugs, which has increased by 72% since 2017. Biological products are particularly expensive, costing hundreds to thousands of dollars per injection.

  • Akilah Weber Pierson

    Legislator

    These are critical treatments, but their high price tags are putting a real strain on patients and our health care system in general. Fortunately, lower cost alternative like generics and biosimilars offer the same clinical results as their brand name counterparts. Over a past decade, studies have consistently shown that switching from a reference product to a biosimilar is not associated with any clinically significant difference in safety, efficacy, or immunogenicity. Despite having many safe, effective, lower cost alternative available, we are not using them to their full potential.

  • Akilah Weber Pierson

    Legislator

    This bill offers two practical ways to encourage biosimilar use to bring down cost and inject more competition into a system that brand name pharmaceutical manufacturers have controlled for a very long time.

  • Akilah Weber Pierson

    Legislator

    First, it allows pharmacists to substitute a lower cost biosimilar for a biologic when appropriate unless a prescriber indicates otherwise by adding do not substitute to the prescription. Second, it allows health plans to require patients to try a generic or biosimilar unless the prescriber indicates otherwise by adding do not substitute to the prescription. The plan is required to provide sixty day advance notice to the patient and provider with the amendments that we're taking in this committee.

  • Akilah Weber Pierson

    Legislator

    This bill only allows health plans to require a patient to try a biosimilar when the net cost of the plan of the biosimilar is lower than the reference product and the patient's cost sharing is the same or lower than the reference product. This bill also requires health plans to report on the impact of this policy on premiums and cost sharing.

  • Akilah Weber Pierson

    Legislator

    According to the California Orchard Probe analysis, this bill is estimated to generate savings for patients in our health system, including $4,000,000 in cost savings for patients who switch to a biosimilar and $90,000,000 in savings in the form of reduced premiums for employers, enrollees, and Medi Cal. At the core, this bill is about affordability, safety, access, which are key components for adherence with any treatment. Is about making sure Californians can get the care they need without having to choose between their health and their financial stability.

  • Akilah Weber Pierson

    Legislator

    Today, speaking in support is Nick Luisos from the California Association of Health Plans and doctor Bering, a pharmacist doctor with Western Health Advantage. Respectfully ask for your aye vote.

  • Mia Bonta

    Legislator

    Thank you. Each have two minutes.

  • Nick Louiseos

    Person

    Great. Thank you, Chair and members. Nick Luisos on behalf of the California Association of Health Plans urging you to support SB 1094 and thank doctor Weber Pearson for her leadership on this critical affordability issue. Policymakers have rightly declared affordability an issue and a top priority.

  • Nick Louiseos

    Person

    This is why our association is actively working to promote policies like SB 1094 to drive down spending while expanding access to FDA approved drugs that are safe, effective, and thus make health care more affordable and accessible for all Californians.

  • Nick Louiseos

    Person

    The author already went over the data about the unsustainable increase in list prices by the drug manufacturers, and we cannot sustain that trajectory unless bold policy moves are made. The independent analysis of this bill, indicates offsets to premiums and savings to consumer at the counter, and the, the author went over those numbers already. But, the bill achieves these savings, by simply updating outdated statutes to reflect modern science.

  • Nick Louiseos

    Person

    It aligns California with FDA clinical evolution and Medicare policy, allowing for the automatic substitution of safe, effective, and lower cost biosimilars. This is a common sense update to expand access to life saving medications without compromising safety.

  • Nick Louiseos

    Person

    Existing law, unfortunately, illogically places barriers in this regard and prevents substitution that save people money. So this bill is carefully crafted. It includes robust consumer protections, notification requirements, and reporting requirements. And this is why you see a broad and diverse coalition of, supporters for this bill. We need more solutions like this to lower the cost of care for all Californians, and we respectfully urge your high vote.

  • Nick Louiseos

    Person

    Thank you.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Karen Firing

    Person

    Hi, everyone. I'm doctor Karen Firing. I am a chief pharmacy officer for Western Health Advantage. I'm in here to support SB 1094 and thank doctor Weber Pearson for the opportunity to be here today. As a pharmacist with more than two decades of experiencing manage and managing medication access and affordability, I have seen firsthand the positive impact biosimilars can have for patients and the health care system.

  • Karen Firing

    Person

    SB 1094 would allow pharmacists to substitute FDA approved biosimilars unless the prescriber indicates otherwise, helping patients access safe, effective, and lower cost treatments while preserving physician oversight. At Western Health Advantage, we recently transitioned our population of patients using Solara to a FDA approved biosimilar. Through proactive physician engagement, patient education, and pharmacist led care coordination, we achieved a exceptionally successful conversion with no member abrasion, no member abrasion, no disruption in care, and continued positive clinical outcomes for our patients.

  • Karen Firing

    Person

    Our experience demonstrates what evidence has already shown. Biosimilars are safe, effective, and can reduce unnecessary health care spending while maintaining high quality patient care.

  • Karen Firing

    Person

    SB 1094 provides pharmacists an important tool to help Californians access these therapies more effectively and affordably. With for these reasons, I respectfully ask for your support in SB 1094. Thank you for your time and consideration.

  • Mia Bonta

    Legislator

    Thank you. Any others in the room who would like to offer support for the measure, please come forward with your name, affiliation, and position on the bill.

  • Matt Akin

    Person

    Good afternoon, Chair and members. Matt Akin on behalf of the Association of California Life and Health Insurance Companies in strong support.

  • John Wenger

    Person

    Madam Chair and members, John Wenger on behalf of America's Health Insurance Plans in support.

  • Dennis Romero

    Person

    Madam Chair and members, Dennis Quavos Romero with CPCA Advocates in Support.

  • Katelin Van Deynze

    Person

    Katie Van Dynes with Health Access California in support and adding on for SEIU California. Thank you.

  • Natalie Pita

    Person

    Natalie Pita on behalf of the California Academy of Family Physicians in support.

  • Andres Suarez

    Person

    Madam Chair and members, Andres Suarez with Blue Shield of California in support.

  • Alex Ramey

    Person

    Chair and members, Alex and Ramey on behalf of the Pharmaceutical Care Management Association in support.

  • Alexis Rodriguez

    Person

    Alexis Rodriguez with the California Chamber of Commerce in support. Thank you.

  • David Gonzalez

    Person

    Thank you, Chair and members. David Gonzalez on behalf of America's Vision Groups in support.

  • Mandy McIssley

    Person

    Mandy mcissley on behalf of CVS Health in support.

  • Michelle Rivas

    Person

    Michelle Rivas with the California Pharmacists Association with the amendments in full support. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Are there any primary witnesses in opposition?

  • Mia Bonta

    Legislator

    You'll have two minutes. Thank you.

  • Timothy Madden

    Person

    Thank you, madam Chair. Tim Madden representing the California Rheumatology Alliance. We currently have an opposed less amended position, but I wanna make it clear, it's on the bill. It's in print. We're in the process of reviewing the amendments that the senators just outlined.

  • Timothy Madden

    Person

    So we're hoping to get through those quickly. But I did wanna start with our appreciation to the Senator and her staff for her time and listening to our concerns. I think she's been overly generous in listening to me talk her ear off about our concerns. And I do believe the amendments that she describes do get at some of the concerns that we have expressed. Maybe not in the exact same fashion, but I do believe that they are intended to address some of our concerns.

  • Timothy Madden

    Person

    So I'm looking forward to working through those with our folks to see where we land. We do have one concern that was not addressed in the amendments and it has to do with the situation where a multi switch is occurring. So this is when a patient is moving from a reference product, a brand name product over to a biosimilar. And then once that switch is made, a subsequent switch is made to a different biosimilar.

  • Timothy Madden

    Person

    And we've also seen situations where they've been switched to a third biosimilar.

  • Timothy Madden

    Person

    So we're concerned with that for two main reasons. One, if there is a adverse reaction to that, the physician is left with not really understanding which of those biosimilars cause that reaction. Probably more importantly, my folks have expressed concerns with as you take more in different biosimilars, you develop antibodies against all of them. And there are some concerns that once you develop those antibodies, it actually inhibits your ability to go back onto the brand name product that you might have been stable on to begin with.

  • Timothy Madden

    Person

    But we have been talking to the Senator about that.

  • Timothy Madden

    Person

    We are talking about, getting into more details in July, and we look forward to having those conversations and available to answer any questions.

  • Mia Bonta

    Legislator

    Thank you. Are there any in the hearing room who would like to offer an opposition position?

  • Gilbert Laurie

    Person

    Gilbert Laurie here with Biocom with an opposed and less amended position also. Thanks.

  • Jennifer Snyder

    Person

    Jennifer Snyder on behalf of the Biotechnology Innovation Organization, opposed and less amended position as well.

  • Matt Back

    Person

    Matt Baack representing Osteopathic Physicians and Amgen. Like Mister Madden said, we had our both our opposition positions are based on the bill in print. We're looking forward to looking at the amendments, and, we'll go from there. Thank you, Senator.

  • Unidentified Speaker 005

    Kasia Hunt with Political Solutions on behalf of the California Dermatologists. We actually are not in opposition anymore. We had an oppose and less amended position, but are now moved to neutral based on the senator's amendments. So thanks to the Senator for all our work.

  • Mia Bonta

    Legislator

    Thank you. I'll bring it back to the committee now for any questions. We'll go Gonzalez and then to Patel.

  • Mark Gonzalez

    Legislator

    Thank you, madam Chair. You know, I was in opposition for this bill that one was in print. I don't know if you're aware. I have a son with special needs, cerebral palsy. So looking at this from the lens of a dad and an advocate and the challenges of of the different meds and then the biosimilars and how's that work, it really put me in a position of of opposition because we've experienced so many challenges.

  • Mark Gonzalez

    Legislator

    But after speaking to some folks on your team and then outside of that team, we learned a little bit more with with that and have moved to a place of support. So I wanna thank you for the for the constant communication, the clarity, and the amendments. I believe there's still a little bit more work to be done, but I think that can be done as we move this forward. So thank you.

  • Akilah Weber Pierson

    Legislator

    Thank you so much for that. Wanna thank, the supporters, but also those who have been in opposition. The notification requirements, the ability to allow providers at the end of the day to determine whether or not the switch is appropriate has been very important to me, and I know many in the opposition. Because when you're talking about these particular drugs, they're so specialized that at times that it takes people a while to get to a a place where they are stable.

  • Akilah Weber Pierson

    Legislator

    And you don't want to mess that up.

  • Akilah Weber Pierson

    Legislator

    Now not everyone takes that same long course, but there are some patients that do. And that's why in this bill, there are much stronger notification requirements than you have for any other medications, including interchangeable biosimilars, which can be switched right now without provider notification in advance. And so we we had the thirty day before, and now we've amended it to sixty day.

  • Akilah Weber Pierson

    Legislator

    And it's not just a basic notification because I get those notifications all the time that there's some new drug on a formulary, but I have no idea which one of my patients is on what health plan or on remember who's on which which medication. And so this one actually informs the provider of the formulary change and the patients that are there that could be impacted by this.

  • Akilah Weber Pierson

    Legislator

    And so if they look and they see, oh, you know, this patient, we've had a hard long road to get them stable. They need to stay on this medication. They have that ability to then go into that patient's chart, write a new prescription, and say do not substitute, and that will be honored by the pharmacist.

  • Mia Bonta

    Legislator

    Assembly member Patel.

  • Darshana Patel

    Legislator

    Thank you, Senator, for bringing this bill forward, and thank you for your willingness to have conversation with me even up to the last minute and make sure I understand the intent of this bill. As someone who worked on biologics in my past career, I'm very sensitive to understanding the difference between biosimilars and interchangeables that are FDA approved as interchangeables.

  • Darshana Patel

    Legislator

    And wanted to, just reflect on that as you clarified just now that even the interchangeables, while designated as essentially interchangeable through studies, those don't have any kind of noticing requirements. And that is very interesting to me as we think about protecting patients and and their changes to their prescriptions. I do have a couple questions for you to help me, understand this bill more fully.

  • Darshana Patel

    Legislator

    Please bear with me. Will this bill allow substitution of a prescribed biologic with any biosimilar, and what are the studies behind the biosimilars being essentially interchangeable? I know that you had cited some in the committee analysis that also described that there are studies that show that they are in practice fairly interchangeable. And are there any concerns around that?

  • Akilah Weber Pierson

    Legislator

    So I will let the my pharmacist talk about when they choose which actual biosimilar because there is a a book that they use similar to generics. But I will briefly touch on the difference between biosimilar versus interchangeable in that designation, and then we'll also let my my other witness, Nick, talk about it too. But inter interchangeability is a legal definition. It's not necessarily a scientific one. It was defined as a part of the ACA.

  • Akilah Weber Pierson

    Legislator

    And even though recently, the Federal Government has essentially said, and I'll I'll read a statement from the FDA, all biological products are approved only after they meet FDA's rigorous approval standards so health care professionals and patients can be confident in the safety and and effectiveness of a biosimilar product whether or not it has been approved as an interchangeable biosimilar just as it would be for the reference product.

  • Akilah Weber Pierson

    Legislator

    And so over time, what you've seen is that in order to get that designation as a as a as an interchangeable, the number of studies have been completely, like, whittled down, and it's really mainly just an application process at this point. The FDA can't change it because it was a part of the ACA, and so it has to be changed through Congress. And we all know how quickly Washington DC moves.

  • Akilah Weber Pierson

    Legislator

    And so because of that, the FDA has basically stated whether you're interchangeable or biosimilar, if we if you are FDA approved, you are basically the same as the reference product, and there was very little difference, if any, between the interchangeable and biosimilar.

  • Akilah Weber Pierson

    Legislator

    But I will let my pharmacist talk about how they choose it, and then Nick can jump on if there's anything else he wants to say about the difference between interchangeability and just basic biosimilars.

  • Akilah Weber Pierson

    Legislator

    So thank you for that, and great question. We get these questions all the time. So I I'm not I'm sure you're familiar with brand and generic medications. This is the most analogic, conversion that you can have is there's brand products, there's generic products. Although the generic is identical in terms of the chemicals, the excipients or maybe the powders or the colors are different.

  • Akilah Weber Pierson

    Legislator

    That's the difference between a brand and a generic. In a biosimilar, just as doctor Weber Pearson stated, it is identical in the in the make and product. What's different with biosimilars is it is a a protein. And although it is as close as as humanly possible, there there could be

  • Mia Bonta

    Legislator

    a little bit of a

  • Akilah Weber Pierson

    Legislator

    a nuance, and that's seen even with generics. So we see this today with, different types of generic and brand products. The bill today, what it's asking is not that we would be able to change the type of biosimilar. It would be in a one to one product. So we're not requesting to have the drug be a different type of mechanism of action.

  • Akilah Weber Pierson

    Legislator

    It would be an identical biosimilar to the reference product. I I have nothing to add. Actually, the Senator said everything that I was gonna say. So thank you.

  • Darshana Patel

    Legislator

    Yeah. Of course, the assumption would be that it wouldn't be a different active target or something like that for for treating that condition, that it would be an actual biosimilar. So I understand that. I just wanna make sure that sometimes as we have excipients and pressed powders or pressed pills, things like that, in the way a biologic is created, there may be differences in cell lines, media cultures, etcetera that could make that formulation slightly different and could react with the patient's body in treatment slightly differently.

  • Darshana Patel

    Legislator

    And when a physician finally has a patient on a treatment of care that seems to be working, we wanna make sure, as you have done in your bill, that you've put in the provisions that if you have a do not substitute, it is not to be substituted.

  • Darshana Patel

    Legislator

    And it also will not be substituted, as I understand, upon renewal of that prescription until a prescribing physician actively asks or makes that change themselves. Is that correct?

  • Akilah Weber Pierson

    Legislator

    That is correct. So once that initial prescription has been completed and you need to do a refill and you put do not substitute, that is exactly what will happen. It will not be substituted.

  • Dawn Addis

    Legislator

    And as a pharmacist practicing

  • Akilah Weber Pierson

    Legislator

    on the bench, we're legally not allowed to substitute once a physician has written do not substitute.

  • Darshana Patel

    Legislator

    Thank you for that clarification. That's important to know as well. And then is this a pause like, when you when a physician gets notified that there are biosimilars available and you've you declared that that the patient's names would actually be listed out. When you get a notification from a pharmacist in your bill, is that do you have to give positive affirmation that, yes, it is okay? Are you checking a box, yes, okay to prescribe?

  • Darshana Patel

    Legislator

    Or is it a notification and you have to say, no. Actually, we wanna keep them on this biosimilar or this the original?

  • Akilah Weber Pierson

    Legislator

    So it is a notification that they will be receiving from the health insurance company once it is on their formulary stating that this is something that could happen to these these patients that are on the medication. It's not coming from the pharmacist sixty days before. The pharmacist, to my knowledge, informs providers, like, I don't know, three or five within three or five days of the switch. So this is sixty days before from the insurance company.

  • Akilah Weber Pierson

    Legislator

    And then the provider would need to go in and say, do not substitute.

  • Akilah Weber Pierson

    Legislator

    Write a prescription that says, do not substitute.

  • Darshana Patel

    Legislator

    And is there a course of action for the patient to say if the physician did not make that notification something happened, they didn't receive it, and then the patient wanted to go back to their their original Oh, yeah. Their reference product. Yeah. They're in the Knox Keane Act that regulates health plans, there is an, expedited exceptions process. So if a person is switched and the medication turns out not to be effective or there are side effects, the, provider, can request to switch back to the original. And that's an expedited process. It's it's seventy two hours if it's nonurgent and twenty four hours if it's emergent. So that's that's the existing process. Yep.

  • Darshana Patel

    Legislator

    Thank you. I do oh, go ahead.

  • Akilah Weber Pierson

    Legislator

    I was just gonna say, and and we absolutely want our patients to advocate for themselves. So if they feel that this is the right medications for them, we we welcome that conversation.

  • Darshana Patel

    Legislator

    Okay. Thank you. I we have had, quite a few conversations, and I've gotten information from your staff on this. I do appreciate that you continue to work with opposition as we move this bill forward, but I am happy to support it today, and I'm look forward to seeing where it finally lands in its language. Thank you.

  • Mia Bonta

    Legislator

    Assemblymember Stephanie.

  • Catherine Stefani

    Legislator

    Thank you, Chair, and, thank you, Senator. I absolutely, agree with the premise of this bill. Health insurance premiums are way too high for several different reasons. And I just wanna make certain that this bill, if it's an affordability bill, that we are guaranteeing that the health plan must pass these savings directly to consumers.

  • Catherine Stefani

    Legislator

    I believe, if a health plan is saving millions by switching patients to lower cost drugs, I want to make sure that we are actually in this bill requiring them to return those savings to patients through lower premiums or lower out of pocket costs.

  • Catherine Stefani

    Legislator

    And my reading of the bill hasn't I haven't seen anything where we're actually requiring that savings to be passed on to consumers.

  • Akilah Weber Pierson

    Legislator

    Thank you so much for that question. That was, one of my initial, very hard conversations with the health plans about ensuring that the, cost would go back down to the actual consumers, and I will let the health plans give, their answer. But it's easier said than done. That's what I'll say. And because of that, that is why in the bill, they are required to give that report that basically lets us know where those savings come from.

  • Akilah Weber Pierson

    Legislator

    But I will turn it over to the plans to explain the complexity of that.

  • Nicholas Louizos

    Person

    Yeah. Thank you, Assembly member, for that question. Obviously, you know, you see us in committee all the time advocating against anything that increases premiums and advocating for policies like SB 1094 that tries to lower spending and, provide some level of affordability for, for consumers. The, independent analysis of this bill shows that, this bill will lead to an offset of premiums of about $90,000,000 and save between $91 and $310 in out of pocket costs for folks that are on these drugs.

  • Nicholas Louizos

    Person

    The bill also has a reporting requirement, because we believe the first step, in this is to, provide some level of transparency.

  • Nicholas Louizos

    Person

    Transparency is always the first step in this. And so there's a reporting requirement in this bill that requires the health plans to the report to the Department of Managed Health Care how the, substitutions and how the formulary modifications related to these drugs are going to impact premiums, and out of pocket cost for consumers. And so we'll analyze that data. Right now, health plans already report drug spending data to the Department of Managed Health Care.

  • Nicholas Louizos

    Person

    And so one of the lines that you'll see in that report, currently is, how rebates offset, premium growth.

  • Nicholas Louizos

    Person

    And so we imagine the department might interpret this bill to, you know, include a line, that way as well. Now this is one piece of the puzzle in affordability. You know, there are several headwinds that our our our members are facing, including, you know, the 1,500,000,000 MCO tax that was passed by the legislature and approved by the governor, which is gonna overwhelm any cost savings associated with this bill. But we need to start promoting bills like this in order to to to turn the tide.

  • Nicholas Louizos

    Person

    And so and wanna appreciate, and acknowledge Senator Weber Pearson's comments and budget committee, related to that tax.

  • Nicholas Louizos

    Person

    But, we you know, transparency is a first step. We'll we'll get the data, and I and I think it'll, serve as a platform for evaluation moving forward.

  • Catherine Stefani

    Legislator

    Through the Chair and and to the health plans, I I do know and I understand that this bill does require reporting on whether cost sharing and premiums are reduced, but reporting isn't the same as requiring savings being shared. It's just not. And I don't understand why you would oppose any language that would force you to pass those savings on.

  • Catherine Stefani

    Legislator

    If it it does require a report to DMHC and CDI on the percentage of substitutions, but this bill does not require that you pass those cost savings on. It's just data reporting.

  • Catherine Stefani

    Legislator

    And that's fine. We can get the reporting. But without requiring you to actually pass that on to the consumers, it leaves me a little skeptical of not the author of the bill, but of your intention on whether or not you would be willing to accept language in the bill that would force you to actually pass it on. Not just report that you've saved millions of dollars, but that you're passing those dollars onto the very patients that need that care.

  • Darshana Patel

    Legislator

    Would you

  • Nicholas Louizos

    Person

    Yeah. So health plans are already subject to the most stringent transparency, requirements, rate review, focus spending targets, etcetera, etcetera. Health plans are also subject to what's called the medical loss ratio. This is not a feature that is imposed on any other sector of the health care universe, which basically says that a health plan has to spend at least 85% of the premium dollar on direct medical care. If we don't meet those obligations, the consumer gets rebated.

  • Nicholas Louizos

    Person

    So, you know, we feel that the, you know, existing, you know, regulatory rigor around cost and affordability as it relates to health plans, provide some mechanisms and triggers in that regard.

  • Akilah Weber Pierson

    Legislator

    So I'm gonna ask my sponsor to specifically address the complexity with ensuring that each individual patient is getting that the cost sharing, whether they have, you know, different types of insurance and how that would work because that was the conversation that I was told when we were having this very same conversation.

  • Nicholas Louizos

    Person

    Yeah. No. Thank thank you, Senator. So the bill only allows for substitution if it's gonna be the it it it it's a lower cost product. And if the consumer is going to see the same or lower share of cost at the pharmacy counter.

  • Nicholas Louizos

    Person

    And so that those are the parameters around when the substitution would actually take place. And so, you know, with respect to the complexities, we already have a co pay cap in existing law for prescription drugs. So a person is not required to pay over a certain amount according to statute. And I wish I had the statute in front of me, and I can tell you that amount.

  • Nicholas Louizos

    Person

    So, you know, with respect to, you know, whether, you know, each and every time a person's gonna see savings at this at at at the counter, that that is most likely to occur.

  • Nicholas Louizos

    Person

    In fact, our our health plans that switched people off of Humira onto the biosimilars version of the drug, a lot of our plans are actually offering zero share of cost for those folks. So people are seeing direct benefits to, you know, at the pharmacy counter with respect to biosimilars.

  • Mia Bonta

    Legislator

    I I fear, Assemblymember, that you are probably not have not been made whole in any of those responses.

  • Catherine Stefani

    Legislator

    Your fear is definite definitely realized. And I do have another question too around patient stability. And, you know, if a patient has found a a biologic that works after months or years of trial and error, This is what really gets me is why should the state make it easier for that therapy to change for financial reasons for the health plans rather than clinical reasons for the patient? Because this is about financial especially if we're not requiring you to actually pass that on.

  • Catherine Stefani

    Legislator

    We we know that you're gonna report the data, but we don't know that it's actually going to benefit the patient anyway, and we're allowing you to change in putting the burden on the doctor, it's now the doctor that's going to have to write do not substitute.

  • Catherine Stefani

    Legislator

    And it's just another form that the doctor is gonna have to fill out, to make certain that the health plans are allowed to realize these cost savings that we're not sure whether or not will actually be passed on.

  • Nicholas Louizos

    Person

    So biosimilars are very well, they're they're defined in both federal and state law. I don't know if, doctor Beyering, you had any, you know, comment to that effect on what we're talking about. I mean, biosimilars basically have to be or, in essence, have to be the same, I mean, as as as the as the biologic. So I'm not exactly sure, you know, how to respond to that other than that. So I'll I'll I'll defer to the doctor on this.

  • Akilah Weber Pierson

    Legislator

    I'll I'll just answer. So, I completely understand your concern, about ensuring that the the cost is passed on to the patients. It is very challenging, to ensure that all of the costs go to each individual patient, but what we're looking at is the health care system overall. And that is one of the reasons why we have that report because let's just say that with all of the bills and all of the things that we add, someone's health insurance premium would have gone up by a $100.

  • Akilah Weber Pierson

    Legislator

    But because we have implemented this bill, it has now reduced that premium from going up a $100 to $10.

  • Akilah Weber Pierson

    Legislator

    We would see that information in the report. Now as far as patients being stable on a medication, that would be up to the provider. If the provider feels like this patient should not be switched, they can give that designation. I don't have that designation really right now. I have no clue when something I prescribe is going to be switched without my permission.

  • Akilah Weber Pierson

    Legislator

    I just write a prescription, and then I and then somebody comes to me and says, oh, I have an issue with this medication. And I look, and I'm like, this is not what I prescribed. But because laws allow for brand names to be switched to generics without providers having the ability to say anything, then, yes, you do have one or two patients depending on, you know, the drug or whatever that has a different type of side effect.

  • Akilah Weber Pierson

    Legislator

    We don't give, unfortunately, that right to doctors or patients upfront for anything else. Now, like I said at at the beginning or during my talk, this is actually implementing a process of notification that we don't have for any other medications that we're prescribing this time.

  • Akilah Weber Pierson

    Legislator

    Brand name, generic, or interchangeable. So I understand the concern about a patient being stable, and and why would we not allow for the patients to to be able to to say, I wanna stay on this drug. I believe, Nick kind of answered that, that they can say that with the work of the pharmacist.

  • Akilah Weber Pierson

    Legislator

    But also the providers very early on can say, I want this patient to stay on this medication and not be switched over, which we do not give providers the opportunity to do for any other class of medication at this time.

  • Catherine Stefani

    Legislator

    Thank you. I'll I'll just I'll just end by saying, the health care system, as you say, is obviously very complicated, very opaque. And for me, you know, I I wanna be there with the Senator on this because I think the intention is there to make sure that, we are lowering health care premiums for patients, while at the same time, there's not a lot of trust I have to make sure that that is actually going to get done.

  • Catherine Stefani

    Legislator

    Data reporting is not requiring the health plans, and I just fear that years down the line, we'll have, you know, we'll have realized that this didn't do really what we thought it would do.

  • Catherine Stefani

    Legislator

    And I just think that, with record profits and no assurance that this is actually going to be passed on to the patients, I I I I'm happy to support the bill today in hopes that, when I see it again, there'll be language that would require you to actually pass those savings on to the patient.

  • Catherine Stefani

    Legislator

    Thank you.

  • Mia Bonta

    Legislator

    Assemblymember Addis.

  • Dawn Addis

    Legislator

    Thank you so much. And I wanna appreciate the comments from our colleague from Sacra San Francisco. Those were very similar to questions and comments that, I had last time. I think it was in BMP when we heard this bill maybe. But, just I just wanna kinda check my understanding as well, which is when I was looking at the CHBURP report, it looks like the majority of people would save somewhere between $1 and $6.

  • Dawn Addis

    Legislator

    Is that just to I'm just trying to clarify who's saving what.

  • Nicholas Louizos

    Person

    Yeah. For yeah. On average, if you spread it out, but the children

  • Dawn Addis

    Legislator

    else Sorry. It's just that the majority of people so the Medi Cal, the CalPERS, the individual, the small group, the large group, if you have those plans and you don't use this medication, you potentially save between 1 and $6. So

  • Nicholas Louizos

    Person

    Right.

  • Dawn Addis

    Legislator

    For for someone like that, and I think many people on the dais may be one of those people. I don't know everyone's insurance or health and health situation. But what would we see what would we see in terms of saving that 1 to $6 if this Yeah.

  • Nicholas Louizos

    Person

    I mean, that would that would that would be a part of the rate review process. So when plans plans need to go through regulatory process for premiums and rates, and their actuaries submit information to the Department of Managed Health Care about their costs. And, the Department of Managed Health Care has the ability to stamp a a a great as unreasonable, if their actuaries disagree with the plan actuaries. So that would be a part of the whole, you know, data collection and review process, at the DMHC.

  • Nicholas Louizos

    Person

    And again, I think the reporting requirement in this bill shines even greater focus, you know, on that, and we're probably valuable to that to that process.

  • Dawn Addis

    Legislator

    But I mean, when I get my insurance bill, it sounds to me like it won't be 1 to $6 less if I don't have this medication, or it won't be 92 to $310 less Yeah. If I do take this medication.

  • Nicholas Louizos

    Person

    That's not will it actually be a line item in your bills, so you're

  • Dawn Addis

    Legislator

    saying would actually when I pay my bills, am I actually gonna have say I do take the medication, am I gonna have 92 to $310 more to spend each year because I'm no longer paying that for insurance?

  • Nicholas Louizos

    Person

    Yeah. I mean, that that that's an estimate by the California Health Benefits Review Program. So if you are switched, and but you can only be switched if it's a if if, it's a lower cost drug, and, that will likely, perhaps not 100% of the time, will result in a lower out of pocket cost for you. So you will see it at the pharmacy counter.

  • Dawn Addis

    Legislator

    So not in the insurance premium. It's when you go to the

  • Nicholas Louizos

    Person

    Yeah.

  • Nicholas Louizos

    Person

    I mean, there's so many factors that go into your premium. Unfortunately, you know, this bill I'm I'll be honest. This bill in and of itself, while it offsets premium growth, it's not gonna lower premiums because there are so many headwinds with respect to affordability and cost, including, you know, the recent tax that was signed by the governor yesterday.

  • Nicholas Louizos

    Person

    You've got and, you know, we stated it in our our, testimony, a massive increase in the cost of drugs and drug spending, you know, over the last several years. Hospital costs, are going up.

  • Nicholas Louizos

    Person

    All those things factor into your premium. So, you know, I'll, you know, I'll just leave it at that. You know you know, are you gonna see it in your actual bill? It'll it'll it's part of the overall, you know, development of the rates.

  • Dawn Addis

    Legislator

    Okay. So it won't lower premiums. Okay. So we've established this bill is not gonna lower premiums.

  • Akilah Weber Pierson

    Legislator

    Well, I wouldn't necessarily say it won't lower premiums. It may not allow for premiums to go up as much as they would without it. And I had already kind of alluded to that.

  • Jennifer Snyder

    Person

    That's correct.

  • Akilah Weber Pierson

    Legislator

    Especially with all of the the items that were just mentioned. When you look at and that's why the report is so important, which I have also stated before. When you look at the report, if it states, because of everything that we've done or what has happened or because of cost of medications, your premiums would have gone up by a $100. But because of biosimilars and maybe some other things, it's only going up $20. You can see that that's a change.

  • Akilah Weber Pierson

    Legislator

    Now your premiums are still going up, but they're not going up as much as they would had something like this not been in place. That's number one. Number two, I think the other thing that I was mentioning is that for individuals who are on these medications, their out of pocket expense will go down because they cannot be switched to anything that would make it go up. So it has to be either the same or lower.

  • Akilah Weber Pierson

    Legislator

    So that's why he was stating that for some people who are paying out of pocket right now when they go in the what they've seen in other states or for other entities that have already established something like this is that people now have, like, a zero out of pocket expense.

  • Akilah Weber Pierson

    Legislator

    And so that is a real savings for that particular patient who's used to paying a significant amount of money out of pocket for these medications.

  • Dawn Addis

    Legislator

    And they'll see that thank you, Senator. Maybe through the Chair. They'll see that where?

  • Akilah Weber Pierson

    Legislator

    At the pharmacy department? Pharmacy. K.

  • Dawn Addis

    Legislator

    I I I'll just say I I I'm gonna support the bill to help it continue moving through the process. My my concerns have not changed, from from when we saw this in the last committee, in turn. And I think they were my colleague from San Francisco expressed it very well. I still remain incredibly concerned about how we talk about health care savings that actual everyday people don't see those savings. We talk about system savings.

  • Dawn Addis

    Legislator

    The plans are saving. But I have massive concerns that regular everyday people, that doesn't get to them. I I under I have absolute respect for you. I don't think that's your intention. I appreciate the report, those pieces.

  • Dawn Addis

    Legislator

    But if we're talking about changing care for people, it doesn't make sense to me that they wouldn't that everything else would just stay the same for them. Right? The premiums stay the same, that all these other pieces would stay the same even if care is changing.

  • Mia Bonta

    Legislator

    Well, I will say that the Senator just responded that one thing that would be changing are the out of pocket costs, and I think that that's an important thing for us to focus on.

  • Mia Bonta

    Legislator

    I think from the discussion, what I am hearing is an overall frustration with the ability to have either health care savings or quite frankly, health care an increase to health care premiums, not for us not to be able to get a full handle around whether one any one particular transaction in our health care system, the one that we're reviewing right now, has an impact on health care premiums. That's, I think, to be honest, a a a problem that is larger than this particular bill.

  • Mia Bonta

    Legislator

    And I think the frustration that we are all feeling, certainly expressed by our Assembly members on this day is that we don't have the ability to, understand whether what kinds of costs, if any, savings will actually go back to, the person who is being insured, the patient.

  • Mia Bonta

    Legislator

    And, and I think you hear in the support, the proponents' testimony and responses to these questions, the the complexity of us actually being able to do that, which quite frankly, I think speaks to why I was supportive of SB 1037.

  • Mia Bonta

    Legislator

    So wanna thank the Senator for making sure which talked about rate reviews. I wanna thank the Senator for bringing forth this bill. I think senate Assembly member Patterson had a question as well, comment.

  • Joe Patterson

    Legislator

    Yeah. Thank you for that. Yeah. A couple items. I just you know, it is complicated system.

  • Joe Patterson

    Legislator

    You know, I think if you look at what I do know is according to the CHURP analysis, without this bill, premiums are gonna go up between 1 and $6. Is that correct?

  • Nicholas Louizos

    Person

    That's correct.

  • Joe Patterson

    Legislator

    Or at minimum, we won't save the 1 to $6. But it gets so complicated. You know, Aye, you know, I have this colon cancer bill that we have had opportunity to talk about every year, and it could be, you know, maybe it maybe this blood test is cheaper to use than maybe a colonoscopy, but maybe it increases access. You know, more people get a colon you know, a screening as a result. So health care costs actually go up.

  • Joe Patterson

    Legislator

    Does that mean we turn it down? You know, it's just so complicated, you know, to to look at it like that. But what I do know because of the CHPRP analysis, which we used every single piece of legislation, is that there's an impact without this with this bill of helping people 1 to $6. Now as you said, there are a lot of headwinds potentially that will increase health care costs, and so they don't actually come down.

  • Joe Patterson

    Legislator

    But there's systemic issues in the health care system that I think everybody's concerned about up here.

  • Joe Patterson

    Legislator

    But I do have some questions about, you know, the the opposition, Mister Madden, or soft opposition or, you know, figuring out how to get to neutral position. You had mentioned something about biosimilars potentially causing, you know, in the like, you'll be resistant now to that biosimilar. And as a result, all the all those classes. Right? All the the interchangeables and and everything.

  • Joe Patterson

    Legislator

    So is that, like, is there any evidence that the biosimilar would cause that more than the biologic? Or is that so you understand what I'm saying? Is the biosimilar an issue in this case where it's more likely to cause people to be immune from receiving the benefits of that drug than than the biologic?

  • Timothy Madden

    Person

    So I'll do my best to give you an answer from a contract lobbyist slash pertaining to a physician.

  • Timothy Madden

    Person

    Hey. I'm the politician up here. I don't understand zero of this. So Be talking the same language. Yeah. And I'll I'll use an example to kind of exhibit what the concern that I'm hearing from the rheumatologist is. And I

  • Timothy Madden

    Person

    and I would start with is that we would disagree. I know there's been a lot of discussion that there is no difference from an efficacy standpoint between biosimilars and the brand name biologic. The experience of the rheumatologist that assures that there are differences. Patients who have these autoimmune conditions, each patient is unique in terms of what medications might work for them. So that's just been our experience.

  • Timothy Madden

    Person

    And I know it it may not be consistent with what's being described from the proponents. But the example I wanted to share was a physician had a patient that was stable on Humira, and they've been stable on Humira for a couple of three years. And they said, okay. Let's we'll just have you back in four months for our normal checkup. The patient left.

  • Timothy Madden

    Person

    Subsequent to that, when their medications was coming from the pharmacy, they had been switched to a biosimilar, and this was in month number one. The next month, they were switched to a different biosimilar. So that's biosimilar number two. And then the next month, they were switched to a third biosimilar. So that's and then as a result of that, they came back after four months and they Harabedian adverse reaction.

  • Timothy Madden

    Person

    And when they sat down with the physician, she was kind of lost because she's like, well, we had you on Humira. What happened? And the patient explained this process of being switched three times. And as the physician explained it to me, she was saying that two problems are is that one, she has no idea which of the three biosimilars caused the reaction.

  • Timothy Madden

    Person

    But more importantly, to try and answer your question, is that she was saying that in this process in taking different biosimilars that your body actually builds up those antibodies against all of them.

  • Timothy Madden

    Person

    So what she said was, she goes, Tim, I don't even know if I can get them back onto Humira because they had taken these other biosimilars that has now given their body the opportunity to kinda figure it out to then get to a place where Humira doesn't even work for them. So that's the concern that I was trying to express, but I'll pause there and see

  • Joe Patterson

    Legislator

    if No. That's that's that's great. That's a great illustration. And so your concern really relies upon that kind of example. Right?

  • Joe Patterson

    Legislator

    Not so much because the physician can write, you know, do not substitute on there. Right? And then that'll be some kind of education, I'm sure, to the providers. But but I guess what so they've addressed a big portion of your bill, correct, or your concerns, right, with do not substitute?

  • Timothy Madden

    Person

    They tightening that up does address their and I'll be a little bit loose on my answer. They the dermatologists, were really focusing on the do not substitute aspects. So I would agree that that's gotten a lot tighter, and it does help our folks as well. In the multi switch examples, I will point out that if you do mark do not substitute, that's kind of a it's either yes or no. So for Humira, there are 10 different biosimilars, eight are interchangeable, two are not.

  • Timothy Madden

    Person

    So if you if you mark do not substitute, the physician is saying you can't switch to any of those 10. So a physician might be okay for a switch to occur between one or two of those. So they may not mark that do not substitute box. So that's that's kind of a scenario that we see. You're right.

  • Timothy Madden

    Person

    They could mark do not substitute, that would avoid this multi switching situation. But for some patients, our folks might be open to that switch occurring.

  • Joe Patterson

    Legislator

    Yeah. Well, you know, I supported this bill last week and intend to support it today as well. You know, that is an interesting dynamic there that I think, you know, maybe we maybe we can have it addressed or not. But but that said, you know, I and I know in this particular practice, you know, actually, if you're blessed enough to have a friend who's a doctor, you know, they get to hear all your problems, like a therapist or something. And so my friend was saying, hey.

  • Joe Patterson

    Legislator

    Look, Joe. You gotta you have an autoimmune. It'll take you forever to figure out what it is. You know? And so, you know, throw that one out the door for now.

  • Joe Patterson

    Legislator

    Right? So I know it's a very hard thing to get to the point where you know, you know, especially what you're gonna prescribe. Right? So I understand the concerns around that, and and I'm glad that you expressed it in a way that I can understand it. And I I'm sure doctor, Weber Pearson is, taking note of that.

  • Joe Patterson

    Legislator

    But I I like the amendments that that have been taken, even since, you know, last week, and I think this is a good really a small step, you know, in addressing affordability crisis. But, also, if there's, in most cases that aren't quite as complicated as that, you know, I think this is gonna be a benefit to the system. And oh, okay. Sure. Yeah.

  • Timothy Madden

    Person

    Yeah. And I just wanna also mention, in the center might be getting teed up to say this as well is because this has been one of the things that we've talked about quite a bit is that I I do think the language and the health and safety code, the amendments, there is a possibility that that would not be allowed. So that's that's part of the conversation that we agreed to just continue to talk through. Yeah.

  • Timothy Madden

    Person

    So it's it's, I think, it's less clear on the B and P Code side in terms of the pharmacist, but nonetheless, we've been having very open conversations about this.

  • Joe Patterson

    Legislator

    So Well, I appreciate both your approach on this, being able to work together to come out with a better product. And, obviously, if you you comment on your closing or whatnot, but appreciate your work on this and looking forward to supporting it today.

  • Mia Bonta

    Legislator

    I think you're raising a a very important concern, Assemblymember Patterson. And my understanding is that the changes that we would seek are are actually in the BMP code. So we are going to have a challenge presented to the Senator for figuring out how we might be able to do that given that that was already heard in BNP. But, Senator, did you wanna make comment on this?

  • Akilah Weber Pierson

    Legislator

    So I wanna just clarify that what the opposition is referring to as far as the switching, that is with interchangeable biosimilars, not with biosimilars. And I've already stated that bios interchangeable biosimilars have a very different regulatory pattern. It is not addressed in this bill. We are continuing conversations to ensure that when we're talking about biosimilars, which cannot do this, that we are making sure that there wouldn't be switch.

  • Akilah Weber Pierson

    Legislator

    But right now, we're talking about a switch from the reference product to one biosimilar, not from a biosimilar to another biosimilar.

  • Akilah Weber Pierson

    Legislator

    So the situation that his client or the physician that he works with is referring to is the fact that interchangeable biosimilars have been changed or switched multiple times, but that has nothing to do with this bill or biosimilars.

  • Mia Bonta

    Legislator

    I I I think what I heard, however, is that they're like, it we would be okay because there would be an ability to change amongst eight different interchangeable biosimilars. But then because there's it's either a yes or no question, you wouldn't have the ability to do that. Did you wanna say a little bit more?

  • Timothy Madden

    Person

    Yeah. No. I think you have it. But I just wanna point out that the bill does expand the ability to switch to biosimilars that are not interchangeable. So it actually increases our concern because we're talking about biosimilars.

  • Timothy Madden

    Person

    And we believe the interchangeable status has value and it means something. So these other two biosimilars in the Humira family have not been tested to be interchangeable with Humira.

  • Mia Bonta

    Legislator

    Okay. Well, I think on this one, the Senator will continue to try to move to can nail this one down so that there's concern it's a it's an opposed unless amended. I think the Senator is very well aware of the specific concern in that, and we will look forward to seeing any changes about that as should this bill move out of committee. I'm going to have Assembly member Patel perhaps offer the last question or comment on this. I have several.

  • Mia Bonta

    Legislator

    Oh my goodness. Such the jokes to you. Go ahead.

  • Darshana Patel

    Legislator

    Thank thank you, madam Chair, for allowing me a second bite at this apple. So with this concern that's brought forward, I'm wondering whether but it sounds like maybe this is something that would have need to have been done in BMP.

  • Mia Bonta

    Legislator

    I think that there are always opportunities to amend legislation, and this is something I think that the Senator is willing to make sure gets addressed as the bill moves forward.

  • Akilah Weber Pierson

    Legislator

    To look into this as we've been having conversations with Mister Madden. However, like I said, the current issue deals with interchangeable biosimilars, which is not addressed in this bill. That issue could be addressed in another bill in the future whether not you allow for interchangeables to be switched from one to one. But in this bill, it talks about allowing the reference biologic process to be switched for a biosimilar. It is not talking about a biosimilar being switched to another biosimilar.

  • Mia Bonta

    Legislator

    Thank you

  • Darshana Patel

    Legislator

    for that, and I look forward to seeing how it lands finally when it comes back to the floor. But this raises some very interesting things to think about going forward. Thank you. Thank you.

  • Mia Bonta

    Legislator

    Seeing no other comments, Senator, would you like to close?

  • Akilah Weber Pierson

    Legislator

    Yes. Really wanna thank the Chair and this committee for for all of the amendments and this very lengthy discussion that we've had today over this extremely important bill. You know? And maybe we should rephrase how we talk about the cost around this bill. Instead of, you know, focusing on the savings of cost, recognize that this is not going to be a driver of increased health care cost.

  • Akilah Weber Pierson

    Legislator

    The vast majority of bills or a lot of the bills that we pass in this space are actually adding cost, whether it's a good thing or not, extra every test, every extra coverage that we do is adding cost. This is not a driver that increases health care cost. And that is extremely important when we talk about the issue of affordability.

  • Akilah Weber Pierson

    Legislator

    It allows for physicians to still determine which medications their patients will be on, at the same time finally doing something within our health care system that will not drive cost up. And for that reason, respectfully ask for your aye vote on s B1094.

  • Akilah Weber Pierson

    Legislator

    Thank you.

  • Mia Bonta

    Legislator

    Alright. We would need a motion. Thank you. Patterson Sanchez. Secretary, please call the roll.

  • Committee Secretary

    The motion is do passes amended to the Appropriations Committee. Bonta?

  • Mia Bonta

    Legislator

    Aye.

  • Committee Secretary

    Bonta, aye. Sanchez? Aye. Sanchez, aye. Addis?

  • Committee Secretary

    Aye. Aye. Aye. Aye. Aye.

  • Committee Secretary

    Aye. Aye. Aye. Aye. A Johnson, Johnson, Aye, Patel, Patel, Aye, Patterson, Patterson, Aye, Rodriguez, Chiavo, Sharp Collins, Stephanie, Stephanie, Aye.

  • Committee Secretary

    Aye. Aye. Aye. Aye. Aye.

  • Committee Secretary

    Aye. Aye. Aye. Aye. Aye.

  • Committee Secretary

    Aye. Aye. Aye. Aye. Aye.

  • Committee Secretary

    Aye. Aye. Aye. Aye. Aye.

  • Committee Secretary

    Aye. Aye. Aye. Aye. Aye.

  • Mia Bonta

    Legislator

    That measure's on call. Thank you, Senator. Thank you for that robust conversation. We are gonna move on to your last item for the day, item number 11 s B1199 by Weber Pearson regarding prescription drug cost sharing.

  • Akilah Weber Pierson

    Legislator

    Okay. Thank you, madam Chair, and I wanna thank you guys so much for putting five of my bills, on the same committee. But my final bill is SB 1199, which would ban the use of co pay accumulators in California joining 20 other states and banning these. I will be accepting the committee amendments today. Co pay accumulators are a harmful practice increasingly used by health insurers that can leave patients with significant out of pocket cost.

  • Akilah Weber Pierson

    Legislator

    Co pay accumulators allow insurers and pharmacy benefit managers to pocket patient assistant intended to help patients meet their share of cost instead of counting those payments toward the enrollees annual out of pocket limit. For individuals living with chronic or terminal illnesses, out of pocket costs can quickly add up when having to pay the health plan's maximum year after year, making it difficult to afford essential medications and treatment. This is especially true for patients diagnosed with conditions that require specialty medications to manage their condition.

  • Akilah Weber Pierson

    Legislator

    Over the past decade, insurers have increasingly shifted the cost sharing of specialty medications to patients by increasing deductibles and charging coinsurance for specialty medications, which allow California regulated plans to avoid California's 250 monthly co pay cap for prescription drugs. As a result, many patients must rely on financial assistance from third parties to afford their vital medications even though they have health care coverage.

  • Akilah Weber Pierson

    Legislator

    However, insurance are increasingly undermining this assistance by not counting the amount of money covered by manufactured or charity co pay assistance programs towards enrollees annual deductible and out of pocket limit. Instead, the co pay assistance funds are accepted by health plans or PBMs, but not counted toward the patient's cost sharing obligation. Banning co pay accumulators can also help avoid situations in which individuals may forego necessary treatments due to cost concerns.

  • Akilah Weber Pierson

    Legislator

    By helping patients maintain adherence to their medications, this legislation can lead to better health outcomes for patients and lower long term costs to our health care system by reducing costly emergency room visits and hospitalizations. Additionally, these co pay assistance programs help address health inequities by making necessary medications available to underinsured and under resourced patients who otherwise would have to choose between food and medicine.

  • Akilah Weber Pierson

    Legislator

    It is imperative that we take action to ensure that all patients have access to the care they need without facing financial obstacles. To date, 20 states, both red and blue, have banned their use, and I would like to add California to that list. Thank you and would respectfully ask for an aye vote at the appropriate time. With me in support is Miguel Mercedes representing the bill sponsor, the Department of Insurance, and Nisha Trivedi. Thanks.

  • Kate Sanchez

    Legislator

    Thank you. You'll each have two minutes. Please go ahead and press your button.

  • Nisha Trivedi

    Person

    Oh, thank you. Good afternoon. My name is Nisha Trivedi, and I live in South San Francisco. I was born with the rare genetic skin disorder epidermolysis bullosa or EB. Because a critical protein that binds the layers of skin together is missing, my skin is very fragile.

  • Nisha Trivedi

    Person

    I get blisters and wounds very easily, so I have to be extremely careful about my daily activity and choice of, say, clothing or shoes. In addition to EB, I also have eczema. As you might imagine, the combination of the two conditions is hugely problematic. Fortunately, for the last five years, I've been on a medication called Dupixent, a twice monthly injectable, and it has helped immensely with itch. The drug costs thousands of dollars per month.

  • Nisha Trivedi

    Person

    Thankfully, I get a co pay assistant card from the manufacturer, so I don't need to pay this out of pocket. However, my insurance plan this year, like others in California, does not count that co pay assistance towards my deductible or my out of pocket Max. Last year, this wasn't the case for me. But when my husband's employer switched plans in January, we discovered that the new plan has a copay accumulator program.

  • Nisha Trivedi

    Person

    As a result, our out of pocket costs for 2026 are nearly $3,000 higher versus 2025.

  • Nisha Trivedi

    Person

    Meanwhile, the insurance company gets to double dip. Please note, I already pay out of pocket for the specialized bandages that I need for EB related wounds. Those supplies have never been covered and probably never will be covered by insurance. SB 1199 will require that health plans count the value of co pay assistance towards cost sharing requirements. This would bring many chronically ill patients like me financial relief.

  • Nisha Trivedi

    Person

    Since DUPIXENT is undergoing clinical trials for use in all EB patients alongside other therapies, this issue has become more urgent than ever for

  • Nisha Trivedi

    Person

    community. And I should also add that the insurance company's argument is that patients should have skin in the game. I hope that from what you've heard, you agree that I have quite enough. So I urge you to please support SB 1199. It will protect patients like me from unethical, harmful co pay accumulator policies.

  • Kate Sanchez

    Legislator

    my

  • Nisha Trivedi

    Person

    Thank you for your consideration and for your leadership.

  • Kate Sanchez

    Legislator

    Thank you.

  • Miguel Bastidas

    Person

    Good afternoon, Chair and committee members. My name is Miguel Bastidas with the California Department of Insurance here under the leadership of insurance commissioner Ricardo Lara. As a proud cosponsor of, or sponsor of SB 1199, commissioner Lara would like to thank Senator Weber Pearson for her leadership in authoring this critical patient protection measure. SB 1199 simply fixes an accounting issue.

  • Miguel Bastidas

    Person

    If cost sharing is paid by a consumer or on their behalf by anyone to obtain their medications, it should count towards the maximum out of pocket limit, also known as MOOP.

  • Miguel Bastidas

    Person

    Existing federal law requires all cost sharing account towards the MOOP. This includes payments made by a consumer, but also payments made on their behalf. In California, existing law bans manufacturer assistance on cost sharing for prescription drugs except in specific circumstances. SB 1199 does not change the underlying policy of the state or Federal Government regarding the use of coupons. Instead, SB 1199 would hydrogenize existing federal requirements related to counting cost sharing with California's existing public policy related to manufacturer coupons.

  • Miguel Bastidas

    Person

    By merging current state and federal requirements, SB 1199 encourages carriers and PBMs to put lower cost generics on their formularies, which in turn helps steer patients away from higher cost brand name drugs and discourages their overuse. At the same time, SB 1199 ensures that patients are able to have their cost sharing count towards their MOOP when legal in California.

  • Miguel Bastidas

    Person

    As one of the regulators of the private health insurance market in California, it is critical that the department has the tools to enforce both state and federal law. SB 1199 simply codifies what is already good federal law. On behalf of insurance commissioner Ricardo Lara, I respectfully ask for your aye vote.

  • Miguel Bastidas

    Person

    And also with me today is Tessa Hodges, assistant chief counsel with our health equity and access office. Thank you.

  • Kate Sanchez

    Legislator

    Thank you. Are there others in the hearing room who would like to register support for this measure? Please come forward.

  • Natalie Pita

    Person

    Hi. Natalie Pita on behalf of the California Academy of Family Physicians in support.

  • Unidentified Speaker 005

    With political solutions on behalf of the California Children's Specialty Care Coalition in support.

  • Timothy Madden

    Person

    Tim Madden representing the California Rheumatology Alliance, the California chapter with the Marion College of Emergency Physicians, and the California chapter California chapter with the Marion College of Cardiology, all in sport.

  • Kel Johnston

    Person

    Kel Johnston with the National Multiple Sclerosis Society in support.

  • Kevin Guzman

    Person

    Kevin Guzman with the California Medical Association in support.

  • Christine Falabel

    Person

    Christine Falabel, American Diabetes Association in support.

  • Ashley Kinst

    Person

    Hi. I'm Ashley Kinst, and I'm here today in support.

  • Lynn Kinst

    Person

    I'm Lynn Kinst. I am, here representing the Bleeding Disorders Council of California and the California Rare Disease Access Coalition in strong support.

  • Cher Gonzalez

    Person

    Sherry Gonzales on behalf of my clients, the Association of Northern California Oncologists and the Medical Oncology Association of Southern California in support.

  • Sandra Poole

    Person

    Sandra Poole on behalf of Western Center on Law and Poverty in support.

  • Ryan Spencer

    Person

    Ryan Spencer on behalf of the Crohn's and Colitis Foundation in support.

  • Bill Roby

    Person

    Bill Roby on behalf of the National Bleeding Disorders Foundation in support.

  • Michelle Rivas

    Person

    Michelle Rivas on behalf of the California Pharmacists Association support, but of the current version of the bill we're reviewing the amendments. Thank you.

  • Kate Sanchez

    Legislator

    Thank you. We will move now to primary witnesses in opposition. Thank you. You'll each have two minutes.

  • Steffanie Watkins

    Person

    Thank you, madam Chair, member Stephanie Watkins on behalf of the Association of California Life and Health Insurance Companies. I'd like to thank the Chair for her thoughtful engagement on this issue as well as the author and the sponsor. We had many very productive conversations early on as well as well with CDI. Unfortunately, we are here today in opposition. While we certainly share the goal of making prescription drugs more affordable, we have serious concerns about codifying the existing federal role related to co pay accumulators.

  • Steffanie Watkins

    Person

    This would require health plans and insurers to count manufacture co pay coupons and other third party payments towards member's deductible and annual out of pocket maximum. Currently, pharmaceutical companies often offer coupons to privately insured patients to provide discounts on brand name drugs even when lower cost generic alternatives are available.

  • Steffanie Watkins

    Person

    While these coupons often lower eliminate the patient's co pays in the short term, In the long term, they could lead to uncertainty about a patient's out of pocket cost from month to month since pharmaceutical companies can chart can change the coupon programs and patient eligibility rules for those programs at any time. We're further concerned that these coupons enable drug manufacturers maintain high list prices and drive up the cost of for all patients through higher insurance premiums.

  • Steffanie Watkins

    Person

    Drug companies often keep their drug prices high by setting their own list price, and they're offering co pay coupons to help some patients afford those high prices.

  • Steffanie Watkins

    Person

    At this time, given the potential cost impact as noted in the CHIPRV analysis, we think it warrants a legislature slowing down the process in order to give us time to evaluate the overall impact. To that end, our position is underscored by the recent bipartisan effort to ask the GAO to assess whether manufacturer co pay coupons steer patients toward higher cost brand name drugs and away from lower cost generics. For those reasons, we remain opposed to the bill.

  • Steffanie Watkins

    Person

    We do certainly look forward to continuing conversations at the forefront. Affordability to all patients and consumers is a top priority to our members. Thank you.

  • John Muir

    Person

    Madam Chair, members, John Muir here on behalf of America's health insurance plans, National Trade Association for the health plans. Also currently opposed to SB 1199, but appreciate the, work on the committee amendments, and, we'll be taking that back to our members. But I think from a broad perspective, AHIP always believes that, co pay coupons, should not be used by manufacturers to manipulate the system and drive up drug prices. And so we believe the amendments move us closer to to achieving that policy position.

  • John Muir

    Person

    We would remain eager and willing to work with the author and the committee on continued amendments to ensure that patients are further protected from high drug prices.

  • John Muir

    Person

    So we are opposed today, but look forward to continuing those conversations on some of the other amendment ideas.

  • Kate Sanchez

    Legislator

    Thank you. Are there others in the hearing room who would like to register opposition? Please come forward.

  • Faith Borges

    Person

    Good evening. Faith Borges on behalf of California agents and health insurance professionals and the California Association of Joint Powers Authorities respectfully opposed for the premiums concerns outlined, but very much looking forward to reviewing the bill in print or as proposed to be amended.

  • Alison Ramey

    Person

    Allison Ramey on behalf of the Pharmaceutical Care Management Association. We also had an oppose and less amended position, but look forward to reviewing the amendments and appreciate the Chair, staff, and author. Thank you.

  • Cassidy Heckman

    Person

    Cassidy Heckman on behalf of the California Association of Health Plans and Opposition.

  • Kate Sanchez

    Legislator

    Thank you. I will now bring it back to committee for any comments or questions. Seeing none. Oh, sorry. Assemblymember Patel.

  • Darshana Patel

    Legislator

    Yes. Thank you for bringing this forward. I have a couple questions. I just wanted to check-in on whether the pharmacies when the patient goes to pick up their prescription and they come with their their coupon, does the pharmacy have to report this to the health plan to make sure that the patient gets credit for it?

  • Unidentified Speaker 010

    Not currently, but I believe that is one of the amendments being proposed.

  • Darshana Patel

    Legislator

    Okay. I'm just trying to make sure that if there's a situation in which the plan and the prescription provider is the same, that that's that message does still get delivered so that the patient is the beneficiary of that credit.

  • Unidentified Speaker 010

    Sorry. I don't quite understand your question. Sorry.

  • Darshana Patel

    Legislator

    Sorry. I as I'm trying to in it is my understanding that you've got some amendments you're working through currently.

  • Darshana Patel

    Legislator

    And that that my train of questions or concerns is more around making sure that the patient is the recipient of that that benefit.

  • Kate Sanchez

    Legislator

    Yeah.

  • Unidentified Speaker 002

    Yeah.

  • Darshana Patel

    Legislator

    And it counts towards the their co pay offset.

  • Unidentified Speaker 010

    Yeah. Yeah.

  • Kate Sanchez

    Legislator

    Okay.

  • Miguel Bastidas

    Person

    If I if I could add. Yeah.

  • Miguel Bastidas

    Person

    That that is the intent of the bill is for the patient to get the credit that is due to them. And we heard from the plans that there's sometimes not a communication between, the pharmacy and and the plan that that that's a get communicated, so there's an accounting issue there. So we are taking amendments to try to address that concern.

  • Darshana Patel

    Legislator

    Okay. Because, we wanna make sure that I guess, there are many other states that are able to do this. So we wanna make sure that California is aligned with the progress that other states are doing. Thank you.

  • Kate Sanchez

    Legislator

    I do think that, oh, some of the amendments that, the Senator has taken through this committee helped to address that concern and make sure that that happens. And I understand that there are still, concerns from the plans on this. I know that the Senator will continue to try to, address some of those as this that bill moves forward, should it get out of this committee at this point. I'm thankful that you've brought forward this bill.

  • Kate Sanchez

    Legislator

    I think you are have shown a package of bills this particular hearing, and certainly throughout your, this legislative cycle that focus on trying to ensure that the out of pocket expenses for individuals, needing care are lower than what they should be.

  • Kate Sanchez

    Legislator

    A lot of this is around prescription drug usage, and we know that one of the main cost drivers to our overall health care system is around prescription prescriptions and the and the distribution of those. So I wanna thank you for bringing forward this piece of legislation. Senator, would you like to close?

  • Akilah Weber Pierson

    Legislator

    Thank you so very much to you, Chair, and this committee. You know, this bill just merely builds on existing state public policy and codifies federal requirements into state law.

  • Akilah Weber Pierson

    Legislator

    As we sit around and we talk about affordability, these co pay accumulators are extremely important because many of these patients are those who have paid a significant amount of money, have conditions where their prescriptions cost a significant amount of money, and any assistance that they get should be able to go to their overall out of pocket expense to help them and their families alleviate the cost of increasing health care pressures. And with that, respectfully ask for an aye vote on SB 1199.

  • Kate Sanchez

    Legislator

    We need a motion by Patel and seconded by Addis. Secretary, please call the roll.

  • Committee Secretary

    The motion is do pass as amended to the Appropriations Committee. bonta.

  • Mia Bonta

    Legislator

    Aye.

  • Committee Secretary

    Vonta, aye. Sanchez, Addis. Aye. Addis, aye. Agaracari, Aarons, Colosa, Carrillo, Jeff Gonzales, Mark Gonzales, Johnson, Patel Patel Patel, aye, Patterson.

  • Committee Secretary

    Rodriguez, Schiavo, Sharp Collins, Stephanie, Stephanie, Aye.

  • Kate Sanchez

    Legislator

    That measure is on call to the senators who are waiting to have their bills heard. The, doctor Weber Pearson binge watch is over. Thank you so much, Senator, for your leadership, and we are going to move on now to any other pieces of legislation that want to be reviewed. We have SB 526 by Perez, SB 1016 by Blake Spear, SB 1244 by Alan, and SB 1271 by Reyes. We can vote on the consent calendar now while we are waiting. Motioned by Patel, seconded by Addis. Please call the roll.

  • Unidentified Speaker 013

    [Roll Call]

  • Kate Sanchez

    Legislator

    That measure is on call. The consent is at calendar is on call. We will now move on to item number three, SB 526 by Perez. We'll just hold. We'll hold for a minute.

  • Kate Sanchez

    Legislator

    Actually, we are actually gonna not do that measure right now. We'll move to item number eight, SB 1016 by Blakespear. Thank you, Senator, whenever you're ready.

  • Catherine Blakespear

    Legislator

    Okay. Good afternoon and early evening. Chair and committee members and staff. Nice to see you all. I'd like to begin by accepting the committee amendments and say thank you for working with me on this bill. SB 1016 bridges a gap in the care court system that leaves those with the most serious mental illness untreated.

  • Catherine Blakespear

    Legislator

    Care court was created to connect individuals with serious mental illness to treatment and housing plans, particularly individuals with untreated schizophrenia spectrum and other psychotic disorders. However, early implementation data has shown that the system is not reaching everyone.

  • Catherine Blakespear

    Legislator

    The Newsom administration originally estimated that between 7,000 and 12,000 people would qualify for care court. But after a year of full implementation throughout the state, as of January 2026, California courts had only received 3,800 care court petitions.

  • Catherine Blakespear

    Legislator

    Of those, judges approved only 893 treatment plans, meaning 77% of those petitions did not receive care through care court.

  • Catherine Blakespear

    Legislator

    That means under a thousand treatment plans statewide were authorized. When care court is not sufficient and the person is not in imminent danger, there is no clear or reliable pathway to escalate care. While existing law does allow for higher levels of intervention for those who are gravely disabled. In practice, that pathway is difficult to access through the 5150 process alone.

  • Catherine Blakespear

    Legislator

    An infrequently used option, section 5200 of the welfare and institutions code, allows courts to order a comprehensive mental health evaluation for individuals who are gravely disabled or a danger to themselves or others. This process requires counties to order a pre petition screening, which confirms probable cause for higher treatment and checks whether the individual would accept help voluntarily.

  • Catherine Blakespear

    Legislator

    Most counties in California currently do not have the processes in place to carry out the pre petition screening. As a result, individuals are frequently dismissed with no assistance and routed through 5150 holds where assessments are limited to short term crisis decisions rather than comprehensive evaluation and care planning.

  • Catherine Blakespear

    Legislator

    SB 1016 helps make sure that people are not simply dismissed from Care Court because they need more intensive mental health care. Following a dismissal, SB 1016 would require the county to tell the court whether the person likely needs a higher level of care than Care Court can provide.

  • Catherine Blakespear

    Legislator

    If they do, the county must explain what type of care would be more appropriate and how the person can be connected. If the court is preparing to dismiss the case because the individual is too severe for care, SB 1016 ensures the court orders the county to begin the section 5200 pre petition screening process before the case is fully closed. This will prevent individuals who may benefit from additional care from being dismissed with no connection to treatment.

  • Catherine Blakespear

    Legislator

    To be clear, a court can only order the pre petition process when there is probable cause to believe the person is gravely disabled. SB 1016 Strengthens Care Court by making it a part of a true continuum of care and not a dead end.

  • Catherine Blakespear

    Legislator

    With me today in support, I have Doctor Erin Meyer, a professor of psychiatry at the University of California San Diego, and Elizabeth Hopper, a mother, 14 year advocate with NAMI Sacramento, Chair of Family Advocates of Individuals with Serious Mental Illness and a Care Act petitioner.

  • Mia Bonta

    Legislator

    Thank you so much. You'll each have two minutes.

  • Aaron Meyer

    Person

    Afternoon, Chair Bonta, members of the committee. Aaron Meyer, Associate Clinical Professor of Psychiatry at the University of California, San Diego, speaking on behalf of California State Association of Psychiatrists, proud sponsor of Senate Bill 1016.

  • Aaron Meyer

    Person

    Care Court was designed to intervene before someone becomes gravely disabled. It already applies to individuals experiencing substantial deterioration or who need services to prevent deterioration likely to result in grave disability or serious harm.

  • Aaron Meyer

    Person

    This bill addresses a critical gap for individuals who are too ill to engage in care and may require a higher level of care.

  • Aaron Meyer

    Person

    When these individuals are too ill to engage, dismissal can delay the care they need. One parent told us, only after arrest, incarceration, and enormous expense that our son reached the residential treatment he had needed for years. Care court data shows that this is not an isolated problem.

  • Aaron Meyer

    Person

    In January 2026, LA County reported 72 petitions were dismissed because the individual required a higher level of care. In February 2026, San Diego County reported 77 petitions were dismissed because the individual was unable or unwilling to engage.

  • Aaron Meyer

    Person

    As a psychiatrist, I know that a brief crisis evaluation often cannot determine whether someone who is unable to engage in care requires a higher level of care. This bill authorizes a pre petition screening by the County Behavioral Health Agency and allows the court to keep the care case open while that assessment occurs. When care court identifies someone who is substantially deteriorating and unable to engage, dismissal should not end the conversation. It should be an opportunity to connect the person to the level of care they need.

  • Aaron Meyer

    Person

    I respectfully ask for your aye vote.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Elizabeth Hopper

    Person

    Thank you, Chair Bonta and committee members for this opportunity to tell my family experience in support of SB 1016. My name is Elizabeth Kaino Hopper, and I live in Carmichael. Both Sacramento County Correctional Health and our family filed care act petitions for my daughter in June 2025. Prior to these petitions, she was incarcerated over 18 months in a state hospital. While she said she wanted housing upon release, her illness made her too unable to accept any of the reentry services offered, including family offers.

  • Elizabeth Hopper

    Person

    She was released to the streets of Sacramento. She refused to engage voluntarily with the Care Act services. She presented well at the September hearing, but no services were put in place. And within weeks, she was in deep psychosis, deteriorating with no secure housing or food, and was physically abused. She did not fail care court.

  • Elizabeth Hopper

    Person

    Care court failed to recognize her needs. It has been a year of added suffering on the streets from streets to emergency departments to short psychiatric stays back to the streets. But now, she is receiving treatment and services. During this time of care, she needed an an appendectomy. She could not give informed consent.

  • Elizabeth Hopper

    Person

    She was too gravely disabled. Family was called, consented, she lived. If she had lived been on the street, she may not have arrived that event. You may have many of you may have seen her on the Capital State Grounds or at Starbucks at 10th And L during her street survival months. She was too gravely disabled to volunteer for treatments and services, but she could ask for handouts from family outreach workers and those passing by.

  • Elizabeth Hopper

    Person

    Civil rights organizations say she was exercising her civil rights by wandering the streets, but this is not honoring her civil rights. This is an unwillingness to prioritize her medical rights. I do still support Care Act as a voluntary program. We've invested too much.

  • Elizabeth Hopper

    Person

    We've met the respondent where they are, but we have not yet done what we have not yet done is face the fact that some care respondents are too gravely disabled to engage and they deserve a civil, not a criminal pathway to psychiatric medical care.

  • Elizabeth Hopper

    Person

    I ask for your support. Thank you.

  • Kate Sanchez

    Legislator

    Thank you. Any others in the hearing room who would like to offer support? please come forward.

  • Danny Offer

    Person

    Danny Offer with the National Alliance on Mental Illness, also known as NAMI California, in strong support of the bill. Thank you.

  • Angela Hill

    Person

    Angela Hill with the California Medical Association in support.

  • Ross Buckley

    Person

    Ross Buckley on behalf of the City of Sacramento. Also on behalf of my colleague Moira Topp on behalf of San Diego Mayor Todd Gloria, and on behalf of the City of Riverside.

  • Kendra Begley

    Person

    Hello. Kendra Begley on behalf of the City of Bakersfield in support.

  • Allison Monroe

    Person

    Allison Monroe, Alameda County Families Advocating for The Seriously Mentally Ill in support.

  • Mary Bernard

    Person

    Mary Ann Bernard, member of NAMI, member of Sacramento Family Advocates for Individuals with Severe Mental Illness, former lawyer to State Mental Hospitals, in strong support.

  • Ann Donnelly

    Person

    Ann Donnelly, my son was seriously mentally ill. He passed away. He was in a full service partnership, but he couldn't and didn't get the help he needed. I think

  • Mia Bonta

    Legislator

    Thank you.

  • Ann Donnelly

    Person

    I fully support this bill.

  • Mia Bonta

    Legislator

    Thank you.

  • Diana Burdick

    Person

    Diana Burdick, mother of a son who was dismissed on care court, and I support this bill.

  • Mia Bonta

    Legislator

    Thank you. Are there any primary witnesses in opposition to this measure? Please come forward.

  • Mia Bonta

    Legislator

    Thank you. Go ahead.

  • Mia Bonta

    Legislator

    You'll have two minutes.

  • Amer Rashid

    Person

    Thank you, Chair and members, for the opportunity to speak to you today. My name is Amer Rashid, Director of Legislative Affairs for the County Behavioral Health Directors Association of California, the leaders of the public behavioral health agencies that serve the mental health and substance use disorder needs of California's MediCal uninsured and underinsured populations.

  • Amer Rashid

    Person

    CBHDA would like to thank the Chair and staff for the proposed amendments and the analysis, which significantly reduce our concerns with the bill by ensuring the court's referral to an involuntary evaluation is permissive and tied to the existing law which retains the county's pre partition screening process, both of which is very helpful.

  • Amer Rashid

    Person

    However, CBHDA remains respectfully opposed to SB 1016 given that courts may have insufficient evidence to order an involuntary evaluation, which, under current law, would involve having the county coordinate with law enforcement to involuntarily detain and transport an individual solely for the purpose of an evaluation based on allegations made by a Care Act petitioner.

  • Amer Rashid

    Person

    Given how new the law is, courts are allowing very different levels of documentation to approve petitions county to county.

  • Amer Rashid

    Person

    In some cases, these petitions have scant documentation. And if SB 28 passes and is signed into law this year, it will significantly reduce the criteria for a petition, which in conjunction with the passage and signing of this bill would result in many more referrals to involuntary detention and evaluation.

  • Amer Rashid

    Person

    While we were, while we very much understand that there is a role for involuntary services, we also understand that when that power is used on individuals for whom it is not warranted, people can be unnecessarily traumatized, justice involved, and ultimately increase the reluctance of individuals to seek out our necessary services.

  • Amer Rashid

    Person

    Counties can already receive requests under WIC 5200, making this law unnecessary. And it is for these reasons that we respectfully remain in opposition and respectfully request your no vote.

  • Mia Bonta

    Legislator

    Thank you. Any others in the hearing room who would like to offer their opposition to this bill?

  • Sarah Weber

    Person

    Sarah Weber with the Drug Policy Alliance in respectful opposition.

  • Samuel Jain

    Person

    Samuel Jain on behalf of Disability Rights California. Really appreciate the committee and the author's work on this bill. We are opposed to the bill in print and are looking at the amendments.

  • Brendan McCarthy

    Person

    Thank you, Madam Chair. Brenda McCarthy with the California State Association of Counties. We're in opposition, but we'll be reviewing the amendments.

  • Mia Bonta

    Legislator

    Thank you.

  • Sarah Dukett

    Person

    Sarah Dukett, on behalf of the Rural County Representatives of California and the Urban Counties of California, oppose the bill in print looking at the amendments. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Bringing it back to committee for any comments or questions? Assembly member Addis.

  • Dawn Addis

    Legislator

    Thank you, Senator. I wanna, just excuse me. I just wanna say thank you to you for bringing this bill forward and to the witnesses for telling your stories. I know that, this is an issue I hear about quite a bit, and it's always from family members. And mostly, it's from moms who have come to our office just simply desperate for help.

  • Dawn Addis

    Legislator

    They've done everything they can to work through the system. They've tried to every turn we hear from siblings, we hear from aunts and uncles, but we mostly hear from moms who are just desperate to have their children helped.

  • Dawn Addis

    Legislator

    And while California has made some progress and care courts have certainly made some progress. There's for sure a gap in what's happening, and I think, many legislators have started to try to do work on this. We've seen a number of efforts on this.

  • Dawn Addis

    Legislator

    I think we're gonna continue to see more efforts because that's what we need. I know there was a different bill when you brought it to this committee, and I wanna appreciate the efforts that you made on the bill that you had before it got here. I think we're landing in an okay place, and certainly, I'm gonna be happy to move the bill.

  • Dawn Addis

    Legislator

    Gonna support the bill today, but wanna make sure that we continue because there are folks out there, and we held both a health subcommittee hearing as well as a panel and district on the issue of folks with hard to treat mental illness and the idea that some folks have a symptom called anosognosia where they just simply don't know that they're sick. They just don't know.

  • Dawn Addis

    Legislator

    And so to say to these folks, the only way you can get treatment is by choice when you simply do not know you're sick is really unfair way that we're treating people, and it's leaving a lot of families in very, very hard places. And it's really harming people in our community that we should be taking care of rather than allowing to go through this kind of trauma and difficulty. So appreciate it. Would love to come on as a coauthor if you're if you're open to coauthors.

  • Dawn Addis

    Legislator

    And thank you for taking your time, and thank you to all the witnesses who spoke today.

  • Mia Bonta

    Legislator

    I wanna thank you, Senator for working with me and committee to be able to help to resolve some of the one of the major concerns that I have with this bill, which is, and, all that kind of come through, which is making sure that we've established a care court program and system that actually ensures that it continues to be voluntary.

  • Mia Bonta

    Legislator

    And appreciate your, also waiting on the additional information that we will receive through the independent research, that will be coming shortly and through the annual report that we shall receive that will, perhaps create a broader number of individuals, for us to be able to understand next steps forward and do so in a balanced way.

  • Mia Bonta

    Legislator

    I just wanted to articulate that there are, that there are two additional amendments that were not included in the analysis for the sake of time because we settled on this over the weekend.

  • Mia Bonta

    Legislator

    That would permit the court to keep a care petition open while the county conducts its review to determine whether a mental health evaluation is necessary and add some more information about these pre petition reviews to the data reporting, which I think we're going to absolutely need in order to be able to keep and maintain this balanced approach.

  • Mia Bonta

    Legislator

    With that, Senator, would you like to close?

  • Catherine Blakespear

    Legislator

    Yes. Thank you. Well, I appreciate the deep engagement on this subject from you and the committee staff. It is very technical, these changes and and improvements to the system. But I think what it's important to keep in mind our North Star, which is that we want people to have confidence in the care court system and to have it work for them.

  • Catherine Blakespear

    Legislator

    And I really appreciate what Assembly member Addis said about hearing so much from family members and moms because that's also my experience is that there are so many families that are desperate for the state, the county, somebody to help them. And they're looking and using the the pathways that we have, and they are finding that they're they are dead ends.

  • Catherine Blakespear

    Legislator

    And so figuring out how we can have our processes work more together, protecting civil rights, of course, as being a core tenant but also making sure that we are helping people who need help. And so I think the state and the care court system and the counties could do a lot better, and people are currently falling through the cracks as my witness, was talking about her daughter who we very well could see right here in Sacramento.

  • Catherine Blakespear

    Legislator

    And we see people we all come to the Capitol every single week, and we see people who desperately need help.

  • Catherine Blakespear

    Legislator

    And so creating systems where the help can be accessed with appropriate safeguards is the goal, and this bill does help us move in that direction. So with that, I respectfully ask for your aye vote.

  • Mia Bonta

    Legislator

    Thank you. We have a motion. We need a second by Sanchez. With that, please call the roll?

  • Committee Secretary

    The motion as do passes amended to the Appropriations Committee.

  • Committee Secretary

    [roll call]

  • Mia Bonta

    Legislator

    That measure's on call. Thank you, Senator. We're gonna move on now to item number three, SB 526 by Perez.

  • Sasha Perez

    Legislator

    Great. Good afternoon, Chair and members. SB 526 authorizes community health centers with affiliate clinics to utilize the CDPH fast tracked licensing process when opening a new health center, relocating an existing one, or changing management. Licensing a new affiliate community health center is a complicated and time consuming process even for health centers with good history.

  • Sasha Perez

    Legislator

    To address this problem, legislation passed in 2010 requiring CDPH to develop a clinic affiliate expedited licensure process to consolidate paperwork and ensure a seamless transition of operations to more quickly process these applications and limit disruption to health care access.

  • Sasha Perez

    Legislator

    This expedited licensing process has been critical to expanding health care capacity and access. Although this expedited process exists, a discrepancy in the law prohibits community health centers licensed before 2010 when this expedited process was established from utilizing it even if they have served the community for longer than the sixteen years the process was established. This issue is highlighted in my district by its effect on Planned Parenthood Pasadena and San Gabriel Valley, which has provided vital health care service for more than ninety years.

  • Sasha Perez

    Legislator

    PPSG to plans to open a new flagship health center in headquarters to replace the oldest health center in Pasadena with an improved facility and central administrative office hub. Establishing a new PPSG flagship health center will address growing service demands while also accounting for continued impacts from the Eaton fire that left the administrative office uninhabitable and forced over a 100 employees to use temporary workspaces.

  • Sasha Perez

    Legislator

    Although all planned parenthoods meet every requirement to establish a new flagship health center through the Fast Track affiliate change of location pathway, it cannot pursue this licensing process because the original health center was established before the creation of the Fast Track process. SB 526 cuts administrative red tape and ensures that health clinics throughout the state can begin serving more patients faster.

  • Sasha Perez

    Legislator

    To testify in support of the bill and help answer technical questions, I'm joined by Angela Pontes from Planned Parenthood Affiliates of California, and at the appropriate time, I ask for your aye vote.

  • Mia Bonta

    Legislator

    Thanks so much. You'll have two minutes.

  • Angela Pontes

    Person

    Thank you, Chair and members. Angela Pontes on behalf of Planned Parenthood Affiliates of California as a cosponsor of SB 526 along with the California Primary Care Association. As outlined by Senator Perez, thiS Bill addresses an issue that our Planned Parenthood affiliate is experiencing in Pasadena. However, if passed, SB 526 will support all seven Planned Parenthood affiliates that operate over 100 health centers.

  • Angela Pontes

    Person

    Although the state streamlined the licensing process for affiliate health centers like ours in 2010, the state's interpretation of the law only applies prospectively.

  • Angela Pontes

    Person

    Planned Parenthood has been in California for nearly a century. As you can imagine, many health centers have operated in their communities for decades. SB 526 does not create anything new. It simply grandfathers older affiliate health centers into the existing process. Quickly approving license changes for affiliate clinics saves money, expands access to care, and reduces administrative burdens. We ask for your aye vote.

  • Mia Bonta

    Legislator

    Thank you. Are there others in the hearing room that would like to offer position of support?

  • Craig Schuller

    Person

    Hi, Chair and members. Craig Schuller on behalf of California Primary Care Association, proud cosponsors of the bill. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Are there any primary witnesses in opposition? Seeing none, are there any in the hearing room who would like to register opposition? Seeing none, I'll bring it back to committee. We have a motion by Addis and a second by Patel.

  • Mia Bonta

    Legislator

    Seeing no other comments from committee, I as well do not have any. I wanna thank you, Senator, for bringing forward this measure and to always making sure that we have an opportunity to provide additional care, particularly for those seeking reproductive care in this moment when we know that our system is incredibly attenuated because of the federal requirements and mandates that are being passed down from Washington DC. With that, would you like to close?

  • Sasha Perez

    Legislator

    Oh, respectfully ask for your aye vote. Thank you.

  • Mia Bonta

    Legislator

    Thank you. We have a motion and a second. Please call the roll.

  • Committee Secretary

    The motion is do passed to appropriations committee. Bonta.

  • Committee Secretary

    Bonta, aye. Sanchez? Sanchez, no. Addis. Aye.

  • Mia Bonta

    Legislator

    Aye.

  • Committee Secretary

    Addis, Aye. Agaracuri, Aarons, Colosa, Carrillo, Jeff Gonzales, Mark Gonzales, Johnson, Patel. Patel, Aye, Patterson. Rodriguez. Rodriguez, Rodriguez, Aye, Schiavo, Sharp Collins, Stephanie.

  • Mia Bonta

    Legislator

    That measure's on call. Thank you. We are waiting on senators Allen and Reyes in the committee hearing room. Majority leader, we're gonna do add ons once you hit your seat. We will start with the consent calendar for add ons.

  • Committee Secretary

    On consent, Sanchez. Sanchez, Aye, Agaracari. Agaracari, Aye, Aarons. Aye. Aarons, Aye.

  • Committee Secretary

    Colosa, Carrillo, Jeff Gonzales, Jeff Gonzales, Aye. Mark Gonzales, Johnson. Rodriguez Rodriguez, Aye. On consent, Shivo, Shivo, Aye. Sharp Collins.

  • Mia Bonta

    Legislator

    That is now out. We'll start at the top of the agenda moving to item number one, SB 331. We're lifting the call on Menjivar bill.

  • Committee Secretary

    [Roll Call]

  • Mia Bonta

    Legislator

    That bill is now out, and we have done all of the business that we could possibly do and items.

  • Mia Bonta

    Legislator

    Alright. We're gonna move on to item number 13, SB 1271 by Reyes regarding midwifery workforce data availability to be a clinical preceptorship. I will say Senator Allen, SB 1244 will be heard as the last bill of the committee, and we are all in love with Senator Reyes' bill. Senator, please begin whenever you're ready.

  • Eloise Gómez Reyes

    Legislator

    I thought I had turned it on. This bill strengthens California's midwifery pipeline training by requiring the medical board to collect data on the capacity of licensed midwives to serve as preceptors and train incoming students. We're finding that many of our midwife, to be's are going out of state to get their training. And we need to get the midwives that we have now who are willing, able, and capable to begin the as preceptors to train our our incoming midwives.

  • Eloise Gómez Reyes

    Legislator

    Midwives, as we all know, are perinatal health professionals who provide community based support services, including maternity, newborn, and postpartum care to ensure a positive birth experience.

  • Eloise Gómez Reyes

    Legislator

    While California has taken steps to improve visibility in this workforce, critical gaps persist in maintaining the training infrastructure that sustains and grows the profession. To become licensed midwives, they must undergo a period of supervised clinical training known as a preceptorship. Midwife preceptors are experienced maternity providers who train, mentor, and supervise students bringing bridging their academic learning with hands on experience. This lack of availability of preceptors is severe and limited methods.

  • Eloise Gómez Reyes

    Legislator

    We have limited methods to find them, and it's left our students to to navigate a broken system on their own.

  • Eloise Gómez Reyes

    Legislator

    And as I said, most of them have to go out of state. SB 1271 addresses this desegregate desegregated pathway by leveraging the state's current data collection to include questions about eligibility, availability, capacity, practice setting, and the barriers to precepting that qualified midwives are facing. I remain committed to working closely with the medical board and HCAI to create a survey that is reflective of our intentions to understand and support the workforce.

  • Eloise Gómez Reyes

    Legislator

    Here to testify in support are Simona Spiegel, who is a PhD candidate at Notre Dame and a student midwife, and Gabrielle Brown, the program manager of Black Maternal Infant Health at Black Women for Wellness Los Angeles, also here with the Solis Policy Institute.

  • Mia Bonta

    Legislator

    Thanks so much. You'll each have two minutes.

  • Gabrielle Brown

    Person

    Good afternoon, Chair and committee members. My name is Gabrielle Brown, and I'm the maternal and infant health program manager at Black Women for Wellness based in South Los Angeles. I am here today in strong support of SB 1271. California has made meaningful investments to address maternal and infant health disparities, including expanding opportunities for families to receive care from licensed midwives. Yet, we remain at a critical moment.

  • Gabrielle Brown

    Person

    Maternity ward closures, particularly in underserved communities, are reducing access to timely perinatal care, while black women and birthing people continue to experience disproportionately high rates of pregnancy related complications and maternal mortality. Improving birth outcomes requires more than expanding coverage. It requires ensuring families have access to high quality, culturally responsive maternity care. Licensed midwives are a critical part of that solution.

  • Gabrielle Brown

    Person

    Research continues to demonstrate that midwifery care is associated with positive birth outcomes, including lower rates of unnecessary interventions, higher patient satisfaction, and improved maternal and infant health.

  • Gabrielle Brown

    Person

    But we cannot we cannot expand access to this model of care if we fail to invest in the workforce that delivers it. Today, student midwives across California are struggling to complete their required clinical training because there are simply not enough qualified preceptors. Without preceptors, students cannot graduate. Without graduates, we cannot grow the midwifery workforce needed to meet the increasing demand for care, particularly in communities experiencing maternity care shortages. SB 1271 provides a practical data driven solution.

  • Gabrielle Brown

    Person

    It does not change scope of practice or clinical standards. Instead, it gives a state the information needed to understand where preceptor shortages exist, identify barriers to clinical training, and develop strategies to strengthen California's midwifery workforce. If we are serious about improving maternal and infant health outcomes, reducing inequities, and ensuring every family has access to safe, high quality maternity care, we must strengthen the pipeline of providers who make those outcomes possible.

  • Mia Bonta

    Legislator

    Thank you. Thank you.

  • Simona Spiegel

    Person

    Good afternoon, madam Chair and members. My name is Simona Spiegel, and I am here today in support of SB 1271. I'm a PhD candidate in medical anthropology at the University of Notre Dame where I research midwifery training and the movement for birth justice in California. I'm also a student midwife and a Medi Cal Doula serving families in the Bay Area. For the past five years, I've worked alongside midwives as a researcher and now as a student midwife.

  • Simona Spiegel

    Person

    I've interviewed and spoken with dozens of students and practicing midwives across California about their experiences in midwifery training. One issue has come up again and again, finding clinical placements and preceptors. I've experienced this challenge myself and traveled four hours round trip from Berkeley to apprentice with a midwife in Santa Cruz for a year. Even in the Bay Area, where there is one of the highest concentrations of licensed midwives in the state, finding a preceptor is difficult.

  • Simona Spiegel

    Person

    I've spoken with students who have delayed their education, traveled long distances, or completed their clinical training out of state because they couldn't find placements in California.

  • Simona Spiegel

    Person

    Those experiences point to a larger problem. Right now, the state doesn't have key data on how many preceptors there are or how to support potential preceptors in taking on students. SB 1271 would give California a clearer picture on how many preceptors there are and how to support them and what it would take to support them in training the next generation of midwives. We can't strengthen California's midwifery workforce without understanding the training pipeline. Let's keep California a leading voice in birth care.

  • Simona Spiegel

    Person

    I respectfully ask for your aye vote on SB 1271. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Are there any in the hearing room who would like to register support for the bill? Please come forward.

  • Yulie Smith

    Person

    Yulie Smith, licensed midwife and proud preceptor representing around birth collective, a cosponsor of this bill. Thank you.

  • Kasha B Hunt

    Person

    Tasha Hunt with political solutions here on behalf of March of Dimes in support. Thank you.

  • Karen Stout

    Person

    Good evening, Chair and members. Karen Stout here on behalf of the California Nurse Midwives Association in support. Thank you. Good almost evening, Chair and members. Carol Gonzales with Latina Advocates on behalf of Hispanas organized for political inequality.

  • Karen Stout

    Person

    Proud to support. Thank you.

  • Mia Bonta

    Legislator

    Thank you. Are there any in the hearing room who would like to have a primary opposition to this bill? Any in the hearing room who would like to register opposition? Seeing none, I will bring it back to the committee. We already have a motion and a second.

  • Mia Bonta

    Legislator

    Senator, I wanna thank you for bringing forward a very thoughtful measure as somebody who used midwives to be able to deliver my beautiful three babies. I'm very thankful for you. With that, can you please call the roll? Oh, would you like to close, Senator?

  • Eloise Gómez Reyes

    Legislator

    I will use what your comments is my close. Thank you.

  • Mia Bonta

    Legislator

    Thank you, Senator. Please call the roll.

  • Committee Secretary

    The motion is do passed to appropriations. Bonta

  • Mia Bonta

    Legislator

    Aye.

  • Committee Secretary

    Bonta, Aye. Sanchez. Sanchez, Aye. Addis. Aye.

  • Committee Secretary

    Addis, Aye. Agaracari. Agaracari, Aye. Arons. Colosa.

  • Committee Secretary

    Colosa, Aye, Carrillo. Carrillo, Aye, Jeff Gonzales. Jeff Gonzales, Aye, Mark Gonzales, Mark Gonzales, Aye, Johnson Patel. Aye. Patel, Aye, Patterson Rodriguez.

  • Committee Secretary

    Rodriguez, Aye, Schiavo, Shiavo, Aye, Sharp Collins, Sharp Collins, Aye, Stephanie.

  • Mia Bonta

    Legislator

    That measure is out. Thank you, Senator. Moving on to item number 12, SB 1244 by Allen regarding public agency benefits intermediary compensation disclosure act. Moved by Gonzales, seconded by Addis. Senator.

  • Benjamin Allen

    Legislator

    Yeah. Thank you so much, madam Chair. Crazy day. We're all racing around. Appreciate your patience.

  • Benjamin Allen

    Legislator

    So this bill requires health insurance brokers and agents and advisors and related professionals to advise local public agencies on employee health care to disclose the compensation that they receive for selling those benefits and plans before entering or renewing a services contract with that agency. So we've got federal law, the Consolidated Appropriations Act of 2021, which requires brokers and related professionals to disclose their compensation to private employers, with plans that are covered under ERISA upon request.

  • Benjamin Allen

    Legislator

    This requirement does not extend to public agencies because public sector plans are, of course, exempt from ERISA. Now existing California law requires health plans and insurers to annually disclose broker compensation to public agency governing boards, but this disclosure has some significant gaps. It only captures when what the health plan or the insurer pays directly to the broker, missing compensation from third party sources, including supplemental insurance and point solution vendors, pharmacy benefit managers, other entities.

  • Benjamin Allen

    Legislator

    So this bill seeks to close gaps in existing law by doing three key things. It seeks to ensure that public agencies benefit from disclosures already available to private employers, requires brokers and agents and related professionals to proactively disclose their compensation to public agencies so that it helps guide decisions before and not after they are made. And it also seeks to capture more forms of compensation than both state law and federal law currently cover. You know, I'm a former school board member.

  • Benjamin Allen

    Legislator

    Many of you have come from local government.

  • Benjamin Allen

    Legislator

    Local public agencies spend billions of of taxpayer dollars annually on employee health benefits. They rely on insurance brokers and agents and related professionals to recommend insurance carriers and negotiate rates and select vendors. But but, you know, it came to my attention how much some of these professionals are are often receiving in compensation from insurers and third parties that public agencies never see.

  • Benjamin Allen

    Legislator

    We've seen some examples of commissions up to, you know, 50% of the premium of some supplemental products, which is built into the premiums that the employers and the employees see pay. Base commissions can then be between three to 6% of the total premium for an entire health insurance plan.

  • Benjamin Allen

    Legislator

    Now there's also gifts, you know, folks that may be treated to trips, other experiences, or some examples of folks brought to the Super Bowl or a luxury resort that, you know, as a result of selling a plan to a public agency that the employer is completely unaware of.

  • Benjamin Allen

    Legislator

    So the fear, of course, is that aside from inflating health care costs that, of course, you know, are passed on to make it harder for public agencies to do their work, these hidden compensation arrangements can sometimes create some really misaligned incentives steering the agencies toward more expensive vendors. And unlike private employers, public agencies are charged with with overseeing taxpayer dollars and ensuring that they're spent appropriately.

  • Benjamin Allen

    Legislator

    But we all know and I say this having with so much respect to all the wonderful financial officials at school districts and elsewhere, but there's I've been so overwhelmed just and understaffed handling the basics of running a budget for a school district that they, you know, they they hope and trust that the agents and brokers that they're working with on insurance side are are acting in their best interest. But this is gonna help to ensure that they they truly do with some more disclosure.

  • Benjamin Allen

    Legislator

    And with that, I am I'm pleased to have Daryl Hemingway here on behalf of the California Teachers Association, and also Chris Reif. We also have Matt Bittner here with the Volition Group who's available to answer technical questions.

  • Mia Bonta

    Legislator

    Thanks. You'll each have two minutes.

  • Unidentified Speaker 016
    ID Pending

    Good afternoon, madam Chair and members of the committee. My name is Daryl Hemenway, and I work for the California Teachers Association as a bargaining specialist. And I'm also a proud constituent of the Chair. I care deeply about educational employees getting the best health and welfare benefits possible for the best cost. And I care deeply about our school districts being good stewards of the public funds they spend on those benefits.

  • Unidentified Speaker 016
    ID Pending

    Our school districts and other public agencies face a health insurance system in which they have fewer protections than the private sector, namely in the area of broker compensation disclosure. Brokers, consultants, and other agents are able to receive undisclosed compensation that results in an unconscionable markup to already expensive premiums. Industry standard, we may receive and we are not a fiduciary are stock phrases they include in their contracts with school districts.

  • Unidentified Speaker 016
    ID Pending

    Retention bonuses and indirect payments from vendors are terms they do not include, But those dollars still get priced into premiums and create significant conflicts of interest. In my opinion, this is stealing from the public.

  • Unidentified Speaker 016
    ID Pending

    And because brokers don't have to disclose, we can't know exactly how much they are skimming out of every premium dollar our educators pay. We know that in the two large joint labor management health trust for k 14 districts, CVT, California's Value Trust, and VEBA, San Diego Schools VEBA, about 98 to 98.5¢of every dollar, premium dollar goes to care. For direct with broker programs, industry patterns suggest that number is closer to 88 to 95¢.

  • Unidentified Speaker 016
    ID Pending

    For a family plan costing $24,000 per year, that is 1,200 to $2,400 per year per employee. For a district with a thousand employees, that's 1,200,000 to 2,400,000 a year.

  • Unidentified Speaker 016
    ID Pending

    This could be the difference between a healthy reserve and a financial crisis. SB 1244 would not put brokers out of business. It would simply require them to disclose what they're paid. That's what lets our unions and our districts work together to get the best benefits of the best cost and to be better stewards of public's money. I respectfully urge your aye vote.

  • Mia Bonta

    Legislator

    Wonderful testimony. No bias at all.

  • Unidentified Speaker 045
    ID Pending

    Good afternoon or evening, madam Chair. Chris Riefe on behalf of California School Boards Association. Late is the hour, so I will be brief. Speaking on behalf of on the issue of trust, as many of you know, nearly 60% of our school districts are small school districts. Many of our school districts are run by what are called superintendent principals.

  • Unidentified Speaker 025
    ID Pending

    They're the ones who engage directly with some of these brokers. Trust is critical in that con that construct because they trust our superintendent principles, trust the brokers to be able to provide them a a coverage that is affordable and be able to meet the needs of their staff. And without that, they can actually turn into a scenario where there actually is greater costs for districts.

  • Unidentified Speaker 025
    ID Pending

    And so from a transparency perspective and speaking for the the vast majority of our school districts who rely on them to be able to provide them quality health care in that regard. We are strongly in strong support of SB 1244.

  • Unidentified Speaker 025
    ID Pending

    Thank you.

  • Mia Bonta

    Legislator

    Thank you. Are there others in the hearing room who would like to register support for this measure?

  • Unidentified Speaker 049
    ID Pending

    Katie Van Dynes with Health Access California in support. Thank you.

  • Unidentified Speaker 043
    ID Pending

    Good evening. Beth Monowski with SEO California in support.

  • Karen Stout

    Person

    Sarah Decade, on behalf of the Rural County representatives of California, the California State Association of Counties, and the Urban Counties of California in support.

  • Mia Bonta

    Legislator

    Thank you. Are there any in the hearing room that would, like to offer primary opposition? Please come forward. Thank you. We'll each have two minutes.

  • Unidentified Speaker 054
    ID Pending

    Thank you. Good afternoon, Chair and members. Thank you for the opportunity to speak today. My name is Faith Borges, and I'm here on behalf of California agents and health insurance professionals in respectful opposition to Senate bill 1244 unless it's amended. First, I want to acknowledge and appreciate Senator Allen's commitment to transparency.

  • Unidentified Speaker 047
    ID Pending

    Consumers absolutely deserve to understand and know how their health care dollars are being spent, and our members support clear and meaningful disclosures. But transparency needs to be accurate, actionable, and aligned with where the costs are actually generated. Health insurance premiums are rising due to the underlying health care costs, hospital pricing, pharmaceutical spending, and utilization trends. No strangers to this committee. Independent agents and brokers do not set premiums.

  • Unidentified Speaker 027
    ID Pending

    We do not control claims, costs and do not negotiate provider pricing. They serve as advocates for their clients, including public agencies and their employees, helping them navigate complex options, control costs where possible, and resolve utilization issues when they arise. Senate bill 1244 as drafted places the burden of significantly expanded disclosure on agents and brokers even though much of the required data is held by carriers and vendors. This creates a system where those without control over the data are held responsible for reporting it.

  • Unidentified Speaker 027
    ID Pending

    That misalignment does not improve transparency.

  • Unidentified Speaker 027
    ID Pending

    It risks confusion, incomplete information, and reduces access to experienced advisers, especially for smaller public agencies. If the goal is to reduce cost for purchasers, policy should remain focused on the drivers of health care spending. Yay for all your work there. While ensuring transparency requirements are placed on the entities that generate and control data, we believe there is a path forward, one that advances transparency, protects consumers, and maintains access to knowledgeable community based professionals.

  • Unidentified Speaker 027
    ID Pending

    We respectfully ask for amendments to address compliance challenges by conforming the language with ERISA, which would align industry reporting, reduce duplicative reporting, and ease administrative burdens.

  • Unidentified Speaker 054
    ID Pending

    Thank you for your time and consideration.

  • Mia Bonta

    Legislator

    Thank you. You'll have two minutes.

  • Unidentified Speaker 035
    ID Pending

    Thank you. Good evening. I'm Sherry McHugh representing the National Association of Insurance and Financial Advisors. Insurance agents play a critical role in California's employee benefit marketplace, particularly for the public sector worker as it pertains specifically to commissions paid to agents. When people hear that an agent might receive up to 50% commission on a supplemental product, it can sound alarming, but we need to put it in context.

  • Unidentified Speaker 035
    ID Pending

    Supplemental products such as accident, critical illness, and hospital indemnity carry much lower premiums than major medical plans. So while the commission percentage may sound higher and be higher, the actual dollar amount paid is often quite modest. The commission supports services like one on one enrollment assistance, year round service, claims help, and administrative support for the employer. Agents help agent agents help public agencies evaluate options, navigate complex markets, and navigate for employees when issues arise. These products are also voluntary for the employee.

  • Unidentified Speaker 035
    ID Pending

    No one is required to enroll. An agent's job is to help employees figure out whether coverage fits their needs and budget, and that effort and work takes time and and experience. Lastly, public agencies are not locked in with their agent. If their agent is not delivering value, controlling costs, improving benefits, and providing strong service, it can be replaced. The relationship between the public entity and their agent is fundamentally performance based.

  • Unidentified Speaker 035
    ID Pending

    As an industry, we would support we do support transparency and parity, and we would remove our opposition if the bill was amended to conform with federal ERISA standards. Thank you very much.

  • Mia Bonta

    Legislator

    Thank you. Any others in the hearing room who would like to register opposition? Seeing none, I will bring it back to committee for any comments or questions. Assembly member Patel.

  • Darshana Patel

    Legislator

    Assembly member Patel. Thank you, Senator Allen, for bringing this bill forward. A little bit of transparency in this process is great and would like to add Allen as a co author. Thank you.

  • Mia Bonta

    Legislator

    No other comments on this side? Senator, I wanna thank you for bringing forward this measure. I did just wanna have you address the issues raised around, basically adopting the ERISA structure to be able to move forward the spelling why you've chosen not to do that.

  • Benjamin Allen

    Legislator

    Yeah. So, I mean, in terms of just just extending the the every set of the public entities. Yeah. So so so so one of the one of the main was one of the things is that one of the differences is that this would it's not just upon request. Right?

  • Benjamin Allen

    Legislator

    It it will require that the disclosures are automatically provided. You know, again, this comes, I think, from all of our experiences working within the maddening bureaucracies of of school districts and local governments that are oftentimes unaware to even make this request.

  • Benjamin Allen

    Legislator

    The bill so so, you know, from my perspective, it's just that it provides some it gives public agencies with some some additional information that, you know, that again, you know, private that that that Arissa would would provide for for folks to to to to to pass on to their to the people they're working with upon request. In this case, we just ask them to do it without the request in in advance. You know, from my perspective, that's more transparency.

  • Benjamin Allen

    Legislator

    But, you know, if people have an issue with that, I'm I'm certainly happy to to discuss it further. The bill includes a couple more forms of compensation that would be disclosed. You know, I I will say that some of that is basically an update on the way the market has evolved over time since the passage of ERISA. We saw since the passage of that federal law, some more forms of compensation that have been identified.

  • Benjamin Allen

    Legislator

    And I I I just think that it's important for public agencies to have a really full picture when they're when they're considering a contract for services.

  • Benjamin Allen

    Legislator

    So, you know, again, if it's important to the committee that we, you know, strictly adhere to what's what's delineating in Arisa, I you know, happy to have the conversation. I guess what I would say is that there are a number the the Arisa was written a little while ago. There are some new things that I think that if they were to rewrite Arisa, they would include.

  • Benjamin Allen

    Legislator

    And and I I that I think is appropriate to to be included because people being compensated in different ways than they were when ERISA was first written.

  • Unidentified Speaker 054
    ID Pending

    But If I may,

  • Unidentified Speaker 029
    ID Pending

    actually, the Consolidated

  • Unidentified Speaker 054
    ID Pending

    Appropriations Act of 2021 does require brokers to proactively disclose compensation before contract. So that has been changed and updated. And when it comes to That's good.

  • Darshana Patel

    Legislator

    Yay. You're alright.

  • Unidentified Speaker 054
    ID Pending

    Common ground. When you're right. Health care is very much evolving. You know, PBMs, I think, were off most of our radar a couple of years ago, but the Consolidated Appropriations Act, again, amended this year, just in 2026, did account for that and did add new forms of compensation that need to be disclosed as models are changing. So those requirements are, very much addressed in in federal compliance, and so we're asking for, the ability to comply.

  • Unidentified Speaker 027
    ID Pending

    If you look at our letter, it is pages and pages of red that are additions that this bill is adding that is in excess of ERISA, which we do frankly wanna caution about, though this bill doesn't contain, some language around fiduciary requirements. There is an active litigation model where the employer as the fiduciary is ultimately held responsible for actively monitoring broker disclosures, and compensation for every element of their plan.

  • Unidentified Speaker 027
    ID Pending

    So when you have all of these layers of reporting that as was addressed, some HR representatives may be overworked and underpaid and not fully understand, they will be litigated to that standard, though, of addressing it. And is some of that probably shifting policy in the right direction for we want employers to understand the components of their health care and what they're paying for and what they're asking employees to pay for.

  • Unidentified Speaker 027
    ID Pending

    But doing so needs to be in a way that it is going to be clearly identified information that is actionable and accurate because, ultimately, if California's introduction of these requirements into what's currently been a federal framework is to be implemented, we've seen this model and wanna make sure that the information is correct.

  • Unidentified Speaker 054
    ID Pending

    So there are federal requirements that vendors disclose to agents what they're paying. And then, of course, an agent can turn around and say, exactly. Here it is. This is exactly what we're paid. We provide that in a way that's clear.

  • Unidentified Speaker 054
    ID Pending

    There's forms to do so. But it's not a small thing to say you're adding these additional criteria because there isn't then an understanding that the employer will be responsible for what's being reported to them, and the language does say that they need to understand what's being reported.

  • Benjamin Allen

    Legislator

    Well well

  • Mia Bonta

    Legislator

    Perhaps, Senator, in your closing, you could respond to that. Yeah. Sure.

  • Benjamin Allen

    Legislator

    Could could I ask them? My my we just had one

  • Benjamin Allen

    Legislator

    One short response relating to litigation.

  • Eloise Gómez Reyes

    Legislator

    Sure.

  • Unidentified Speaker 016
    ID Pending

    One of one of the specific

  • Mia Bonta

    Legislator

    Please press your button.

  • Unidentified Speaker 016
    ID Pending

    I'm sorry. One of the specific requirements in the bill exempts public employers from litigation and from that liability.

  • Unidentified Speaker 016
    ID Pending

    very specific thing put in there to protect against that.

  • Benjamin Allen

    Legislator

    It's a

  • Mia Bonta

    Legislator

    K. Thank you.

  • Benjamin Allen

    Legislator

    Okay.

  • Mia Bonta

    Legislator

    We have a motion and a second on your bill.

  • Benjamin Allen

    Legislator

    Fantastic. Okay. Well, I I really appreciate the the good discussion. We we did we got this letter last week, and we're reviewing it. We're very open to further discussions.

  • Benjamin Allen

    Legislator

    I I certainly don't wanna be overly broad, but I I I do wanna, you know, re I do wanna iterate that I don't think that the strict adherence to ERISA as was written is is appropriate here, especially given the fact that they're also it was also written for private sector entities, and there are some unique circumstances associated with public entity, JPA, etcetera, that might that that that needs to be written in. That being said, I'd love to continue working with you and with the committee.

  • Benjamin Allen

    Legislator

    I I would also say that we in the bill, we only require brokers and and professionals to disclose compensation that they receive. And I think it's it's it's you know, at the end of the day, they have to know about it for them to be, you know, responsible for the reporting under this bill. So we're certainly not asking them to look behind the the cover, you know, at at the at the, you know, with with the with the with the company.

  • Benjamin Allen

    Legislator

    They just have to report what they what they know about in terms of compensation that they've received and gifts and that kind of thing. But with that all being said, look forward to working more with the opposition, working with the committee to get this to a good place in a respect for Ashford and I vote.

  • Mia Bonta

    Legislator

    Thank you, Senator. We have a motion and a second. Please call the roll.

  • Unidentified Speaker 013
    ID Pending

    The motion is do passed to appropriations committee. Bonta. Aye. Bonta, aye. Sanchez.

  • Unidentified Speaker 013
    ID Pending

    Aye. Addis, aye. Agaracuri. Agaracari, Aye. Arons?

  • Unidentified Speaker 013
    ID Pending

    Aye. Arons, Aye. Colosa? Aye. Colosa, Aye.

  • Unidentified Speaker 013
    ID Pending

    Carrillo? Aye. Carrillo, Aye. Jeff Gonzales? Mark Gonzales?

  • Unidentified Speaker 013
    ID Pending

    Mark Gonzales, Aye. Patel? Patel, Aye. Patterson? Rodriguez, Rodriguez, Aye, Schiavo, Schiavo, Aye, Sharp Collins, Sharp Collins, Aye, Stephanie.

  • Benjamin Allen

    Legislator

    Thank you, members. Thank you very much.

  • Mia Bonta

    Legislator

    That measures out. Thank you. Thank you. Bye. Alright.

  • Mia Bonta

    Legislator

    For the members who need to add on we only have add ons left. Right? Okay. Alright. We are gonna start with the consent calendar for add ons.

  • Unidentified Speaker 013

    [Roll Call]

  • Mia Bonta

    Legislator

    The consent calendar is still out. We'll start at the top. Any committee members who wish to register a vote should get into the committee hearing room right now. We are only going to do this once. Item number one, SB 331 by Menjivar for add ons.

  • Unidentified Speaker 013

    [Roll Call]

  • Mia Bonta

    Legislator

    And, with that, we are adjourning our hearing.

Currently Discussing

No Bills Identified

Speakers